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Abstract 
The molecular recognition layer generally immobilised on the active interface of a 
biosensor is one of the key factors in governing the biosensor’s performance, and in 
particular its sensitivity and selectivity. The aim of this thesis was to investigate a 
novel non-immunoglobulin-based recognition molecule as the capture molecule for 
electrochemical biosensors with the aim to improve sensitivity and specificity of 
label-free biosensing. 
To understand the characteristics of the biomolecular layer of a biosensor formed 
from the non-immunoglobulin-based recognition molecule, the Adhiron scaffold 
developed at the University of Leeds was used as the model system.  The Adhiron 
scaffold consists of one !-helix, four "-sheets, and three variable regions. The three 
variable regions comprise two surface-exposed loops and the N-terminus of the 
protein. Adhiron-based binders against a well-characterised antibody, the anti-myc 
tag antibody, were selected using phage-display and used as a model system for this 
study.  The phage-display library was constructed by inserting randomised peptides 
into the three variable regions of the Adhiron scaffold. The best performing binder, 
selected from the ten Adhiron myc binders panned from a phage display screen 
against polyclonal anti-myc tag antibodies, myc binder 2, was chosen as the 
biological recognition molecules for the development of an electrochemical 
impedimetric biosensor. 
Cloning of the Adhiron binders in pET-11(a) expression vector, optimisation of 
expression and purification of the binders, was carried out and the binders were 
obtained in soluble form.  Adhiron myc binder 2, which showed the best binding 
against monoclonal anti-myc tag antibodies, showed a high thermal stability of 
85º C, with well-defined !-helical and "-sheet structures. This binder was 
thoroughly characterised further before being used as a recognition molecule of an 
electrochemical biosensor. 
An electrochemical Adhiron-based myc binder 2 sensor was fabricated to detect 
monoclonal anti-myc tag antibodies over a range of concentrations. The Adhiron 
myc binder 2 based EIS biosensor comprised a highly sensitive insulating layer 
formed by a self-assembled monolayer of carboxylic acid terminated alkylthiol-PEG 
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onto which Adhiron myc binder 2 was grafted. The sensing mechanism was based 
on the change in phase of the electrochemical impedance measured at 0.1 Hz 
observed upon binding of monoclonal anti-myc tag antibodies onto the sensor. 
Monoclonal anti-myc tag antibodies were detected down to a concentration of less 
than 100 pM, over a range from 0.1–200 nM anti-myc tag antibodies. These findings 
demonstrated for the first time the successful use of Adhiron-based antibody-
mimetics as recognition molecules in label-free biosensors. 
To improve the sensitivity of the Adhiron-based electrochemical biosensor, and 
potentially to modulate the sensitivity in situ, the performance of the sensor at 
different electrochemical DC-biases was investigated. The sensitivity of the sensor 
was observed to increase with increasing DC bias applied to the sensor surface. This 
sensitivity modulation was demonstrated to be reversible, therefore opening up a 
range of opportunities for future label-free biosensor architectures. 
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Chapter 1. Introduction 
 
Enormous resources are dedicated to the treatment of some of today’s most prevalent 
diseases because of their high mortality and morbidity rate and associated high 
healthcare costs. These include diabetes, cardiovascular disease and cancer. Each year 
cardiovascular disease (CVD) causes over 4 million deaths in Europe of which 1.9 
million are in the European Union (EU) (Nichols et al., 2012). In the European Union, 
the estimated expense related to cardiovascular diseases has been around  !196 billion 
annually. Furthermore, there were an estimated 3.45 million new cases of cancer 
(excluding non-melanoma skin cancer) and 1.75 million deaths from cancer in Europe 
in 2012 (Ferlay et al., 2013). According to a study done by the international diabetes 
federation, 35 million adults were reported to be suffering from diabetes (both type 1 
and type 2) in 2011 in Europe, and this number is predicted to increase by 23%, to 43 
million, by 2030 (Whiting et al., 2011). In Europe the overall estimated cost for the 
treatment and management of diabetes is estimated to be !89 billion annually (Freitag, 
2012). 
The high mortality rate and scale of expenditure related to a particular disease could 
be reduced significantly by early and reliable diagnosis of the disease, through 
enabling, early intervention. Delays in diagnosis and thus delays in treatment can 
increase the health complications associated with the disease as well as increase the 
healthcare costs. The prerequisites to address the challenge of early diagnostics 
require the detection of even very small changes in the body, that are indicative of a 
particular disease or the onset thereof. Arguably, a very promising route is the 
measurement of biomarkers in body fluids.  
 
1.1.  Biomarkers 
In general a biomarker is a physiological or pathological measurable object, which is 
related to a particular disease, and any change, increase or decrease, in concentration 
can be indicative of a particular disease. For example, micro RNAs form a class of 
small non-coding RNAs that control gene expression in cells. Their abnormal 
expression can initiate human diseases like cancer. Increased expression of a 
microRNA called miR-21 has been reported in case of breast cancer cell lines that can 
be used to predict breast cancer (Iorio et al., 2005). However, genes govern the 
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production of proteins, and genetic mutations cause modifications in the protein 
signaling pathway that can lead to differential expression of a protein in a cell i.e. 
over-expressed or modified as a consequence of the disease. The level of gene 
expression (m-RNA transcripts) and the protein expression cannot be reliably 
correlated therefore it becomes more feasible to detect the differentially expressed 
proteins, which can be used as biomarkers to indicate a diseased state (see section 
2.1). For example, the differentially expressed protein high sensitivity CRP (hs-CRP) 
has emerged as a major cardiovascular biomarker (Calabrò et al., 2009).  
Currently, the early detection of diseases using different biomarkers is carried out 
using various diagnostic techniques. Most of the diagnostic techniques use labelled 
biological recognition molecules or analytes and are based on Enzyme-Linked 
Immunosorbent Assay (ELISA). ELISA is a solid phase immunoassay technique used 
in clinical laboratories to detect biomarkers in the blood or other body fluids of a 
patient using a biological recognition molecule. Antibodies are used as the biological 
recognition molecules in ELISA that bind specifically to the biomarkers in the sample 
of body fluids. In order to detect the biomarkers, either a primary antibody (that 
recognises a specific biomarker), conjugated to an enzyme is used for direct detection 
or a secondary antibody conjugated to an enzyme is used that binds to the primary 
antibody. The binding is detected using an enzyme catalysed light emiting reaction 
(chemiluminescsence). Various strategies of antibody immobilisation and signal 
amplification are used for detection of antibodies and antigens (see section 3.2.1.4).  
Although these techniques can measure a wide range of analytes like hormones, 
antibodies, enzymes etc and can be performed in centralised laboratories, they are not 
well suited for fast and convenient in vitro diagnostics. Transportation of sample to 
the laboratory, pre-treatment, measurement and then return of the data to the patient is 
time consuming and expensive. Moreover the highly automated, high throughput 
machines required in the centralised laboratories lead to stupendous expenditure, in 
particular in terms of maintenance, as well as technical assistance. One of the aims of 
biosensor development is to move clinical analysis from centralised laboratories to the  
doctor’s clinic or even to a patient’s home to make detection tools easier to handle, 
cheaper and convenient to use.  
To enable early detection of disease through the detection of small deviations of 
protein biomarker concentrations from the normal levels expected for a healthy 
person, an analytical device that offers a fast, reliable response with high sensitivity 
and is cost efficient and simple to use, is required in the field of clinical diagnostics. 
17 
 
 
1.2. Biosensors 
Clinical diagnostics is one of  the most progressive as well as demanding field where 
new technologies that offer better specificity and sensitivity, are sought constantly. 
The analytical devices employed to detect the presence of biomarkers for clinical 
diagnostics are generally referred to as biosensors. Biosensors are trying to move 
clinical analysis from centralised laboratories to the doctor’s clinic or the patient’s 
home to make detection tools easier to handle, cheaper and convenient to use. A 
recent definition of a biosensor by Newman et al. (2004) defines a biosensor as ‘a 
compact analytical device incorporating a biological or biologically-derived sensing 
element either integrated within or intimately associated with a physicochemical 
transducer’.  
 
 
Figure 1-1 Schematic representation of the constituents of a biosensor. 
The molecular recognition layer binds the analyte molecules (extreme left) and the 
signal transducer converts the binding event into an electrical signal. 
 
The biological component of a biosensor is the recognition molecule that binds the 
target molecule. In electronic biosensors, the binding of the target molecule to the 
biological component leads to a change of the environment of the sensor which is then 
converted into an electrical signal by a transducer.  
 
1.2.1. Transducers 
The main types of transducers used commercially and in research laboratories are 
optical, mechanical and electrochemical.  
Optical biosensors are based on the change in absorbance (Hulko et al., 2011) or 
luminescence (Holst and Grunwald, 2001) in the environment of the biosensor that 
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takes place in UV / infrared or visible spectral regions of light. Optical biosensing is 
most commonly done using an enzyme-based assay (ELISA) where fluorescence-
tagged antibodies are used to detect the binding of a biological recognition molecule 
to the analyte.  
Mechanical biosensors are based on the detection of change in the mechanical 
properties of a surface due to binding of analyte molecules to the recognition layer 
e.g. measuring change in stress on a cantilever surface that is immobilised with 
biological recognition molecules (Datar et al., 2009) or change in the acoustic 
properties of the surface e.g. measuring shift in resonance frequency of the sensing 
surface on binding of the analyte molecules (Chaste et al., 2012). 
Electrochemical biosensors are based on measuring the electrical properties of a 
surface onto which a biological recognition layer is immobilised. The interaction of 
the analyte with the biological recognition molecules is detected by the change in 
current (amperometric response) (Cass et al., 1984), voltage (potentiometric response) 
(Yamamoto et al., 1980) or impedance (impedimetric response) (Zhang et al., 2013). 
 
1.2.2. Biological recognition molecules 
The majority of the effort devoted to the development of biosensors has been focussed 
on improving the signal transduction feature of the biosensors to make them more 
efficient for clinical diagnostics. Most of the aspects required for the development of 
an efficient biosensor from the point of care prospective are expected to be 
addressable via engineering of the electronics, but the performance of the biosensor is 
also dependent on the biological component. Moreover to understand the behaviour of 
a biosensor it is important to understand the characteristics and behaviour of the 
molecular component of the biosensor.  
This thesis aims at improving the performance of biosensors through the engineering 
of biological recognition layer for an electrochemical biosensor. The interaction of the 
analyte with the biological recognition molecule determines the sensitivity, specificity 
and ultimately the limit of detection of the biosensor. These characteristics have 
significant consequences when clinical samples are used where the biological analytes 
are sometimes present only in pg/mL concentration or less. The engineering of 
biorecognition layer can be useful to modify important structural or conformational 
features that  have a major impact on the working of a biosensor affecting its 
sensitivity, selectivity and non-specfic binding. Furthermore, the stability of the 
biological recognition layer plays a vital role in the shelf life of a biosensor. As the 
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biological layer is also susceptible to degradation, the use of a biosensor in different 
environmental conditions is determined by the conditions suitable for the storage of 
the biological component. Various classes of recognition molecules have been 
explored to constitute the molecular component of biosensors.  
In the course of development of biosensors, enzymes had been the initial tools used as 
biological recognition elements. Glucose biosensors are probably the most studied and 
commercially most important biosensors for monitoring glucose levels in diabetic 
patients. They exploit the catalytic activity as well as the specificity of the enzyme 
glucose oxidase as biological recognition element.  
Another class of recognition molecules is formed by antibodies. Antibodies or 
immunoglobulins are protein molecules produced by the immune system (body’s self 
defence mechanism) when the immune cells encounter a foreign molecule or antigen. 
It is a complex Y-shaped multi domain complex consisting of two identical 
polypeptides - heavy chain and two identical polypeptides - light chains, which are 
held together by glycosylation and disulphide linkages. Antibodies interact with 
specific sites on an antigen molecule termed the antibody epitopes (see section 3.1.6). 
The specificity and selectivity of antibodies has been widely exploited for forming the 
biological recognition molecules for the detection of various biomarkers. 
Although they are currently the most widely used biological recognition molecules in 
state-of-the-art biosensors, the complex structure of antibodies is a limitation in their 
application on different biosensing platforms giving rise to problems like irreversible 
denaturation, poor shelf-life (Colas, 2008). Furthermore, post-translational 
modifications are required to maintain the structural domains of antibody 
(glycosylation and disulphide bonding), which makes the expression of antibodies 
difficult in bacterial hosts. 
In order to overcome the limitations associated with antibodies alternatives to 
antibodies have been explored. Smaller yet functional forms of antibodies called 
antibody fragments have been used such as scFv (single-chain Fv fragments). 
Although they can be expressed in bacterial cells, their stability in the reducing 
bacterial environment is reduced as the disulphide bonds are not formed (Wörn and 
Plückthun, 2001). 
The constraints encountered in case of antibody based biological recognition 
molecules have led to non-antibody-based and even non-protein-based recognition 
molecules. A class of molecules based on nucleic acid, DNA and RNA, called nucleic 
acid aptamers have been used for the recognition of biological molecules. These 
recognition molecules are single stranded DNA or RNA molecules that bind to target 
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molecules like amino acids, peptides and proteins (Jayasena, 1999). The selection of 
the aptamers is done using a technique called Systematic Evolution of Ligands by 
Exponential enrichment (SELEX), wherein the nucleic acid aptamers against different 
targets are selected from a random pool of oligonucleotides (Tuerk and Gold, 1990). 
A drawback of RNA aptamers is that they are prone to nuclease degradation unlike 
DNA aptamers that are more resistant to nuclease degradation. Moreover the synthesis 
of chemically modified RNA oligonucleotides that are nuclease resistant is an 
expensive process. 
A different class of non-antibody based recognition molecules that can mimic 
antibodies for binding different targets called peptide aptamers have been developed. 
Peptide aptamers are based on well-defined protein scaffolds that present peptides 
designed to allow an interaction with a biological target molecule. They do not require 
disulphide bonds or glycosylation for their stability and therefore can be expressed in 
bacterial cells.  
Some of the scaffolds exploited so far are affibodies (Nord et al., 1997), Kunitz 
domains (Dennis and Lazarus, 1994b), anticalins (Skerra, 2008), DARPins (Stumpp et 
al., 2008), scaffolds based on Thioredoxin A (Lu et al., 1995; Colas et al., 1996), !-
lactamase based scaffold (Legendre et al., 2002), fibronectins (Koide et al., 1998) and 
stefin A triple mutant (Woodman et al., 2005).  
The small size, robustness and flexibility to structural modifications in order to bind a 
desired target molecule makes these engineered protein scaffolds promising in the 
field of biosensing (Colas, 2008; Song et al., 2011).  
A novel scaffold called Adhiron based on consensus protein design was developed by 
the McPherson group at the Astbury Centre for the structural molecular biology at the 
University of Leeds. Adhirons are discussed briefly in the following section. 
 
1.2.2.1.  Adhiron scaffold 
The Adhiron scaffold was engineered on the basis of a consensus sequence of plant-
derived phytocystatins (Tiede et al., 2014). Consensus design strategy helps to 
engineer proteins based on multiple sequence alignment, and thus the designed 
proteins are structurally more robust than their counterparts (Main et al., 2003). This 
makes the scaffold suitable to present various peptides against different targets. 
Adhiron is structurally compact with four-strand anti-parallel "-sheet core and a 
central helical structure. Two variable regions and an N-terminus site of the scaffold 
form the peptide insertion sites. 
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Adhiron based binders presenting different peptide sequences were selected against 
anti-myc tag antibodies through phage display library. The binding of anti-myc tag 
antibodies against c myc epitope (EQKLISEEDL) has been well studied (Evan et al., 
1985) and myc tag was therefore chosen as a proof of concept system to study 
adhirons as recognition molecules in biosensors.  
. 
1.3. Summary of the project 
To develop a biological recognition layer based on the best Adhiron myc binder 
against monoclonal anti myc tag antibodies, ten Adhiron myc binders were chosen 
from the binders obtained from the phage display by the BSTG group group 
(Bioscreening Technology Group, Biomedical and Health Research Centre, 
University of Leeds).  
The ten binders were cloned into an expression vector, expressed, purified and 
characterised. The best binder was chosen to form the biomolecular layer of a 
transducer surface.  
Amongst the various transducers discussed above it was important to choose an 
electronic transducer that has properties suitable for point-of-care diagnostics. From 
the point of care diagnostics a biosensor should not require any pre-treatment of 
sample, give a fast response and should be amenable to miniaturisation. 
Electrochemical impedance spectroscopy, an electrochemical based label-free 
detection of analytes seems to have potential to build a point-of-care biosensor. EIS is 
an electrochemical technique used to measure impedance of a surface by measuring 
the response against the applied AC signal. Impedance biosensors can be miniaturised 
using microfabricated arrays that can detect multiple analytes at the same time, or a 
single analyte on different electrodes. Such promising characterstics of EIS based 
biosensing platform can be used for the point-of-care application. 
After choosing the best Adhiron myc binder to form the biological recognition layer, 
EIS was used to create a biosensor for the detection of monoclonal anti-myc tag 
antibodies. The impedimetric biosensor employing a well-characterised biological 
recognition layer of Adhiron binders against monoclonal anti-myc tag antibodies was 
developed and used as proof-of-principle for the working of a biosensing system.  
This thesis discusses the various strategies developed in order to overcome a range of 
limitations faced during the development of the system. The results of the myc 
biosensor were then taken forward to investigate the interesting phenomenon of 
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modulating the sensitivity of an Adhiron based biosensor by applying different 
electrochemical DC biases. This approach shows great potential to tune dynamically 
the sensitivity and dynamic range of a label-free sensing system. This thesis discusses 
the development of impedimetric biosensor, its limitations and how they can be 
overcome.  
 
1.4. Organisation of the thesis 
 
1.4.1. Chapter 2 
Chapter 2 contains a literature review that gives an account of the foundation of 
biosensors and their application in the field of diagnostics. It discusses the 
development of different biological recognition molecules against various biomarkers 
along with their integration with different sensing platforms with the advent of 
growing technology. It discusses the different types of biosensors by segregating a 
biosensor into the biological recognition molecule and the transducer. It describes the 
use of integrating an antibody mimetic probe with an impedimetric transducer as a 
promising tool to create a label-free, multiplexed, miniaturised biosensor. 
 
1.4.2. Chapter 3 
Describes the background of various techniques and introduces the terminologies used 
in this work that are important to understand the context of the following chapters. 
 
1.4.3. Chapter 4 
This chapter describes the cloning, expression and purification of the adhiron based 
anti myc antibody binders. It also describes the characterisation of the binders using 
circular dichroism (CD), differential scanning calorimetry (DSC) and enzyme linked 
immunosorbent assay (ELISA). Furthermore, it illustrates the three-dimensional 
structure, thermal stability of the adhiron scaffold, as well as the effect of inserting 
different peptides into the variable regions. 
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1.4.4. Chapter 5 
Chapter 5 describes the development of a myc-biosensor as a proof-of-concept for 
using Adhiron binders in label-free electronic biosensor. The chapter details the 
design, surface chemistry and electrochemical detection of the monoclonal anti-myc 
antibodies. The chapter explains the various issues experienced during the 
development of the biosensor, as well as the strategies adopted to overcome these 
impediments. The various important observations and conclusions drawn in this 
chapter have been implemented in demonstrating a concept based on change in 
sensitivity using DC voltage bias in the following chapter. 
 
1.4.5. Chapter 6 
During the fabrication of the EIS based biosensor, it was found that the application of 
different electrochemical DC biases can be exploited to modulate the sensitivity of the 
biosensor.  This is discussed in detail in this chapter. 
 
1.4.6. Chapter 7 
This chapter summarises the findings of the thesis and discusses their impact on the 
research field of biosensors. It also discusses the potential future directions of this 
work. 
 
 
24 
 
 
Chapter 2.  Literature review 
   
Disease diagnosis has been an indispensable step in clinical healthcare to identify 
diseases and thus intervene for the improvement of the individual. Early detection can 
help to reduce the overall healthcare costs of taking care of the patient in the later 
stages of the ailment.  
The early medical diagnosis was primarily based on observations of clinical 
symptoms that would describe dysfunctions in the digestive tract, blood circulation, 
liver and spleen. The practice of examining the body fluids for the detection of a 
disease also became significant after Hippocratic doctrine of humoral pathology that 
recognised disorders in the body fluids as the cause of all diseases (Berger, 1999).  
During 17th century the invention of the microscope opened new ways to investigate 
disease causing organisms. Later new advanced diagnostic tools such as high-
magnification microscope, X-ray, chemical and bacteriological detections started 
invading the field of clinical diagnosis.  
The organisms responsible for tuberculosis, cholera, typhoid, and diphtheria were 
isolated in the 1880s. A number of laboratory tests were introduced to detect these 
diseases e.g. the Wasserman test for syphilis was introduced in 1906 after spirochete 
was identified as the organism responsible for the disease (Wassermann and Bruck, 
1906). These advancements reduced the dependence of clinicians on the observation-
based opinions, and the detection of diseases was based on the level of biomarkers in 
the patient’s samples. 
 
2.1. Biomarkers 
Biomarkers are defined as “cellular, biochemical or molecular alterations that are 
measurable in biological media such as human tissues, cells, or fluids” (Hulka and 
Wilcosky, 1988). It is a vital tool for detection, diagnosis and treatment of a disease. 
In 1949 Pauling and his colleagues discovered that sickle cell anaemia was caused due 
to a single amino acid change at the !-globin chain and coined the term molecular 
disease (Pauling et al., 1949). Later the molecular basis of various other genetic 
diseases like !-thalassemia (Orkin et al., 1983) and phenylketonurea (Chakraborty et 
al., 1987) was also studied. 
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In the year 2001 with the advent of Human Genome Project, the complete sequencing 
of human DNA (3 billion base pairs) was unravelled (Venter et al., 2001). With this 
major breakthrough in the field of molecular diagnostics, along with the high 
throughput molecular techniques, many genetic mutations were linked to a genetic 
disease. These mutations were characteristic of a particular pathogenic infection or the 
outcome of a genetic disorder, and thus biomarkers for the corresponding diseases.  
As the molecular alterations were occurring much earlier than the first sign of 
physiological or clinical symptoms were noticeable, the nucleic acid (RNA / DNA) 
based technology became important part of diagnosis. 
Although genome sequencing has helped to discover diagnostically relevant 
biomarkers, the genetic information gives only a glimpse of what may occur. The 
information provided by the sequencing of the genome needs to be associated with the 
genetic products. The genetic information is transcribed into messenger RNA 
(mRNA) molecules, which are then translated into polypeptide chains. These 
polypeptide chains undergo post-translational modifications to form mature protein 
products (Figure 2-1). 
 
 
Figure 2-1 The flow of genetic information. 
Shows the flow of genetic information from genome to proteome through the 
transcription of DNA into mRNA (messenger RNA) or vice versa (reverse 
transcription) and translation of m-RNA into a polypeptide chain of aminoacids. The 
mature protein is formed after the post-translational modifications.  
 
The overall cellular function of a cell can be interrogated in principle by the direct 
measurement of the level of protein expression. There is a poor correlation between 
the mRNA transcripts and the protein level in the cell and therefore the biochemical 
state of the cell cannot be directly related to mRNA levels (Gygi et al., 1999; 
Anderson and Seilhamer, 1997; Greenbaum et al., 2003). This requires the direct 
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analysis of proteins and identifying protein biomarkers and the difference in their 
level of expression in a diseased and a healthy cell. Protein based biomarkers also 
enhance the understanding of biochemical changes that occur during the progression 
of the disease and thus can help in the efficient treatment.  
With the advent of proteomics that refers to the study of structure and function of 
proteins, high throughput techniques have been used to analyse large number of 
proteins in parallel. 2D PAGE (two dimensional polyacrylamide gel electrophoresis) 
has been used to identify tumour associated antigens (TAA) as potential biomarkers in 
hepatocellular carcinoma (Yau et al., 2013). In 2D PAGE, protein samples are 
resolved on the basis of their isoelectric points as well as molecular weights and 
visualised using different staining techniques. 
Various protein biomarkers associated with clinical dysfunctions have been 
discovered like interleukin-6 (IL-6) and tumor necrosis factor-" (TNF-") against 
autoimmune disorders (Castro and Gourley, 2010). The detection of these biomarkers 
in the patient’s body fluid can reduce the mortality rate,  as well as guide the 
physicians through the treatment of these diseases. These protein biomarkers are 
present in the readily available body fluids like serum, urine or saliva.  
Although the convergence of proteomics and genomics has resulted in the discovery 
of a wide range of biomarkers against various types of diseases, the detection of these 
biomarkers in the biological fluids demands the development of analytical devices. 
These analytical devices are referred to as biosensors. 
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2.2. Biosensors 
 
A biosensor consists of a biological recognition layer immobilised on to a transducer 
surface. The binding of analyte molecules or biomarkers to the recognition layer 
causes changes in the vicinity of the sensor surface , which is converted into an 
electrical signal by the transducer (see Figure1-1 section 1.2).  
The following section discusses the various types of biosensors based on the different 
types of biological recognition molecules and transducers. 
 
2.2.1.  Biological recognition molecules 
The biological recognition molecules form a critical part of the biosensing devices in 
sensing the analyte molecules. 
Historically, important enzyme-based assays that rely upon the use of enzymes for 
sensing still remain commercially important e.g. glucose biosensors based on Gox 
(Glucose oxidase) has been the most widely used glucose sensor for monitoring 
glucose level by diabetic patients (MediSense Inc).  
On the other hand, non-enzyme based recognition molecules called bio-affinity based 
recognition molecules rely upon binding interaction of biological recognition 
molecules to the specific analytes. The use of affinity-based biosensing has increased 
dramatically. The most widely used technique in biosensing called ELISA is based on 
the affinity of antibodies to various analytes (see section 3.2.1.4). The antibody based 
sensors or immunosensors have been designed for monitoring various vital 
biomarkers, such as human chorionic gonadotropin (hCG) which is an important 
diagnostic marker in pregnancy test and is detected by anti-hCG antibodies (Canfield 
et al., 1987).  
Although antibodies are the most widely used biorecognition molecules because of 
their specificity towards the target molecules, their complex structure having four 
polypeptide chains, disulphide bonds and involvement of glycosylation (post-
translational modification) make it difficult to produce antibodies in bacterial hosts. 
With advances in technology, artificial recognition elements or biomimics such as 
nucleic acid aptamers, peptides, protein aptamers and molecularly imprinted polymers 
(MIPs) have been developed in the laboratories to allow improved stability and 
reproducibility in biosensing. 
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Biological recognition molecules are classified as non-protein based and protein based 
recognition molecules. The following section describes the two categories of 
biological recognition molecules. 
 
2.2.1.1. Non-protein based capture molecules 
Molecularly Imprinted Polymers (MIP) 
“The molecular imprinting technique can be defined as the formation of specific nano-
sized cavities by means of template-directed synthesis” (Zhang et al., 2006). 
One of the greatest advantages of the artificial receptors over the naturally occurring 
ones is the freedom of molecular design. There are two methods of fabricating 
molecularly imprinted polymers (Wulff, 2002). One is based on non-covalent 
interaction such as hydrogen bonds, electrostatic interactions, hydrophobic 
interactions and van der Waals forces. The appropriate monomers bearing the desired 
functionality are introduced into the polymers by copolymerization in presence of the 
crosslinkers through intermolecular interactions. The other is covalent molecular 
imprinting in which the monomer mixture contains functional monomers that 
conjugate with the template through covalent bonds. In both cases, after the removal 
of the template an imprint containing the binding sites corresponding to the target 
molecules are obtained (Arshady and Mosbach, 1981).  
There are potential advantages of imprinted polymers such as the robustness of the 
polymer and the flexibility to incorporate desired functional monomers in the 
polymer.  
Molecular imprinting has been used effectively to create capture molecules for small 
molecules such as drugs, pesticides and explosive markers (Vasapollo et al., 2011). 
Although imprinting of proteins has been reported (Venton and Gudipati, 1995; Chou 
et al., 2005) but it is much constrained by the dynamic nature of protein molecules. 
Because of the three dimensional structure of proteins, the functional groups 
responsible for the binding to the analyte, are located at different positions on the 
polypeptide chain (Wulff, 2002). This makes it difficult to use a protein as a template 
for molecular imprinting.  
Another problem related to molecular imprinting of proteins has been the solubility 
issue. Most of the molecular imprinting takes place in presence of non-polar solvents. 
This can lead to destabilization and denaturation of the proteins.  In order to lower the 
effect of organic solvents a hydrophilic crosslinker N,N#-methylene bisacrylamide 
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(MBAA) was used to prepare protein imprinted hydrogels (Kimhi and Bianco-Peled, 
2007).  
 
Nucleic acid Aptamers 
Nucleic acid aptamers are single stranded DNA or RNA molecules that can bind to 
other biomolecules. They are selected from a random pool of oligonucleotides by a 
process called Systematic Evolution of Ligands by Exponential enrichment (SELEX) 
(Tuerk and Gold, 1990; Ellington and Szostak, 1990). SELEX method is conceptually 
based on the ability of the selected oligonucleotides to bind to various target 
molecules. The process involves a number of randomised oligonucleotides that have a 
complexity based on the number of oligonucleotide positions present in the linear 
oligomers. The oligonucleotide library pool is incubated with the target of interest. 
The bound sequences are separated from the rest of the pool using different elution 
methods. The eluted oligonucleotides are further amplified by polymerase chain 
reaction (PCR) so as to obtain an enriched library of oligonucleotides that specifically 
bind the target. PCR is a widely used to amplify the desired segment of DNA using an 
enzyme called DNA polymerase (Bartlett and Stirling, 2003).  
In the aptamer selection technology, the binding affinity and specificity of an aptamer 
can further be improved by doing a round of second selection using a biased library. 
The biased library comprises of variants of the primary aptamer that were not present 
in the first round of SELEX. Therefore as an in vitro process the selection of 
improved aptamers against their targets becomes more feasible unlike in case of 
in vivo methods for producing antibodies.  
The ability of single stranded nucleic acids to fold into complex structures is a source 
of functional diversity that can be used to bind many biologically relevant markers 
(Patel et al., 1997; Harada and Frankel, 1995). 
With the advent of SELEX various aptamers have been developed against important 
clinical targets where these aptamers act as inhibitors. An antagonist aptamer of von 
Willebrand Factor (vWF) was developed as a novel antithrombotic agent for use in 
patients with acute coronary syndromes (Gilbert et al., 2007). Two synthetic aptamers 
were identified that bind to prostrate cancer cells via the prostrate specific membrane 
antigen (PSMA) (Lupold et al., 2002). Aptamers that bind E-selectin, expressed in 
endothelial cell surface of vessels during inflammation, have also been developed 
(Mann et al., 2010). RNA aptamers targeted against various cell surface markers have 
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been used to deliver siRNA (small interfering RNA) as a therapeutic agent through 
RNA interference (Chu et al., 2006).  
The biosensors based on nucleic acid aptamers are designed using different strategies. 
For example, the conformational change of aptamers upon binding has been used in 
the detection of platelet-derived growth factor (PDGF). DNA aptamer modified with 
methylene blue at one end is tethered to the gold electrode from the other end. It 
remains in an unfolded state when PDGF is absent that keeps methylene blue far from 
the electrode surface. On binding to the target, PDGF, the aptamer undergoes 
conformational change and the distance between the electrode and methylene blue 
decreases. This increases the electron transfer with an increase in current (Lai et al., 
2006).  
The easy synthesis and desired functionalisation of the nucleic acid aptamers 
elaborates the use of different immobilisation chemistries in biosensors. Despite many 
advances very few aptamers have been identified that bind specific protein post-
translational modifications. This is because the aptamers are selected through in vitro 
screening against recombinant proteins, which either lack the post-translational 
modification or misfold in the in vitro conditions. Thus the selected aptamer can lack 
the recognition for a post translationally modified target protein in the biological 
sample (Mann et al., 2010). 
 
2.2.1.2. Protein Based Recognition Molecules  
Enzymes 
Enzymes are proteins that catalyse specific chemical reactions without being 
consumed in the process. The three-dimensional structure of an enzyme formed by the 
folding of the polypeptide chain consists of a binding site that interacts with the 
substrate to form an enzyme substrate complex. The specificity of the enzymes 
towards their substrate is the major characteristic exploited widely in the enzyme-
based biosensors. The enzymatic reactions are accompanied by the production or 
consumption of various species such as gases (CO2, NH3, O2) that can be detected 
optically or electrochemically (Moreno-Bondi et al., 1990).  
The first generation enzyme based sensors such as those developed by Clarke, were 
based on immobilisation of the enzyme on an ion selective electrode and the 
production or consumption of specific ions was monitored (Clark and Lyons, 1962). 
The major drawback in these enzyme-based sensors was that during the analysis of 
real samples, detection of products was interfered by ions or dissolved gases in the 
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biological samples. This led to the incorporation of an artificial mediator and the 
commercial launch of the first biosensor by research groups in Oxford and Cranfield 
(Cass et al., 1984). It was based on electron mediated transfer mechanism using 
glucose oxidase enzyme and ferrocene. Ferrocene (Fc) was used as an electron 
transfer mediator, as it acts as a good electron acceptor. Glucose was converted by 
glucose oxidase into gluconolactone, which led to glucose oxidase (GOXox) to be 
reduced into GOXred. Ferrocene accepts electrons from GOXred to get reduced and 
thus diffuses to the electrode where it is reoxidised.  
Due to the role of cholesterol in the cardiovascular diseases there has been a focus on 
the determination of cholesterol level in the blood. For the clinical analysis of 
cholesterol, its oxidase has been used most frequently. During the interaction of 
cholesterol oxidase with its substrate, the consumption of oxygen is detected by using 
a dye whose fluorescence is quenched by molecular oxygen (Trettnak and Wolfbeis, 
1990). Enzyme based biosensors have been reported for the detection of uric acid for 
the diagnosis of inflammatory arthritis or hyperurecemia (Cete et al., 2006)). 
The major disadvantages with the enzyme-based sensors are related to their 
operational stability and shelf life and attempts have been made to improve their 
properties (Chaniotakis, 2004).  
Another important limitation of enzyme-based biosensors is that the enzymes can be 
used as biological recognition molecules only for a limited number of biomarkers. To 
circumvent this problem, another class of enzymes known as allosteric enzymes have 
been employed as the recognition molecules in biosensing as they exhibit regulatory 
catalytic activity. An allosteric enzyme has a receptor site where modulation occurs 
and an active site where the substrate binds. The receptor site binds to non-substrate 
molecules that influence the activity of the active site. This influence can be either 
enhancing or impairing the enzyme activity. Modulation of the allosteric sites by 
displaying the sensing elements at these sites enables the detection of new targets by 
the enzyme. E. coli alkaline phosphatase has been modulated by inserting an epitope 
from HIV-1 gp120 protein near the active site of the enzyme to detect anti-gp120 
monoclonal antibody (Brennan et al., 1994). 
 
Molecular receptors 
Molecular receptors are membrane proteins that bind specific molecules and undergo 
a conformational change triggering a cellular response. The signal transduction in the 
cells is an example of how nature detects the presence of something for the 
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biochemical changes taking place in the cells. These receptors are generally 
membrane receptors that trigger responses on binding to hormones, aminoacids, 
insulin, and neurotransmitters and also to various non-biological species like drugs. 
The specificity, speed and sensitivity that helps the cells to carry out signal 
transduction in such a complex environments have inspired the development of 
biosensors  based on such principles. It has led to creating sensors based on 
structure-switching molecules or receptors, which can be converted into a detectable 
signal (Plaxco and Soh, 2011). 
Biosensor based on apo-riboflavin binding protein was used to detect 
riboflavin / vitamin B2. It was based on the principle of displacement of riboflavin 
analogue from the riboflavin receptor molecules (Yao and Rechnitz, 1987). 
Protein polymyxin b derived from the cell membrane of Baccilus polymyxa was used 
as a biorecognition molecule to detect a liposaccharide endotoxin (LPS) (James et al., 
1996). LPS is an immune stimulant that causes the clinical syndrome called sepsis, an 
immunological disorder leading to inflammation and blood clotting.  
The major drawbacks in the use of protein receptors in biosensing include the 
difficulty in isolating the multimeric membrane receptor proteins and maintenance of 
their biological activity on isolation and immobilisation. 
 
Antibodies 
Antibodies are proteins produced by the immune system of an organism in response to  
foreign antigens. They form the most widely used class of biological recognition 
molecules in the field of biosensing. The general structure of antibodies consists of a 
variable region and a constant region (see section 3.1.6). The variable region binds to 
the target through complementarity-determining region (CDR), whereas the constant 
region binds the other molecules of immune system. The CDR forms the epitope 
binding site of an antibody to its target antigen. The diversity of antibodies, their 
specificity and affinity against different antigens in the immune system, makes them 
more reliable as biological recognition molecules in the field of diagnostics.  
The production of antibodies depends on the in vivo immune response elicited by an 
immunogen called as an antigen. An antigen is recognised as a foreign molecule by 
the immune system and antibodies are synthesised against that antigen. The antibody 
recognises a specific region of the antigen called as antibody epitope. Antibodies can 
be raised against proteins, peptides, nucleic acids or carbohydrates etc.  
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Depending on the type of specificity of an antibody towards an antigen, antibodies are 
classified as polyclonal and monoclonal antibodies. Polyclonal antibodies are 
produced by immunisation of host organisms with immunogens / antigens. The 
antibodies produced are derived from multiple plasma cells that recognise the same 
target but different epitopes on the target. Also each polyclonal serum even if 
produced from the same animal is unique and not reproducible (Bradbury et al., 
2003).  
With the establishment of monoclonal antibody technology by Köhler and Milstein, 
cell clones were used that produced monoclonal antibodies more specific to target 
proteins (Köhler and Milstein, 1975). The use of monoclonal antibodies instead of 
polyclonal antibodies enhanced specificity and sensitivity of the antibody based 
assays.  
Owing to their high specificity and binding verstality the most commonly used 
detection method, ELISA, is based on binding of antibodies to different antigens. 
Antibodies have been used in the detection of cancer biomarkers (Malhotra et al., 
2010), bacteria and viruses (Carnes and Wilkins, 2005).  
Although antibodies are most commonly used for detecting analyte molecules but due 
to their complex and large size, they tend to be more fragile which most likely also 
affects the shelf life and sensitivity when used on a sensing platform (Jayasena, 1999). 
In order to produce smaller yet functional forms of antibodies, re-engineering of 
antibodies has been employed. Single-chain Fvs (25 kD) with improved stability have 
been reported that are engineered by removing the intradomain disulphide bond and 
applying a reducing redox potential during ribosome display (Jermutus et al., 2001). 
Futhermore, it was discovered that a part of the humoral immune response of camels 
and llamas is based on the interaction of the antigens with only one single variable 
domain of the antibodies called the VH (variable heavy chain) domain. The 
recombinant single domain meets most of the desired properties of small recognition 
units (Muyldermans, 2001).  
Many biomolecular diversity or display technologies like phage display (Hoogenboom 
and Chames, 2000) and in vitro display (FitzGerald, 2000) have been used to select 
antibodies against specific biomarkers with improved sensitivities due to ability to 
screen larger recombinant libraries.  
In phage display the antibody fragments are fused with the phage coat proteins and the 
genetic information is encapsulated inside the phage capsid. The displayed antibody 
fragments are, therefore physically linked to their nucleic acid sequences allowing 
selection of binding partners in the phage display library (see section 3.1.7). In case of 
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ribosome display / in vitro display the complex of the mRNA, ribosome and nascent 
antibody is selected against immobilised antigens. The mRNA is isolated from the 
bound complex and reverse transcribed to cDNA. The nucleotide sequence obtained 
from the cDNA can then be used for creating better binding antibodies. The other 
techniques used are yeast two hybrid (Fu et al., 2013) and mRNA display (Fukuda et 
al., 2006).  
An alternative to the antibody based recognition molecules is the use of non-antibody 
based protein scaffolds called peptide aptamers. 
 
Peptide Aptamers 
Imitating the humoral response, efforts have been made to design antibody-mimicking 
protein scaffolds that constitute variable peptide regions mimicking the 
complementarity determining regions (CDR) of antibodies. Such protein scaffolds can 
be used to present binding functionalities in their variable regions, thus forming 
biological recognition molecules called peptide aptamers. The less complex and 
smaller peptide aptamers in comparison with  antibodies are promising alternatives in 
the field of biosensing.  
Figure 2-2 shows a schematic representation of comparison between an antibody and 
a peptide aptamer. The important characteristics that distinguish a peptide aptamer 
from an antibody are their smaller, less complex  structure (formed from a single 
polypeptide chain) than antibodies (~150 kDa), which impart more stability and 
longer shelf life to the peptide aptamers (Jayasena, 1999; Song et al., 2011; Colas, 
2008). Moreover, peptide aptamers do not require disulphide bonding or 
posttranslational modifications for maintaining their stability unlike antibodies (Colas, 
2008).  
Their simple structure can be modified according to the desired features required for 
changing the sensitivity, non-specific binding and stability of the biological 
recognition layer in a biosensor.  
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Figure 2-2 Shows a schematic diagram comparing an antibody with a 
peptide aptamer. 
(a) An antibody comprising of two identical light chains and two identical heavy chains 
held together by multiple intrachain and interchain disulphide bonds (b) a protein 
scaffold (peptide aptamer) comprising of a single polypeptide chain and two variable 
loops  with a constrained peptide in loop 2. Adapted from (Colas, 2008). 
 
In the engineering of peptide aptamers, a protein framework is used to constrain 
peptides into their variable loops (Figure 2-2(b)). Peptides with both ends attached to 
a protein framework are called as constrained peptides (CP) and have a preferred 
conformation. As biological recognition molecules, these constrained peptides possess 
unique advantages over the flexible peptides with free ends. Linear or unconstrained 
peptides can take up large number of different conformations through internal 
rotations (Ladner et al., 1993). Therefore, the analyte molecule can accept the 
unconstrained polypeptide in one or few conformations due to the favourable van der 
Waals and other non-covalent interactions. Whereas the constrained peptides with 
restricted number of free rotations will most likely exhibit different affinity, but more 
specificity to its analyte as compared to its unconstrained counterpart (Koivunen et 
al., 1995).  
The thermodynamic aspect of the protein conformation is an imperative aspect 
because the optimal binding site for the ligand should be a perfect complement for the 
ligand. It should also be rigid, so that the loss of conformational entropy upon binding 
is minimal (Chia-en et al., 2007). 
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Engineering a peptide aptamer 
For engineering different scaffolds various strategies have been used to improve the 
various characteristics of the scaffold like stability, recombinant expression yield, 
solubility (Binz et al., 2005). Once a suitable scaffold is optimised it is modified for 
the desired ligand binding function. One of the approaches to engineer a binding site 
is using combinatorial engineering approach in which a random library based on 
insertion of aminoacid sequences is first generated by targeting different positions on 
the peptide aptamer, e.g. within the variable loops (Koide et al., 1998) or inserting 
random peptide sequences into the loops (Colas et al., 1996). The mutants with the 
desired binding specificities are selected using different systems like the yeast two-
hybrid system (Young, 1998), filamentous phage display (Smith, 1985) followed by 
panning in the presence of the ligand. Other techniques used are colony screening 
assays (Schlehuber et al., 2000), plasmid-binding repressor fusion proteins (Cull et 
al., 1992), and ‘ribosome display’ (Roberts, 1999).  
 
Scaffold based on thioredoxin (TrxA) 
A pioneering work in the development of peptide aptamers against a specific target 
was done using a  scaffold based on thioredoxin A (TrxA) protein (Colas et al., 1996). 
TrxA which is a small enzyme involved in cytosolic thio-disulphide equilibrium in 
E. coli. It is a highly soluble, rigid protein that can be expressed in large amounts. A 
short active sequence in the enzyme forms a solvent accessible, disulphide-
constrained loop that can be used for insertion of various peptide sequences and will 
inactivate the enzyme. Colas et al reported the expression of combinatorial library of 
conformationally constrained 20-residue peptides displayed in the active site loop of 
E. coli trxA scaffold. The binders were selected against human CDK2 using yeast 
two-hybrid system. Prior to this work, the entire coding sequence of E. coli 
thioredoxin (TrxA) protein was inserted into partially functional flagella on the 
bacterial cell surface and the active loops of the E. coli trxA were replaced by random 
dodecapeptide sequences (Lu et al., 1995). Selection of variants was done against 
three murine monoclonal antibodies, that resulted in mapping three different antibody 
epitopes.  
The other most advanced approaches in the field of peptide aptamers comprise of the 
following. 
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Affibodies  
This protein scaffold is based on the Z-domain of Staphylococcal protein-A (SPA) 
that binds to the Fc region of immunoglobulin G (Nilsson et al., 1987). (Nord et al., 
1997). Z domain consists of repetitive structure consisting of small thermally and 
proteolytically stable domain. It contains three "-helices, which are arranged in an 
antiparallel three-helix bundle. It is well expressed in soluble form in E. coli and 
devoid of disulphide bridges. A combinatorial library was constructed based on the 
mutagenesis of Fc binding regions of Z domain (Nord et al., 1995). The repertoire of 
mutagenised Z-domains was used to detect Taq DNA polymerase, human insulin and 
human apo-lipoprotein A-1 (Andersson et al., 2003; Nord et al., 1997). 
 
Kunitz domains  
Kunitz domains are stable proteins with 50-60 amino acid residues (6 cysteine 
residues) present in various protease inhibitors. They have been engineered to produce 
high affinity binding molecules using using phage display libraries to bind to various 
proteases (Nixon and Wood, 2006; Dennis and Lazarus, 1994a). Variants of the first 
Kunitz domain of human lipoprotein-associated coagulation inhibitor (LACI-D1) 
were displayed on M13 bacteriophage using pIII protein to select high affinity and 
stable binders against a serine protease called plasmin (Markland et al., 1996). 
 
Anticalins  
They are derived from the lipocalins, a small (60 residues), functionally diverse 
family of proteins containing a conserved !-barrel of 8 anti-parallel !-strands, four 
variable loops and a C-terminal "-helix (Schlehuber and Skerra, 2005). The four 
variable loops at the open end of anticalins (< 20 kDa) can be modified to derive 
binding sites against different target molecules (Skerra, 2008). 
 
DARPins, designed ankyrin repeat domains  
DARPins are based on natural ankyrin repeat proteins, which are one of the major 
repeat proteins, involved in protein-protein interactions in organisms from various 
phyla. DARPins (14-18 kDa) are based on a consensus design strategy of ankyrin 
repeat proteins and consists of well conserved sequences for maintaining the repeat 
structure and randomised residues for interacting with the target proteins (Kohl et al., 
2003; Binz et al., 2004; Binz et al., 2005; Stumpp et al., 2008). 
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Fibronectin type III domain 
Fibronectin type III domain is based on protein fibronectin that is essential for the 
formation of extracellular matrix and cell-cell interaction. Fibronectin consists of 
repeats of three types of small domains (I, II and III). Fibronectin type III domain 
(FN3) belongs to Ig superfamily and consists of variable loops constrained by the 
!-sandwich structure resembling the CDR region of antibodies. Unlike antibodies 
FN3 does not contain any disulphide bonds and therefore can be expressed in bacterial 
hosts. The mutant FN3 was designed using combinatorial engineering and showed 
conformational stability. The designed mutant FN3 showed binding to a test analyte 
ubiquitin molecule (Koide et al., 1998). 
 
Stefin A triple mutant (STM) 
It is based on a protein called Human stefin A, a member of the cystatin superfamily. 
Cystatin superfamily consists of reversibly-binding inhibitors of the papain-like 
cysteine proteinases (Brzin et al., 1983). Stefin A subgroup of this family consists of 
proteins that are relatively small (100 amino acids), single domain and require no 
posttranslational modifications (Woodman et al., 2005). Different gene mutations 
were incorporated in the Stefin A protein scaffold to form a biologically inert protein 
scaffold called Stefin A triple mutant (STM). The three-dimensional structure of STM 
consists of an "-helix, !-sheets with two variable loops for peptide insertions and 
shows a thermal stability of 81ºC (Woodman et al., 2005). Peptide inserts were 
incorporated into the variable loops of the scaffold to target various analyte molecules 
e.g. a peptide aptamer based on STM has been used to target a cell signalling 
molecule called cyclin dependent kinase-2 (CDK-2) (Evans et al., 2008). These Stefin 
based peptide aptamers, now termed as Affimers were used to target an inflammatory 
biomarker, C-reactive protein (CRP) (Johnson et al., 2012). 
 
Repebodies 
A newly designed scaffold named as repebody is based on variable lymphocyte 
receptors that are non-immunoglobulin antibodies in jawless vertebrates (Lee et al., 
2012). Repebodies are composed of leucine-rich repeats each of which has a !-strand-
turn-" helix structure. Since they are derived from naturally occuring antibodies 
composed of repeat units, therefore they are called as repebodies.  They showed high 
level of soluble expression in E. coli and displayed high thermal (melting temperature 
of 85ºC) and pH stability (pH range 3-12). A phage display library was constructed to 
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select repebodies with different binding affinities against interleukin-6 (IL6) (Lee et 
al., 2012).  
 
2.2.2.  Transducers 
The function of a transducer is to gather the analytical information when in contact 
with the sample detecting the presence of the analyte and produce a signal. In general, 
one can categorise the different transducers into labelled and label-free system.  In 
labelled systems, the transducer detects the binding of the analyte to the recognition 
molecule indirectly through detecting the presence of a label which is normally 
attached to the target. In contrast, in label-free systems, the binding is detected 
directly without the need for a label. In the following section biosensors based on 
different transducers are discussed.   
 
Optical Biosensors 
Optical transducers can sense changes in the optical properties of their environment, 
and hence can detect the binding of analyte to the biological recognition molecules. 
The optical detection is mainly based on the change in absorbance or luminescence in 
the vicinity of the transducing surface. Different compounds absorb at different 
wavelenths of the electromagnetic spectrum depending upon their electronic 
configuration. Absorbance at a specific wavelength is measured by passing a beam of 
monochromatic light through the sample and the amount of light absorbed is then 
proportional to the concentration of the compound in the sample. On the other hand, 
luminescence is the phenomenon of emission of light when electrons, excited due to 
absorbance of energy, return from an excited state to the ground state emitting 
photons, which are detected using a photodetector. Depending upon the state of 
excitation, the phenomenon of luminescence can further be divided into 
phosphorescene, fluorescence and chemiluminescence. 
In the field of biosensing fluorescence has been one of the most widely used optical 
properties for detecting and quantifying biomolecules. Many biomolecules have 
intrinsic fluorescent properties such that they can be used as fluorescent probes. Each  
fluorophore has a characteristic spectrum depending upon its electronic configuration. 
For example, a protein called green fluorescent protein (GFP) has been used to detect 
protein-protein interactions. GFP is obtained from jellyfish Aequorea victoria. 
Recombinant fluorescent proteins have been constructed using GFPs. When the 
analyte binds to the recombinant protein, it causes conformational change that is 
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observed in the change in fluorescence of the GFP (Doi and Yanagawa, 1999; 
Feilmeier et al., 2000). 
Other than naturally occuring fluorophores, synthetic fluorophores have been used in 
protein based or nucleic acid based biosensors. These fluorophores are incorporated 
into the recognition molecules by modifying specific amino acid residues e.g. a 
glucose biosensor was designed by using E. coli based glucose-binding protein with 
cysteine residues incorporated at specific sites to covalently attached a thiol reactive 
fluorophore (Marvin and Hellinga, 1998). 
Although fluorescence spectroscopy has been widely used in detecting molecular 
interactions, there are a number of drawbacks. The fluorophores undergo irreversible 
photodegradation called photobleaching, that decreases the sensitivity of the assays 
(Greenbaum et al., 2000). Moreover, controlling the number of fluorophores bound to 
the recognition molecules can affect the quantitative analysis of the analyte binding to 
the recognition molecules (Cox and Singer, 2004). The fluorophores may lead to 
conformational changes when covalently bound to a protein which hampers the 
biologically significant conformation (Ramachandran et al., 2005).  
Another commonly used optical sensing method is called chemiluminescence. 
Chemiluminescence is the emission of light due to a chemical reaction wherein one of 
the intermediate products is excited to a higher energy level and emits photons while 
approaching the ground state. This phenomenon is widely used in ELISA based 
detection assays (see section 3.2.1.4). 
In contrast to the use of labelled biosensors that are based on the fluorescence of the 
biomolecules or the synthetic fluorophores, label-free optical detection of analyte 
molecules has been developed.  
The more recent development of label-free, very sensitive, non-invasive and 
continuous real time measurements is based on surface plasmon resonance (SPR). 
SPR is based on detecting the change in refractive index due to binding of the analyte 
molecules to the biological recognition layer immobilised on to a gold sensor surface 
(see section 3.2.5). The binding of the molecules can be monitored in real time using 
very low amounts of compound and the association-dissociation kinetics can also be 
analysed. The biochemical properties of a domain in tumor repressor protein were 
investigated using SPR (Deka et al., 1998).  
In order to improve the signals obtained from the conventional SPR biosensors, 
metallic nanostructures that enable an efficient coupling of incident light to plasmon 
resonance (LSPs / Localized surface plasmons) (Anker et al., 2008). Use of LSPR for 
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the detection of avian influenza DNA hybridization has improved sensitivity over the 
conventional SPR (Shin Ae et al., 2010). 
Currently, since the miniaturisation of biosensors is in progress, the important 
constituents of the optical biosensors like the light source and detectors used are still 
bulky. The integration of the light source, detector and the biorecognition platform 
becomes a constraint. 
 
Mechanical Biosensors 
Mechanical biosensors are based on the detection of parameters associated with 
mechanical deformation e.g. force, stress (force per cross sectional area) or 
mechanical waves (acoustics), that is transformed into a suitable output signal.  
In case of biosensors based on mechanical deformation biological recognition 
molecules are, for example, immobilised on one side of a microcantilever. When the 
analyte binds to the biological recognition layer, it causes a change in the surface 
strain on the side of the microcantilever containing the biological recognition layer, 
which leads to a deflection of the microcantilever. The microcantilever deflection is 
measured by optical or electrical means.  
Microfabricated cantilevers functionalised with biological recognition molecules e.g. 
anti-creatine kinase and anti-myoglobin antibodies were used to detect two cardiac 
biomarkers creatine kinase and myoglobin respectively (Arntz et al., 2003). The 
detection was based on the optical changes measured when the laser beam is focused 
on the free end of the cantilever and the deflection in the cantilever is measured by a 
photodetector. 
A microcantilever mechanical sensor based on piezoresistive detection was developed 
in which the microcantilever was embedded into a polymer (Porter et al., 2003). 
Piezoelectric change corresponds to change in the electrical resistivity on the surface 
in response to change in pressure or stress. On binding of analytes to the polymer, the 
polymer swelled thus changing the surface stress, which was detected by the change 
in the surface resistance. 
The microfabrication process must be controlled to such an extent that the mechanical 
properties of all the cantilevers fabricated are similar. This is because the micro-
cantilevers are very sensitive to external influences like temperature drift and 
disturbances during fluid exchange. 
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Another class of mechanical biosensors is based on the dependence of the resonance 
frequency of the mechanical system, i.e. the frequency at which the surface vibrates 
with maximum amplitude as compared to other frequencies, on changes of the overall 
mass of the system. In this type of biosensor, the mechanical structure, e.g. a disc, 
operates as an oscillator. The recognition molecules are immobilised on to the disc 
surface, which oscillates at resonance frequency. When target molecules bind to the 
immobilised capture molecules, the mass of the system changes which in turn leads to 
a change in resosnace frequency. This shift in the resonance frequency can be detected 
and used to quantify the binding of the analyte to the biological recognition layer. 
Further, the properties of the propagation of acoustic waves across a surface or 
through bulk can be exploited for biosensing. Changes in the overall mass of the 
system lead to changes of the propagation of the acoustic wave. Depending upon 
where the propagation of the acoustic wave takes place, the sensors are classified as 
bulk acoustic waves (BAW) sensors and surface acoustic waves (SAW). In BAW 
based sensors the acoustic wave travels through the bulk of the material. One of the 
most commonly used mechanical biosensor is the QCM quartz crystal microbalance. 
QCM is based on BAW based technology. It has been widely used for detecting 
molecular interactions (Yao et al., 2010). In SAW based sensors the acoustic wave is 
confined to the surface of the sensor, which increases the sensitivity of the sensor to 
any change occuring at the surface (Gronewold, 2007).  
 
Electrochemical Biosensors 
Electrochemical biosensors are based on the detection of analytes by measuring the 
change in the electrochemical properties of the sensor. The electrochemical change 
can be measured in the form of current (amperometric), voltage (potentiometric) or 
impedance (impedimetric). 
In general electrochemical processes are measured at the electrode-electrolyte 
interface. It usually requires a working electrode where the biological recognition 
molecules detect the analyte, a reference electrode that maintains a stable potential 
and a counter electrode that maintains the flow of current through the working 
electrode (see section 3.2.6.2). The different types of electrochemical biosensors have 
been discussed in the following sections. 
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Amperometric Biosensors 
Amperometric biosensors involve the measurement of current at a constant potential 
resulting from the redox reactions taking place at the electrode surface. Redox 
reactions involve the loss (oxidation) or gain (reduction) of electrons.  
This electrochemical redox reaction taking place at the working electrode generates a 
measurable amount of current. Amperometric biosensors use redox enzymes to 
produce oxidation / reduction reactions. The first amperometric sensor was proposed 
by Clark at the New York Academy of Sciences symposium in 1962. The sensor 
consisted of the enzyme glucose oxidase trapped close to the surface of platinum 
electrode that converted glucose into glucuronic acid and hydrogen peroxide in 
presence of oxygen. The oxygen was reduced at the metal electrode and the flow of 
current was proportional to the concentration of oxygen in the solution (Clark and 
Lyons, 1962). 
In order to obtain high currents and increased sensitivity in the amperometric 
biosensors mediators like ferrocene have been used (Cass et al., 1984). Mediators are 
molecules that help to carry the charge between the active site of the enzyme and the 
electrode, thus providing a high rate of electron transfer. 
Although it is useful to detect analytes by using enzyme-substrate reactions, almost 
none of the clinically relevant analytes are natural substrates for enzymes. The major 
challenges in the amperometric biosensors include the enzyme instability, 
biomolecular interference from endogenous and exogenous species that can undergo 
reactions with the working electrodes (Lowry and O'Neill, 1992). 
 
Potentiometric Biosensors 
Potentiometric biosensors are based on development of a potential at the working 
electrode compared to the reference electrode when ideally no current flows between 
the working and the reference electrode. The development of potential is related to the 
charge accumulated at the electrodes, which can be related to the ionic activity taking 
place in the electrochemical cell (Malon et al., 2006). 
The relationship between the concentration of the ions and the potential can be 
determined using the Nernst equation as following: 
Ecell = E0cell - RT/nF  In([Ia]/[Ic]) 
Ecell represents the observed cell potential at zero current, E0cell is a constant potential 
contribution to the cell. R, T, n and F represent the universal gas constant (Joules 
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Kelvin-1mole-1), the absolute temperature (Kelvin), the charge number of the electrode 
reaction and the Faraday constant (Coulombs mole-1) respectively. Ia, Ic represent the 
ionic concentration at the anode and the  ionic concentration at the cathode 
respectively. 
Nernst equation provides the fundamental basis for the working of most of the 
potentiometric biosensors. The binding of analyte molecules to the biological 
recognition layer, immobilised on to a membrane, changes the transmembrane 
potential due to change in the ionic flux across the membrane. The ionic flux can also 
be deliberately induced by adding ionic markers to the solution (Ozdemir et al., 2013). 
 
Impedimetric Biosensors 
Impedimetric biosensors are based on electrochemical impedance spectroscopy (EIS) 
and thus also called as EIS based biosensors. EIS is a technique that measures the two 
components of impedance, the real part is the ohmic or resistive contribution and the 
imaginary part is the capacitance contribution (see section 3.2.6.4). It is used to 
measure intrinsic properties of a surface or a process that affects the resistive and the 
capacitive behaviour of an electrochemical system. 
EIS based biosensors are based on the change in the resistive or capacitive properties 
of materials upon the binding of analyte to the biorecognition molecules at the 
electrode surface. Based on the component of impedance being measured in an EIS 
based biosensor they are classified as faradaic and non-faradaic biosensors.  
In the faradaic biosensors the response is based on the transfer of the electrons across 
the interface, and therefore requires a redox probe that needs corresponding DC bias 
voltage so as to maintain the transfer of electrons from its reduced to its oxidised state. 
This transfer of electrons can be measured as electron transfer resistance. Faradaic 
measurements were used to detect thrombin protein using a gold electrode 
functionalised with a thrombin binding aptamer (Cai et al., 2006). The binding of p53 
gene sequence (tumor biomarker) to complementary DNA probes immobilised on to 
graphite electrodes was detected by measuring the change in faradaic impedance 
(Marquette et al., 2006). An impedimetric biosensor for the detection of 
microorganism B. anthracis, used  in biological warfares was developed using capture 
probe complementary to target DNA sequence (Kara et al., 2008).  
On the the other hand, non-faradaic biosensors do not require a redox probe and are 
mainly dependent on the change in resistance or capacitance at the interfacial surface 
formed by the biological recognition molecules and the electrolyte. An impedimetric 
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biosensor was fabricated wherein polymeric film containing acetylcholine receptors 
was immobilised on to an interdigitated electrode to detect cholinergic agents (Taylor 
et al., 1988). The detection was based on the change in electrical properties of the 
sensing surface (change in conformation of the receptors or change in ionic flux). 
Later it was observed that the interdigitated electrodes behave like capacitors that 
store or release charges as the analyte binds to the receptors (Taylor et al., 1991).  
In order to improve the sensing platform various methods have been used to 
immobilise the biological recognition layer on to the substrate. It was observed that 
the initial capacitance of the sensor surface should be high so as to detect binding of 
the analyte molecules (see section 3.2.1.4). An ultra thin insulating layer of tantalium 
oxide  was deposited on the electrode surface forming a capacitor, wherein the 
electrode formed one of the plates of the  capacitor and the second plate was formed 
by the electrolyte at the interface separated by an insulating layer in between (Gebbert 
et al., 1992). The biological recognition molecules were immobilised on to the 
insulating layer. The detection of the binding of analyte was measured by the change 
in capacitance of the sensing layer.  
One of the most commonly used insulating layers in the field of biosensing is self 
assembled monolayer, which are organic molecules consisting of polar head group to 
attach to the substrate (e.g. gold-thiol bond), hydrophobic tail and a functional group 
at the end of the tail for covalent attachment of biological recognition molecules 
(Whitesides et al., 2005). An EIS based immunosensor for the detection of protein 
interferon-gamma (IFN-gamma) was developed by immobilisation of anti IFN-
gamma antibodies on self assembled monolayer of acetylcysteine with a detection 
limit of 0.02 fg/ml (Dijksma et al., 2001). Label-free detection of DNA hybridisation 
using impedimetric biosensors have been used wherein binding of complementaey 
DNA oligomers to DNA probe molecules have been detected (Tlili et al., 2005).  
A capacitive biosensor was fabricated based on the immobilisation of monoclonal 
antibodies on to SAM formed by thiotic acid on gold surface to detect human 
chorionic gonadotropin hormone with a detection limit of 0.5 pg/ml (Berggren and 
Johansson, 1997).  
The current trend in biosensors is in creating point-of-care diagnostic methods. The 
EIS based biosensing is considered as a potential technology for the fabrication of 
miniaturized biosensors. The label-free detection that avoids the use of complex and 
expensive pretreatment processes, ease of miniaturisation, cost effectiveness makes 
the impedimetric biosensors more attractive for the fabrication of multiplex analysis 
of different targets (Evans et al., 2008). 
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Chapter 3. Background and techniques  
 
Since the fields of biology, chemistry, electrical engineering, and physics all 
congregate in biosensors, this chapter is an effort to bring essentially the concepts of 
biotechnology and electrical engineering together. 
3.1. Background  
 
3.1.1. Prokaryotic gene expression 
Gene expression is the process by which the genetic information on the DNA in the 
form of nucleotide sequence is used to direct the synthesis of proteins required for the 
sustenance of the cell.  
Prokaryotic gene expression is controlled at two basic levels: the DNA is first 
transcripted into messenger RNA (mRNA) and then the mRNA sequence is translated 
into the polypeptide chain that forms protein. 
As there is no compartmentalisation of the prokaryotic cell (no nucleus) unlike the 
eukaryotes, the transcription of the DNA and the translation of m-RNA are coupled 
together. This coupled transcription and translation is required for gene regulation. 
 
3.1.1.1. Transcription   
The prokaryotic transcription is initiated by binding of an enzyme called RNA 
polymerase to a specialized upstream DNA sequence called promoter. The RNA 
polymerase “core enzyme” binds to the DNA upstream of the gene in the promoter 
region, upon binding it is joined by another sub unit called sigma unit and starts 
unwinding the DNA double helix. It moves along the template strand and synthesis 
the complementary mRNA by adding nucleotides on the 3’ end of the growing strand. 
At the terminator region that is usually present at the end of the coding sequence, the 
transcription is stopped and the mRNA molecule is released.  
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3.1.1.2. Translation 
During the process of translation the mRNA is read according to the genetic code. A 
genetic codon is constituted by a group of three base pairs, which specifies a particular 
amino acid in a protein. The process of translation takes place in a specialised 
organelle called ribosome, which binds to the mRNA while it is still being transcribed. 
Ribosome consists of two subunits the large 50S and the small 30S (S for Svedberg 
unit). Simultaneously more than one ribosome binds to the mRNA forming a complex 
called polysome or polyribosome. 
Initiation of translation involves the assembly of the ribosomal subunits on mRNA 
along with the first aminoacyl tRNA (the tRNA charged with the first amino acid) and 
the initiation factors. Elongation of the polypeptide chain takes place with the addition 
of amino acids to the carboxyl end of the growing chain. Finally, the termination of 
the chain occurs at the stop codon and the polypeptide chain is released from the 
ribosomal complex. 
 
3.1.2. Gene regulation system – Operon 
The bacterial cells are exposed to various environmental changes but most of the cells 
are able to adjust to these wide ranges of environmental changes. They are able to use 
their cellular resources in an efficient way by regulating the expression of genes that 
helps in economical production of various gene products. The simplest form of this 
regulation can be explained using the operon model.  
An operon consist of an uninterrupted, continuous sequences of nucleotides usually 
clustered together under the same regulatory system.  These clustered genes are 
generally responsible for a particular function like biochemical synthesis or 
metabolism. The best-studied cluster of such system is a group of three genes lacZ, 
lacY, lacA constituting the lac operon (Figure 3-1). These structural genes are 
involved in the metabolism of sugar lactose as an energy source in bacteria. This 
operon is usually off and is turned on only when lactose is present. Therefore, it is 
called an inducible operon. In case of lac operon, the lac I gene transcribes a repressor 
protein. This gene is continuously expressed and the repressor protein binds to the 
regulatory region called operator. Operator is present close to promoter and therefore, 
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in presence of the repressor protein, RNA polymerase cannot initiate transcription. 
When lactose is present in the environment, it enters the cell and gets converted into 
allolactose. Allolactose binds to repressor and inhibits it from binding the operator. 
This successful binding of RNA polymerase to the promoter turns the operon on and 
leads to transcription of all genes resulting in metabolism of lactose (Table 1). When 
the lactose level drops, less allolactose is present and repressor is active again. 
Isopropyl "-D-1-thiogalactopyranoside (IPTG) is a molecular mimic of allolactose 
and can be used to artificially induce the lac operon. 
 
3.1.2.1. Catabolite repression of lac operon in Escherichia coli. 
E. coli prefers to use glucose over lactose when both of these molecules are present in 
the environment. Concentration of glucose in the environment inversely regulates the 
concentration of cyclic AMP (cAMP). Promoter of the lac operator has another 
binding site for the CAP (Catabolite activator protein) and the cyclic AMP (cAMP) 
shown in Figure 3-1. This complex assists the binding of RNA polymerase to the 
promoter of lac operon. As the amount of glucose increases the cAMP concentration 
decreases and the operon is turned off. This is called catabolite repression (Table 1). 
The choice of right promoters and regulatory mechanisms helps in expression of 
recombinant proteins in the E. coli expression system. 
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Figure 3-1 Schematic representation of the lac operon in E. coli. 
The lac operon consist of four genes involved in lactose metabolism, lac1 transcribes a 
repressor protein in absence of lactose in the environment, CAP binding site is the 
target for catabolite repression, promoter is the binding site for the RNA polymerase 
and the repressor protein produced by the lacI binds to the operator. The three structural 
genes lacZ, lacY and lacA encode for the enzymes "-galactosidase, "-galactoside 
permease and "-galactoside transacetylase.  
 
Concentration 
of glucose 
Concentration 
of lactose 
Regulatory mechanism 
Expression of  lac 
genes 
High Available 
CAP, promoter and operator free 
for binding 
On, basal expression 
of lac genes 
 
High Unavailable 
Repressor protein binds to the 
Operator 
Off, no expression of 
lac genes 
Low Unavailable 
cAMP binds to CAP and 
repressor protein binds to the 
operator 
Off, no expression of 
lac genes 
Low Available 
cAMP binds to the operator, 
Allolactose binds to the repressor 
protein and RNA polymerase 
binds to the promoter 
On, of lac genes 
strongly expressed 
 
Table 1- Regulation of lac operon under variable concentrations of glucose and 
lactose.  
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3.1.3. Recombinant DNA technology 
Recombinant DNA technology provides the researcher with the opportunity of 
manipulating genetic information of an organism by integrating the DNA from 
different organisms. A DNA molecule obtained in vitro by unification of DNA from 
various sources is referred as a recombinant DNA.   
 
3.1.3.1. Vector 
A vector is a recombinant DNA molecule that is used as a vehicle to carry foreign 
material into a host cell where it can be maintained in a stable condition and can 
replicate along with the host chromosomal DNA. E. coli is the most commonly used 
host organism because it  can be grown easily and economically (Brown, 2001).  
Vectors are developed from naturally occurring molecules such as bacterial plasmids. 
A plasmid is an extra chromosomal element of DNA in bacteria (about 2000-
10,000bp). It is a small, covalently closed circular molecule independent of the host 
chromosome carrying genes that confer resistance to antibiotics, conjugation or 
metabolism of unusual substrates. Some plasmids are capable of replicating at a high 
rate in bacteria such as E. coli thus they can serve as carriers or vectors to allow 
replication of recombinant DNAs. Figure 3-2 shows a schematic diagram of a vector. 
A vector typically has :  
• Genes that confer resistance to antibiotics. One of these genes allows the cells 
to grow on a media containing an appropriate antibiotic e.g. ampicillin and 
tetracycline. Only the cells containing the antibiotic resistant genes will grow 
to form colonies.  
• The bacterial origin of DNA replication that ensures replication of plasmid 
with the host cell. 
• Restriction sites – Each restriction enzyme used for producing nicks in the 
DNA has a unique recognition site known as the restriction site. Plasmids are 
engineered to contain single recognition site for different restriction enzymes 
that include Eco RI, Bam HI, Nhe I, Nde I etc. These enzymes linearise the 
vector by creating sticky ends or blunt ends that help in ligation of foreign 
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DNA into the vector backbone. In some vectors many unique restriction sites 
are clustered into a region called multiple cloning site (MCS), to provide a 
choice of different restriction enzymes that can be used for manipulation.  
 
 
Figure 3-2 Schematic representation of a cloning vector.  
A cloning vector comprises of the origin of replication, antibiotic (Ab) resistance genes 
and a number of restriction sites (RS).  
 
3.1.3.2. Restriction digestion and ligation 
The process of linearising the vector by use of restriction enzymes specific to the 
restriction sites present in the MCS of the vector is called restriction digestion. The 
linearised vector is treated with an alkaline phosphatase, this removes the 
5’ phosphate groups and thus prevents the vector molecule from recircularising. A 
foreign DNA flanked by the same restriction site can be integrated in the linearised 
plasmid to form a circular recombinant vector (Figure 3-3). The process of joining 
two DNA molecules, in this case the linearised vector and the foreign DNA fragment 
is termed as ligation. The enzyme involved in ligation is called DNA ligase.  The two 
DNAs are incubated together with DNA ligase that seals the nicks (unformed 
phosphodiester bonds) by catalyzing the formation of phosphodiester bond. The 
5’-phosphate of the foreign DNA and the 3’-hydroxyl of the plasmid can still be 
ligated and the nick will be repaired by the host bacterial system.  
 
52 
 
 
 
Figure 3-3 Restriction digestion and ligation of foreign DNA and vector 
to generate a recombinant vector.  
The vector and the foreign DNA molecule are cleaved using the same restriction 
endonuclease enzyme (Eco RI) to generate the complimentary sticky ends. The foreign 
DNA molecule is ligated into the linearised vector by DNA ligase enzyme to form the 
recombinant plasmid. Adapted from (Wolfwikis). 
 
3.1.3.3. Transformation 
The recombinant vector prepared by ligation of the foreign DNA into the vector 
backbone is introduced in the host bacterial cell by the process of transformation. The 
cells are made competent by treating them with calcium at 4ºC to make their 
membranes leaky. This permits entry of foreign DNA into the host cell. These cells 
can uptake DNA when subjected to a brief increase in temperature called heat shock 
treatment. Alternatively, electroporation is used where an electric potential is used to 
drive DNA into the cells.  
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3.1.4. Recombinant protein expression 
The expression of a foreign gene ligated into a vector is dependent on regulatory 
elements surrounding it. The regulatory elements for gene expression in E. coli are: 
Promoter - the binding site for bacterial polymerase to initiate transcription of the 
inserted gene. 
Terminator- contains signal for the bacterial polymerase to terminate transcription. 
Ribosome binding site - a nucleotide sequence recognised by the bacterial ribosome as 
the point of attachment on the m-RNA. 
A foreign gene (eukaryotic / non-bacterial) is surrounded by eukaryotic / non-bacterial 
regulatory elements that are not recognised by the bacterial system. Thus, the 
recombinant vector has to be carefully designed by inserting the foreign DNA 
molecule with its regulatory elements after the regulatory elements of the bacterial 
system to accomplish expression of the inserted gene in a desired manner. The cloning 
vectors that can be used to produce recombinant proteins are called expression 
vectors. One of the popularly used expression vector is pET expression vector. 
 
3.1.4.1. pET expression system 
The pET vectors are one of the most well developed cloning and expression systems 
for recombinant proteins in E. coli. It is based on a strong bacteriophage T7 promoter 
driven system (Studier and Moffatt, 1986; Rosenberg et al., 1987; Studier et al., 
1990). T7 phage produces a T7 RNA polymerase that is very specific to the T7 
promoter site and thus transcribes genes downstream of the T7 promoter. The gene of 
interest is downstream of the T7 promoter in the pET vector and the vector is 
introduced into an E. coli strain that has a chromosomal copy of bacteriophage T7 
polymerase. T7 promoter is not recognised by the host cell RNA polymerase thus 
maintaining the gene in a transcriptionally silent state. The T7 polymerase gene is 
under the control of lacUV5 promoter (Studier and Moffatt, 1986). The lacUV5 
promoter is insensitive to cAMP-CAP complex that does not require binding of RNA 
polymerase to the promoter to initiate transcription (Figure 3-1). Therefore, the 
protein expression is driven by this mutant promoter even in rich nutrient broth. The 
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lacUV5 promoter is inducible by IPTG and transcribes T7 RNA polymerase gene, 
which in turn expresses the target protein. 
Using IPTG for the induction of the protein expression under the control of 
T7 lac promoter has many disadvantages. To achieve optimal induction conditions, it 
needs constant monitoring of the bacterial growth and addition of inducer at the 
proper stage of growth. Moreover, unintended expression of the proteins can be 
caused due to small amount of lactose present in the complex media. Therefore, 
development of non-inducing or auto-inducing media to inhibit undesired induction of 
the T7 lac promoter is essential. 
  
3.1.4.2. Auto induction media 
Autoinducing media (AIM) have been formulated (Studier, 2005) for high level of 
protein expression without the need of monitoring the cell growth or adding an 
inducer. AIM is formulated to grow IPTG–inducible expression strains in a defined 
media based on a mix of carbon sources (generally glucose, lactose and glycerol). The 
glucose is metabolised preferentially preventing the uptake of lactose. Lactose uptake 
starts once the glucose concentration drops and !-galactosidase converts lactose to 
allolactose. Allolactose releases the lac repressor and induces the T7 RNA polymerase 
expression from lacUV5 promoter in DE3 strains allowing the expression of the target 
gene.   
 
3.1.5. Proteins 
Proteins form the centre of action in biological processes. Proteins are major active 
elements in expression of genetic information. An organism’s protein composition is 
the direct expression of its genetic composition. They can work as enzymes  
catalysing the complex set of chemical reactions that are collectively responsible for 
the cellular function; or act as chemical messengers known as hormones and are also 
the receptors for those hormones or as immunoglobulin that form an essential 
biological defence mechanism in higher organisms.  
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The structural description of proteins has been traditionally described in terms of four 
forms: primary, secondary, tertiary and quaternary structure (Voet and Voet, 1995).  
The primary structure of a protein, amino acid chain is depicted in Figure 3-4. Amino 
acids are joined together through the formation of peptide bonds. The pair of linked 
amino acids is called a dipeptide and a long chain of amino acids is known as 
polypeptide. Proteins have an N-terminus (containing an amino group) and a 
C-terminus (containing a carboxylic acid group). 
 
 
Figure 3-4 Primary structure of a protein. 
The primary structure of a protein consists of a backbone of amino acids wherein each 
amino acid comprises of an amine group at one end and a carboxylic group at the other 
end. Two amino acids are bonded  together via a peptide bond between the carboxylic 
group of one amino acid and amine group of another amino acid. The side residues are 
designated as R.  
 
The secondary structure is the local spatial arrangement of the polypeptide’s 
backbone. The main elements of the protein secondary structure  are the helices and 
the pleated sheet structures. The helices have chirality i.e. they can be either 
right-handed or a left-handed helix. In the !-pleated sheets the hydrogen bonding 
takes place between neighbouring polypeptide chains rather than within the same 
chain as in "-helix. It comes in two varieties: The anti-parallel !-pleated sheet in 
which the neighbouring hydrogen bonded polypeptide chains run in opposite 
directions and the parallel !-pleated sheet in which the hydrogen bonded chains 
extend in the same direction. !-structure is stabilised by intermolecular hydrogen 
bonds between –NH and –CO groups of adjacent polypeptide chains (Figure 3-5(a)). 
The protein’s remaining polypeptide segments have a coil or loop conformation. 
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Tertiary Structure of a protein is the three dimensional structure of the entire 
polypeptide chain shown in Figure 3-5(c). It involves the folding of its secondary 
structural elements, together with the orientation of its side chains. It is constituted by 
steric relationship between the amino acids located far apart but brought closer by 
folding. Many proteins are composed of two or more polypeptide chains referred to as 
subunits, bound through non-covalent interaction or disulphide linkages. The 
arrangement of the subunits of two or more polypeptide chains forms the quaternary 
structure shown in Figure 3-5(d). The contact regions between the subunits consist of 
packed non-polar side chains, hydrogen bonds involving the polypeptide backbones 
and their side chains, and in some cases interchain disulphide bonds too. 
 
 
Figure 3-5 Secondary, tertiary and quaternary structure of protein.  
Structure of Human CDK-2 (Schulze-Gahmen et al., 1996): a) "-sheets, b) $-helix, c) 
Tertiary structure and (d) Quaternary structure of Haemoglobin (Safo and Abraham, 
2005).  
 
3.1.6. Antibodies 
Antibody molecules are made up of four peptide chains consisting of two identical 
light chains (25,000 Da MW) and two identical heavy chains (MW >50,000 Da). Each 
light chain is bound to a heavy chain by a disulphide bond and by other non-covalent 
interactions such as salt linkages, hydrogen bonds and hydrophobic bonds to form a 
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heterodimer (H-L) shown in Figure 3-6. Such interactions connect the two identical 
heavy and light (H-L) chain combinations to each other thus forming the basic 
antibody structure. Amongst the antibodies of different specificity the first 110 amino 
acids of the amino terminal region of a light chain or a heavy chain show variability 
These regions are called V regions: VL in light chain and VH in heavy chain (Kindt et 
al., 2007).  
   
  
Figure 3-6 Basic structure of an antibody (immunoglobulin). 
(a) IgG antibodies consist of four chains, two heavy chains (blue) and two light chains 
(red), linked by disulphide bonds. The heavy and light chains come together to form 
Fab domains, which have the antigen-binding sites at the ends. The two heavy chains 
form the Fc domain. The Fab domains are linked to the Fc domain by flexible linkers. 
(b) A schematic representation of an IgG molecule showing the antigen bonding sites, 
variable and constant region of heavy and light chains, and the disulphide bonds 
holding them together (Berg et al., 2002). 
 
The structure of each of the four heavy and light chain domains has the characteristic 
immunoglobulin fold consisting of two antiparallel sheets with an intermolecular 
disulphide bond. Most of the variation in the V region lies in the areas called 
complementarity–determining–regions (CDR’s) and these CDRs (hypervariable 
loops) on both heavy and light chains form the antigen-binding site of the antibody 
molecule. The diversity in the variable region of the antibodies in living systems is 
generated through various factors such as the re-arrangement of the multiple gene 
segments in the germline DNA, somatic hypermutations, junctional flexibility. This 
unique property of antibodies is the key to their usefulness in immunosensors where a 
58 
 
 
device comprising an antigen or antibody species is coupled to a signal transducer, 
which detects the binding of the complementary species (Kindt et al., 2007).  
 
3.1.7. Phage Display Library 
Phage display is a molecular technique where peptides or protein variants are 
displayed on the outer surface of bacteriophage (viruses infecting bacteria), 
encapsulating the genome of the displayed chimeric protein inside the phage particle. 
 
3.1.7.1. M13 phage genome 
Filamentous bacteriophage M13 infects bacterial strains containing thread like 
appendages called F pilus. The bacteriophage particle is approximately 6.5 nm in 
diameter with a single stranded genome of about 6400 nucleotides. The phage genome 
is encapsulated in a flexible cylinder that is composed of major coat proteins pVIII 
encoded by gene VIII (Figure 3-7). At one end of the cylinder there are five molecules 
each of gene III and gene VI proteins. On the other end five molecules each of the 
small hydrophobic gene VII and gene IX proteins. This end contains packaging signal 
and is the first part of the phage to be assembled (Barbas et al., 2001). 
 
3.1.7.2. Phage infection 
The phage infection in a bacterial cell starts from the interaction of the F conjugative 
pilus of the bacteria with one of the domains of pIII protein of the bacteriophage 
(Figure 3-7). The pilus retracts and brings the pIII protein end into the periplasm of 
the bacterial cell. As the phage DNA is translocated into the cytoplasm the major and 
minor capsid proteins disassemble and join the population of newly synthesised phage 
proteins. The bacterial enzymes synthesise a complementary strand (-) against the 
viral single stranded DNA. The two strands form a covalently closed, supercoiled 
double stranded DNA called the parental replicative form (RF) DNA. The negative 
strand of the RF is the template for replication, which produce mRNAs that are then 
translated into phage proteins. The pII protein nicks the (+) strand resulting in a 
3’hydroxyl that acts as a primer and a new viral strand is synthesized via rolling circle 
mechanism using bacterial enzymes. After one round the pII circularise the displaced 
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(+) strand which then forms a double stranded RF. The pV binds to the progeny (+) 
strands and prevents the RF formation. The pX also helps in proper replication of 
phage DNA. pII, pX, pV are present in the cytoplasm whereas the other phage 
proteins are incorporated into the bacterial membrane. 
 
 
Figure 3-7 Filamentous bacteriophage M13. 
In a M13 bacteriophage, the single strandedviral DNA coding for the proteins scFv and 
pIII is encapsulated by major coat protein pVIII. Typically five copies of pIII and one 
or zero copy of the scFv is displayed on the phage. The other proteins pVI, pIX and 
pVII are provided by the helper phage genome in the E. coli. 
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Figure 3-8 Life cycle of bacteriophage.  
The life cycle of bacteriophage in bacteria involves infection, amplification of viral 
genome and assembly and release of new phage particles out of bacterial cell. The 
filamentous bacteriophage uses F pilus of the E. coli to insert its single stranded DNA. 
Single stranded DNA of the virus is changed into a double stranded molecule by the 
host machinery and is called replicative form (RF). Then the host machinery leads to 
production of viral proteins that are later assembled as new phage particles and released 
outside the bacterial cell. Adapted from (Drew, c2011). 
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3.1.7.3. Display of recombinant proteins on phage particles 
In conventional phage display libraries, DNA fragments encoding peptides or proteins 
are incorporated into the phage genome so that the foreign peptides or proteins are 
displayed on the surface of the phage particles. Generally proteins are fused to pVIII 
and pIII coat proteins of filamentous phage. Insertion of the fusion sequence along the 
pVIII protein produces phage particles exposed along the surface of the phage but the 
inserts more than 6-8 residues are less efficiently packaged into the capsids. In case of 
pIII chimeric proteins larger inserts can be packaged well into the capsids. Although, a 
truncated form of pIII expressing the carboxy domain helps in  incorporation of the 
fusion proteins into the phage coat proteins but the amino terminal domain of pIII 
prevents superinfection of a bacterial cell already infected once by a phage. To 
overcome these problems and enhance the phage display screening a phagemid vector 
is used. 
 
Phagemid 
A phagemid is a plasmid that bears a plasmid origin of replication, an antibiotic 
resistant marker for selection, origin of replication for viral and complementary strand 
synthesis. The phage particles are not released from the E. coli cells unless they are 
infected by helper phage. Helper phage provides structural proteins that are required 
for replication of the phagemid genome. To design phagemid vectors that express pIII 
fusion proteins, the amino terminal domain of pIII is deleted in order to allow 
infection by helper phage. Therefore only a part of pIII contains the displayed protein 
whereas the rest of the domain is expressed in the helper phage genome, which 
expresses the wild type pIII. 
The phagemid DNA is packaged into the phage particles when the helper phage 
superinfects the bacterial cells. The helper phage bears a defective origin of 
replication so that packaging of the phagemid genome is favoured over the helper 
phage genome.  
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pBSTG1  
pBSTG1 is a phagemid derived from pDHis II that was developed from pHEN1 
(Hoogenboom et al., 1991). It was used in the project to clone  gene sequence for 
Adhiron 92 (see section 4.1) at Nhe I and Not I restriction sites (Figure 3-9). It 
consisted of a recombinant coding sequence flanked by Nhe I and Not I restriction 
sites. The fusion coding sequence in the phagemid vector consisted of DsbA secretion 
signal peptide, Adhiron, TAG codon and C-terminal half of gene III (gIII) of M13 
bacteriophage. A signal sequence of DsbA (a periplasmic disulphide bond 
oxidoreductase) -DsbAss is fused to the protein coding sequence to allow efficient 
translocation to the periplasm. A histidine tag is introduced at the C-terminus of the 
Adhiron before the amber stop codon that helps in its purification using metal ion 
affinity column. A C-terminal fusion of a truncated gIII coding sequence is generated, 
allowing expression of a protein – pIII coat protein fusion. A small-unstructured 
colicin linker is inserted between the protein of interest and the pIII coat protein to 
present the protein of interest away from the surface of phage particles. The phagemid 
is referred to as pBSTG1-Adh. Only domain 3 of the pIII coat protein, which is 
required for insertion into the phage particle coat, is expressed. Therefore, one of the 
coat proteins on the surface of the phage particle must be from the wild-type pIII 
(from helper phage) in order for the phage to be able to re-infect E. coli and allow 
further rounds of screening. A small-unstructured colicin linker is inserted between 
the Adhiron and the pIII coat protein to present the Adhiron away from the surface of 
phage particles. A supressible amber stop codon (TAG) is included between the 
protein of interest and pIII coat protein coding sequences, which is not recognised as a 
stop codon by supressor strains of E. coli (supE strains) such as BL21 Star or ER2738. 
Supressor strains have a mutation in the tRNA anti-codon loop which reads the TAG 
codon as glutamine instead of a stop codon thus generating the full-length fusion 
protein linked to the pIII coat protein. In non-supressor strains (e.g. JM83), the amber 
stop codon is translated as a stop codon thus generating only solube protein fragments, 
not linked to the pIII coat proteins.  
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Figure 3-9 Shows the vector map of pBSTG1 Adh phagemid.  
The binder sequence is PHYT57 (Phytocystatin 57) is flanked by Nhe I and Not I 
restriction sites followed by 6 histidine tags. Colicin linker coding sequence codes for a 
small linker between the binder and the coat protein to present the binder away from the 
surface of phage particles. gIII gene fused with the binder sequence expresses the 
truncated part of the pIII coat proteins and helps in incorporating the fusion proteins 
into phage coat proteins. DsbAss signal sequence targets translocation of the fusion 
protein to the periplasm. (Figure provided by Sarah Deacon, Astbury Centre for 
Structural Molecular Biology). 
 
3.1.7.4. Biopanning   
Once the chimeric protein is presented on the surface of the bacteriophage, the phage 
particles are selected against the targets (antibodies, enzymes and other protein or 
non-protein molecules) using a selection process called panning (Figure 3-10). The 
library of the phage-displaying chimeric proteins is incubated on a receptor-coated 
surface. The surface is washed to remove non-specifically bound phages and the 
specifically bound phage particles are eluted out.  
To enrich the pool of binding sequences bacterial cells are infected with the eluted 
phage followed by an infection with a helper phage. This cycle can be repeated 3-4 
times with each cycle followed by an amplification step for more effective selection. 
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Figure 3-10  Phage selection using Biopanning. 
The phage display libraries displaying peptide product on the bacteriophage are selected 
by an affinity based selection procedure called panning. It involves binding of the phage 
displaying chimeric protein by incubation on the receptor coated surface. The non-
specifically bound phage particles are removed by washing and the specifically bound 
phage particles are eluted in end and the eluted pool is enriched by repetitive cycles of 
infection of selected phage particles in E. coli. Adapted from (Microbewiki, 2010). 
 
.
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3.2. Techniques 
 
3.2.1. Electrophoretic techniques 
Electrophoresis is defined as the migration of charged particles under the effect of 
electric field induced between the positive (anode) and the negative (cathode) 
electrode. Various biomolecules like proteins, oligonucleotides and nucleic acids 
exist as charged molecules at a particular pH in a solution. When an electric field is 
applied to move the molecules through the gel matrix, the cations (positively charged 
ions) move towards the cathode and the anions (negatively charged ions) move 
towards the anode (Wilson and Walker, 2000). A potential gradient, E is generated 
when a voltage difference is applied across the electrodes. E is equal to applied 
voltage (V) divided by the distance between the electrodes (d). 
The velocity of the charged molecule is dependent on the force applied on the 
molecules bearing charge, (q) Coulombs. The force applied is equal to E x q 
Newtons. Taking into consideration the frictional force (f is the frictional force 
coefficient) on the molecule due to shape of the molecule, viscosity of the buffer, 
pore size of the medium, the velocity of the molecule is given by Equation (3.1)  
v = E q / f                                                      (3.1) 
Ratio of the velocity of the ions to the electric field is termed as electrophoretic 
mobility (%). The movement of the molecules when a potential difference is applied 
is dependent on their charge as well as the molecular weight.  
A current is generated in the solution by the buffer ions as well as by the sample ions 
to a small proportion. Ohm’s law expresses the relationship as between voltage, 
current and resistance as (Equation 3.2):  
                           V/I = R                                                           (3.2) 
V is the voltage applied between the electrodes (Volt), I is the current generated 
(Ampere) and R is the resistance (Ohm).  
Ohm’s law demonstrates that if the voltage is increased, it leads to increase in 
current and thus accelerates the electrophoretic separation. However, current 
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produces heat and excessive heat can lead to irregular movement of samples in the 
gel.  
Electrophoresis is carried out on a porous support in which the buffer ions and the 
samples are able to migrate under the applied electric field. The two commonly used 
gel matrixes are:  
Agarose gel 
Agarose is a natural linear polysaccharide made up of agarobiose, which comprises 
of repeating units of D-galactose and 3,6-anhydrogalactose. On dissolving the 
agarose powder in a boiling buffer solution a macroporous matrix is formed which 
has a pore size depending on the percentage of agarose used. It is used in a 
concentration range of 1-3% depending on the size molecules to be resolved. These 
gels are used both for proteins and nucleic acids. As the pore size is larger therefore, 
its mostly used for DNA fragments of 50-20,000 bp in size.  
Polyacrylamide gel 
Polyacrlyamide is formed by polymerization of acrylamide monomer cross-linked by 
N, N’-methyl-bis-acrylamide (BIS). The polymerization of the acrylamide molecules 
takes place as a free radical catalysis in presence of ammonium persulphate (APS) 
and base N. N, N’, N’-tetramethylenediamine (TEMED). These gels can have varied 
pore size depending upon the percentage of both acrylamide and bis-acrylamide. 
Gels composed of higher percentage of acrylamide (12-20% w/v) retard the 
migration of large molecules more than the smaller ones whereas in gels composed 
of lower percentage of acrylamide (4-8% w/v) higher molecular weight molecules 
move faster than the smaller molecules. In SDS gel electrophoresis higher 
percentage of acrylamide (10 to 20 % w/v) is used for the separation of protein 
molecules. 
 
3.2.1.1. Agarose gel electrophoresis of DNA 
DNA molecules are mostly run on an agarose gel because of their large size as 
compared to proteins. The smaller the DNA molecule the faster it moves. For DNA 
size that ranges from 5-60 kb, 0.3% (w/v)  agarose is used and for DNA size in the 
range of 0.1-3 kb, 2% (w/v) agarose concentration is used. The conformation of 
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DNA affects the mobility of the DNA molecule in the gel. During the plasmid DNA 
preparation there are different forms of DNA observed on the gel. The uncut plasmid 
migrates faster than the linearised plasmid. In the uncut DNA, the supercoiled form 
of the DNA moves faster than the relaxed DNA of the same mass because the 
supercoiled DNA is more compact. 
The DNA in the gel is stained with a fluorescent dye called ethidium bromide that 
intercalates between the DNA base pairs. Under the ultra violet light (300nm 
wavelength), DNA bands appear orange red. Considering the harmful effects of 
ethidium bromide as a carcinogen, there are many alternatives to ethidium bromide 
like SYBR-based dyes used in nucleic acid detection that are significantly less 
mutagenic. It is essential to protect eyes from UV while visualising the DNA bands. 
 
3.2.1.2. Electrophoresis of proteins  
Sodium dodecylsulphate (SDS) polyacrylamide gel electrophoresis (PAGE) is used 
for the separation of protein mixtures according to their size. SDS 
(CH3-CH210-CH2OSO3-Na+) is an anionic detergent that binds to the proteins and 
creates a constant charge : mass ratio on the proteins. All proteins acquire a constant 
mass to negative charge ratio and thus, the separation of the proteins is based on 
their size. For denaturation, the protein samples are treated with !-mercaptoethanol 
and SDS that reduce the disulphide bridges present in the protein tertiary structure 
and disrupts all inter and intra molecular interactions in proteins. This yields 
polypeptide chains that are resolved on the gel on the basis of their molecular 
weight.  
The SDS PAGE is prepared with a narrow lower percentage polyacrylamide stacking 
gel poured over a primary polyacrylamide resolving gel. Proteins are loaded into the 
wells and under the applied electric field, the negatively charged protein molecules 
move through the stacking gel towards the anode. 
 This is done to concentrate the proteins in the stacking gel forming a sharp band 
before they enter the main resolving gel. This is important so that all the proteins in 
the sample enter the separating gel at the same time thus improving the resolution of 
the protein separation. Owing to its small size bromophenol blue dye is used in the 
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protein samples to indicate the electrophoresis front. The gel is removed and stained 
in Commassie Brilliant Blue that forms a non-covalent complex with the proteins 
producing a blue colour, which is seen on the gel. The gel is then destained which 
removes the unbound background. 
 
3.2.1.3. Western blotting 
Western blotting is a method to detect specific proteins that have been separated on a 
gel according to their size by gel electrophoresis. The gel containing the separated 
proteins is placed next to the membrane and the application of electrical current 
induces the proteins in the gel to move to the membrane. The detection of the 
specific proteins is done using antibodies against the target protein. 
The method used in this thesis to transfer the proteins to the nitrocellulose membrane 
is called semi-dry blotting wherein a sandwich of paper / gel / membrane / paper 
wetted in transfer buffer is held between two horizontal plate electrodes (cathode and 
anode). The blotted nitrocellulose membrane is then incubated with BSA (bovine 
serum albumin) or non-fat dried milk to block the hydrophobic sites on the 
membrane. Then it is incubated in primary antibody directed against the protein of 
interest. To visualise the interaction of the primary antibody with the protein of 
interest, the membrane is incubated in an enzyme conjugated secondary antibody, 
that binds to the primary antibody. The blot is then incubated in enzyme-substrate 
solution wherein the enzyme converts the substrate into a coloured product that is 
observed as a band on the nitrocellulose. One of the most common enzymes used in 
conjugation with the secondary antibodies is horseradish peroxidase (HRP). HRP is 
a 44 kDa glycosylated hemoprotein that acts as an oxidoreductase that is used to 
reduce hydrogen peroxide. This property of HRP is used to generate fluorescent or 
luminescent signals. Horseradish peroxidase can also be used in enhanced 
chemiluminescene (ECL). In ECL the substrate is hydrogen peroxide and a 
chemiluminescent substrate called luminol. HRP oxidizes luminol to produce light, 
which can be detected by exposing a photographic film to the emitted light.  
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3.2.1.4. Enzyme-Linked Immunosorbent Assay (ELISA) 
Enzyme-Linked Immunosorbent Assay (ELISA) is a solid phase technique designed 
to detect and quantify molecules like peptides, proteins, antibodies and hormones. 
The antigens are immobilized on the wells of a microtitre plate either directly to the 
surface or through capture antibodies. The primary antibodies are then applied that 
bind the antigens. If the primary antibody is conjugated with an enzyme, the 
detection of the antigens can be done directly. Depending upon the target molecule 
under investigation, the different types of ELISA shown in Figure 3-11 are as 
follows: 
Direct ELISA  
Antigens are immobilized on the surface and detected using enzyme-conjugated 
antibodies. On addition of an enzyme substrate, a visible colour is obtained which 
can be quantified using a spectrophotometer. The colour intensity can be correlated 
to the amount of the analyte (antibody or antigen) present in the sample 
(Figure 3-11(a)). 
Indirect ELISA  
Due to the constraint of the availability of enzyme-linked antibody specific against 
each target antigen, a single labelled antibody that can be used against different 
antibodies is used. This has led to the use of indirect ELISA where an unlabelled 
antibody against the antigen is used and is detected by using an enzyme labelled 
anti-immunoglobulin (Figure 3-11(b)). 
Sandwich ELISA 
 The antigen to be measured is bound to the surface through capture antibodies. The 
antigen is detected using an enzyme-conjugated antibody by forming a sandwich of 
the analyte between two primary antibodies (Figure 3-11(c)). 
Competitive ELISA 
A mixture of unlabelled antibody and the sample containing antigen are incubated 
together and then added to an antigen-coated well. After washing the wells to 
remove excess antibodies, a secondary antibody conjugated with an enzyme is added 
which is detected using an enzyme substrate reaction. If the amount of antigen is 
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high in the sample the signal obtained is low as the amount of antibodies bound to 
the coated antigens is low and vice versa (Figure 3-11(d)).  
 
 
 
Figure 3-11 Schematic representation of different types of ELISA.  
Adapted from (Abnova, c2014) 
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3.2.1.5. Protein purification using metal chelate chromatography 
In this affinity chromatography an immobilised metal ion such as Cu, Zn, Hg, Cd or 
a transition metal like Co, Ni or Mn is used to purify proteins by reacting with indole 
groups in tryptophan, thiol groups in cysteine and imidazole groups in histidine 
tagged fusion proteins. The metals are generally bound to the matrix (agarose, 
sepharose) through iminodiacetate or tris (carboxymethyl) ethylenediamine ligands. 
The proteins with surface exposed amino acids form a coordinate bond that must be 
sufficiently stable to allow the protein to attach to the matrix and also can be retained 
when the non-specific contaminants are removed during elution. The strength of the 
binding of protein to the metal ions is dependent on various factors like pH of 
buffers, length of affinity tag. The release of proteins can be achieved by 
destabilizing the protein metal complex by changing the pH of the elution buffer or 
by using a complexing agent like imidazole. Histidine tagged proteins that contain a 
long stretch of histidine residues at the carboxyl or amino terminus of the protein 
binds to divalent or trivalent ions. 
 
3.2.2. Spectrophotometry 
Spectrophotometer is used to estimate the concentration of analyte in a sample based 
on the absorption or reflection of light by the sample. Spectrophotometry is based on 
the Beer-Lambert law, which states that the amount of light of a particular 
wavelength absorbed by a substance across a constant pathlength is directly 
proportional to both the concentration of absorber as well as the thickness of the 
layer as given in Equation (3.3). 
                                                           A = # cl                                                      (3.3) 
Where # is the molar absorbance coefficient for the absorber at a particular 
wavelength (L mol-1 cm-1); c is the concentration of absorbing solution (mol L-1); l is 
the pathlength of the solution (cm). 
Spectrophotometer consists of a light source capable of producing a whole range of 
continuous wavelengths. To allow only small range of wavelengths to be directed to 
the sample, filters and diffraction gratings are used to separate the light into its 
component wavelengths. After passing through the sample compartment, the 
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outcoming light is detected by the photodetector that converts the signal into 
absorbance, transmittance or the concentration values. The wavelength of light to be 
used depends on the sample to be detected. (The UV region lies between 200 to 
400 nm and the visible region ranges from 400-700 nm) 
In case of proteins with the aromatic amino acid residues namely tyrosine and 
tryptophan exhibits an absorption maxima at 280 nm (Pace et al., 1995). 
Consequently proteins absorb UV-light in proportion to the aromatic amino acid 
content and the total concentration. The absorptivity coefficient of the proteins once 
established using their amino acid composition, the concentration of the proteins can 
be calculated.  
The nucleic acids concentration can be measured at 260 nm mainly due to the 
electronic transitions by purines and pyrimidine components.  
 
3.2.3. Circular Dichroism (CD) 
Circular dichroism is one of the methods to assess the structural properties of 
biomolecules. CD spectroscopy can analyse only optically active species. The 
optically active or chimeric molecules exist as mirror images.  
CD is based on the concept of circular polarisation. When two linearly polarised 
light beams, oscillating perpendicular to each other and propagating with a phase 
difference of quarter wave superimpose on each other, the resultant wave is a helix 
and is called as a circularly polarize light (CPL). The helices are either right-handed 
or left handed CPL. Depending on the sample to be analysed different light sources 
are used in CD like far-UV  to study secondary proteins, UV - analyse the tertiary 
structure of proteins and visible light- to monitor the interaction of proteins with 
metal ions. 
In the CD spectrometer the sample is placed in a cuvette and a beam of light is 
passed through the sample. The light coming from the source is converted to CPL by 
an optical element termed as quarter-wave plate that keeps the two polarization 
states out of phase by a one quarter wave (Kelly et al., 2005; Greenfield, 2007a; Van 
Holde et al., 2006). Proteins have some important chromophores that include peptide 
bonds, disulphide bonds and aromatic amino acids. When a circularly polarised light 
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falls on a protein the secondary structural elements such as "-helices, !-sheets, 
!-turns and random coil structures induce bands of distinct shape and magnitude 
(Figure 3-12). A helical structure shows an intense positive band at 190 nm and a 
negative band at 208 nm. The !-sheet protein has a negative band at 210-220 nm and 
a positive band between 195-200 nm. !-sheets may be parallel or anti parallel or 
mixed and therefore are more complex than the "-helices. The spectrum showing a 
negative band around 200 nm may depict disorderliness / random coils in the 
protein. 
 
 
Figure 3-12 Circular dichroism spectra. 
CD spectra of poly L-Lysine at pH 11.1 in the 1(black) "-helical and red 2 (red) 
antiparallel !-sheet conformations and at pH 5.7 in the 3 (green) extended 
conformations and placental collagen in its 4 (blue) native triple-helical and 5 (cyan) 
denatured forms (Greenfield, 2007). 
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3.2.4. Differential scanning calorimetry (DSC) 
DSC measures the change in the difference in heat flow rate to the sample and the 
reference material while the two specimens are subjected to identical temperature 
regimes in an environment heated or cooled at a controlled rate (Bhadeshia, 2002). 
Various DSC-based techniques have been developed to study the molecular 
transitions of biomolecules that includes unfolding processes in proteins, 
polynucleotides, and lipid assemblies. The heat capacity of a molecule changes as 
the thermal transitions take place with time and temperature.   
By definition specific heat capacity is the amount of heat required to raise the 
temperature of a unit mass of a substance by 1Kelvin. Molar heat capacity of a 
solution at constant pressure as a function of temperature is denoted as Cp.  
In a basic DSC experiment, the sample cell contains a solution with the molecule of 
interest and a reference cell with only the solvent (Figure 3-13). Both the solutions in 
the cells are heated at constant rate. Difference in the heat energy uptake between the 
sample cell and the reference cell so as to maintain both the cells at the same 
temperature corresponds to the difference in heat capacities. This difference in heat 
capacity reveals the ability of the molecule to absorb heat and experience an increase 
in temperature. The output from any DSC experiment is a thermogram showing the 
excess heat capacity (Cp, sample minus reference) as a function of temperature 
(Cooper et al., 2000). 
In case of a protein molecule, as the temperature increases the protein changes its 
form from native to unfolded state that leads to change in the heat capacity of the 
protein.  
Water (solvent) has a higher heat capacity than the protein because of its extensive 
hydrogen-bonding network. The non-polar groups of the protein molecule cannot 
make hydrogen bonds with the water molecules surrounding them. Therefore, the 
water molecules tend to maximize the hydrogen bonding within themselves leading 
to clathrate formation (Shinoda, 1977). Figure 3-13 shows three regions of 
thermogram of a simple globular protein: the pre-transition baseline, the endothermic 
unfolding transition and the post transition baseline.  
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As the temperature increases, the protein absorbs heat and the water molecules are 
exposed to the unfolding polypeptide chain and start reorganizing themselves as 
more non-polar side groups are exposed. The unfolding of the protein takes place 
over a temperature range characteristic for that protein. The pre-transition baseline 
shows a slightly positive slope as the heat capacity increases gradually with the 
temperature, giving rise to endothermic peak. The peak reaches to approximately the 
mid point temperature of process or the transition temperature (Tm). At the transition 
point 50% of the protein is in the native state and the rest is denatured. A sharper 
peak in the thermogram indicates that the process is cooperative such that change in 
a single structural association disturbs all other points of association. 
During the post transition process, the unfolding is complete and heat absorption 
decreases. A new baseline is established, that represents the Cp of the unfolded 
polypeptide and is usually found at a higher level than the pre transition baseline. 
The shift in the baseline is denoted as $Cp. The partial heat capacity (Cp) of the 
protein includes the heat capacity of the protein as well as the effect that protein has 
on the solvent (Freire, 1995). The heat capacity contributed by the protein is 
determined by subtracting a scan of a buffer blank from the protein sample before 
analyzing the data.  (Arntfield and Murray, 1981). 
The various factors responsible for the stability of the proteins involve hydrophobic 
interactions, hydrogen bonding, and conformational entropy (Pace et al., 1996). The 
melting point or the transition point indicates the thermal stability of the protein. The 
higher the melting point, less susceptible the protein is to unfolding and denaturation 
at lower temperatures (Bruylants et al., 2005). Reversibility of unfolding can be 
established by rescanning the sample under same conditions so as to obtain a second 
endothermic peak that superimposes the first peak. The determination of the 
reversibility of unfolding is important for extracting the complete thermodynamic 
properties of the protein (Chôma, 2006). 
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Figure 3-13 Differential scanning calorimetry.  
Shows two cells heated at the same rate , the reference cell and the sample cell. On the 
right hand side is a thermogram that shows the change in partial heat capacity (CP) as 
the temperature increases. The CP increases as the protein unfolds from its native state 
to an unfolded state At the peak temperature TM, half of the proteins are in native state 
and the rest are in denatured state. Adapted from (Frasca, c2014). 
 
3.2.5. Surface plasmon resonance (SPR) 
It is a technique to measure label-free biomolecular interactions in a real time 
environment while the ligands are immobilized on the surface and the analytes are 
passed over the surface. SPR based instruments use an optical method to measure the 
refractive index at an interface between two media of different refractive index. 
When a linearly polarised light comes from the higher refractive index (half circular 
prism), it bends towards the plane of interface (Figure 3-14). At a certain incident 
angle called the critical angle all the incident light is reflected within the circular 
prism. This phenomenon is called as the total internal reflection. Although the 
incident light is completely reflected but the electromagnetic field component is 
created in the lower refractive index media. This field is called as evanescent wave 
because there is an exponential decay of the wave amplitude with increasing distance 
from the interface. It has a depth of ~300 nm from the sensor surface that is used for 
the measurements.  
On the reflection side the prism is coated with a thin film of a noble metal. Gold is 
the most common metal used in most of the cases because it gives an SPR signal at 
convenient combinations of reflectance angle and wavelength. The intensity of 
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reflected light is reduced because of energy transfer to the gold electrons. When the 
energy of the incident light is just enough to excite the electrons on the gold surface, 
surface plasmon resonance is induced causing a dip in the intensity of reflected light. 
The angle at which the resonance occurs is called the resonance angle that depends 
on the refractive index of media on both sides of the thin gold film as well as the 
mass adsorbed onto the immediate vicinity of the film. The angle of resonance is 
sensitive to any change in the refractive index (RI) of the medium adjacent to the 
metal surface. For the detection of an interaction, one molecule (the ligand) is 
immobilised onto the sensor surface and an aqueous solution of the target molecule 
(analyte) is injected. When the binding takes place and the mass of analyte increases 
on the surface, there is a change in refractive index. This change of refractive index 
causes change in the angle of light at which the surface plasmon resonance occurs. 
Since it is not advantageous to directly deposit the biomolecules onto the surface, 
therefore surface functionalisation is done to create functionally active environment 
and to reduce non-specific binding. 
This change in refractive index is measured in real time depicted by a sensograms 
and the result is depicted as response units (RU). The sensorgram provides important 
information about the rate of interaction including association and dissociation 
constants that provides information about the ligand-analyte binding kinetics.  
 
 
Figure 3-14 Surface plasma resonance.  
The incident light falls on the hemi-cylindrical prism, it bends towards the plane of 
interface due to total internal reflection. Also there is an electromagnetic field 
component created in the lower refractive index that causes a dip in the intensity of 
reflected light. Adapted from (Biocompare, 2012) 
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3.2.6. Electrochemistry 
Electrochemistry is the study of interplay between electricity and chemistry i.e. the 
relationship of chemical aspects to the electrical entities like current, potential or 
charge. Electrochemical processes take place at the electrode-electrolyte interface . 
The electrode surface forms a junction between the two phases formed by an ionic 
conductor and electronic conductor. This project involves the study of the processes 
between the two neighbouring phases that is influenced by the change in the 
properties of the interface. To understand the interfacial layer of the electrode and 
the electrolyte it is important to understand the concept of electrical double layer. 
 
3.2.6.1. Electrochemical double layer 
Electrical double layer (EDL) is made up of electrical charge at the surface of the 
electrode itself and the charge of ions in the solution at small distance from the 
electrode surface. The charge on the electrode surface attract ions of opposite charge 
thus forming an ion atmosphere in the immediate vicinity of the electrode. This 
structure is called as electric double layer.  
The electrical properties of the double layer can be related to a conventional plate 
condenser where the capacitance is given by Equation (3.4) 
                                                            C= ##0 A/d                                                   (3.4) 
Where C, capacitance between the parallel plates of the condenser (Farad /F); #, 
permittivity of the medium between the condenser plates (F/m); #0, permittivity of 
the vacuum (F/m); A, electrode area (m2); d, distance between the charged plates 
(m). 
The factors that affect the electrical double layer capacitance include the electrode 
material, area of the electrode, the electrolyte surrounding the electrode (Lu et al., 
2013). 
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3.2.6.2. Electrolytic cell 
Electrolytic cell consists of a working electrode (WE) and a reference electrode (RE) 
surrounded by an electrolytic solution.  One of the main electroanalytical 
instruments used to measure electrochemical reactions when a metal electrode is 
surrounded by an electrolyte is called a potentiostat. The potentiostat keeps the 
working electrode at a fixed potential with respect to the RE. The following section 
describes the different types of electrodes in an electrolytic cell. 
 
 
Figure 3-15 Schematic of electrochemical cell. 
Shows the three electrode system of an electrolytic cell containing a reference, 
working and a counter electrode immersed in an electrolytic solution. The potential is 
applied on the working electrode with respect to the reference electrode and the 
current flow through the reference is controlled by allowing the current to flow 
through the counter electrode. Adapted from (Béron et al., 2010)  
 
Electrodes 
Working electrode (WE) 
It is the electrode where the electrochemical reaction stake place and is generally 
made up of inert metals like gold, platinum etc. 
Reference electrode (RE) 
One of the most commonly used RE is a Ag/AgCl reference electrode. It consists of 
a glass tube containing a silver wire (Ag) coated with a layer of solid silver chloride 
(AgCl), immersed in a solution that is saturated with KCl and AgCl. The lower end 
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of the glass tube is sealed with a ceramic frit that allows the slow movement of ions 
from the inner chamber (filling solution) to the outer electrolyte. This steady 
movement of electrolytes through the porous ceramic frit can lead to development of 
a junction potential or can also cause contamination on the electrode surface. To 
overcome this problem a double junction reference electrode is constructed where 
inner element formed by the silver / silver chloride cell is inserted into an outer tube 
containing a different electrolyte which is then in contact with solution in the 
electrochemical cell through a second porous frit (Figure 3-16).   
This double junction acts like a salt bridge and stabilises the potential between 
different solutions. 
 
 
 
Figure 3-16 Shows a double junction electrode with a built in reference 
electrode.  
Adapted from (Zoski, 2007) 
 
Counter electrode (CE) 
During the electrochemical process in a two-electrode system, the current flows from 
the WE to the RE, which leads to charge accumulation on the RE, and thus the RE 
potential is not stable over time. Therefore, a three electrode system is used wherein 
a third electrode called as the counter electrode is connected to the WE. This 
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maintains the current flows between the RE and the CE. The counter electrode is 
generally made up of platinum wire due to its inertness and conducting property.  
 
3.2.6.3. Cyclic voltametry (CV) 
It is one of the commonly used methods to detect qualitative information about 
electrochemical reactions or interfacial properties of an electrode. CV uses the 
property of the surface to become positively or negatively charged by applying a 
voltage on it. By placing the electrode in a solution containing an electroactive 
component, the electrons are accepted or gained by the electroactive component 
from the surface. In CV a particular potential is swept between two potential values 
(V1 and V2). The surface is subjected to starting voltage of V1 with respect to the 
reference electrode and then surface voltage is changed to higher or lower voltage at 
a particular rate. Finally the voltage is changed back to the original value (V1) at the 
same rate. During this process the surface becomes negative or positive and the 
electroactive species gains or loses electrons to the surface. This leads to a 
measurable current. The CV voltametry is presented between current and potential, 
potential on X axis and current on the Y-axis.  
If we consider an electrochemical reaction in an electrolytic solution containing a 
redox probe [Fe(CN)6]3-/4-. In the forward scan Fe3+ gets reduced to Fe2+ and when 
the scan is reversed the product gets converted to Fe3+. The flow of current is in the 
opposite sense to the forward sweep.  
Figure 3-17 represents a typical voltamogram. In the voltamogram, Epa represents 
the peak potential of the anodic sweep, and Epc represents the peak potential for 
cathodic sweep.  The difference between the anodic peak and the cathodic peak, 
&Epeak, can be calculated. For a reversible redox couple &Epeak is given by 
Equation (3.5) 
                                               n & Epeak= 59 mV                                                    (3.5) 
where n is the number of electrons involved in the redox reaction. 
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The ratio of the anodic peak current (ipa) to the cathodic peak current (ipc) is given by 
Equation (3.6). 
                                          ipa / ipc = 1                                                         (3.6) 
The formal potential Eo, for a reversible redox couple is the average of the two peak 
potentials given by Equation (3.7). 
                                                   Eo= (Epa + Epc) / 2                                               (3.7) 
 
 
Figure 3-17 Cyclic voltametry.  
Shows a voltamogram of a reversible redox couple for a single potential cycle. EPC = 
Peak cathodic potential; Ipc = Peak cathodic current; EPA = Peak anodic potential; IPA 
= Peak anodic current. 
 
Cyclic voltametry has been widely used to analyse the surface properties of an 
electrode as well as to know the oxidation / reduction state of a compound in an 
electrolyte. 
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3.2.6.4. EIS concept 
Electrochemical impedance spectroscopy (EIS) is a technique for the study of 
conducting materials and interfaces. Unlike the most common electrochemical 
techniques that are based on the application of direct current or voltage, EIS is based 
on the superimposition of sine wave potential of small amplitude over polarization 
potential of constant value. Electrochemical impedance is measured using a small 
excitation signal expressed as function of time as given in Equation (3.8). 
E(t) = E0 sin(!t)                                                   (3.8) 
E(t) is the potential at time t, E0 is the amplitude of the signal, and % is the radial 
frequency (%=2&f, frequency is expressed as f). In a linear system, the response 
signal, I(t), is shifted in phase (') and has a different amplitude, I0 as given in 
Equation (3.9). 
I(t) = I0 sin(!t + ')                                            (3.9) 
According to Ohm’s law the resistance to the flow of current through an electrical 
resistor is the ratio of voltage and current as given in Equation (3.10). 
                                                         R = V/I .                                                       (3.10) 
An expression analogous to Ohm’s law allows us to calculate the impedance of the 
system as ratio of E(t) and I(t) as given in Equation (3.11). 
                                                          Z = E(t)/ I(t)                                    (3.11) 
                                      = E0 sin(!t) / I0 sin (!t + ' ) 
                                                                 = Z0 sin(%t) / sin (!t + ' )               
Using Euler’s relation (e j'= cos(() + j sin((), this can be written as 
                                                              Z = Z0 e j
'                                                (3.12) 
The impedance is therefore expressed in terms of magnitude, Z0, and a phase, ' as 
given in Equation (3.12). It accounts for the combined opposition of all the 
84 
 
 
components within the electrochemical cell (resistors, capacitors) to the electron 
flow. 
Impedance is expressed in the form of real and imaginary components. Ohmic 
resistance is the real component and the capacitive reactance is the imaginary one. 
When the imaginary impedance component (Z") is plotted against the real 
impedance (Z') at each excitation frequency, it is called as Nyquist plot (Figure 3-
18(a)). Each point on the Nyquist plot is the impedance at one frequency. Impedance 
can be represented by vector arrow of length |Z| and the angle between the vector 
and x-axis is called the phase angle '. The lower frequency region is on the right 
hand side of the plot and the higher frequency region on the left hand side.  
If both the logarithm of the absolute impedance, |Z| and the phase shift, ', of the 
impedance, are plotted against the logarithm of the excitation frequency, it is called 
as Bode plot (Figure 3-18(b)). The Nyquist plot does not show the frequency 
information unlike the Bode plot. 
 
 
Figure 3-18 The Nyquist plot and the Bode plot. 
(a) The Nyquist plot shows the real part of Z(%) is plotted on x axis (ReZ) and the 
imaginary part is plotted on the y axis (-ImZ). (b) In the Bode plot impedance is plotted 
with log frequency on the x-axis and both the absolute values of the impedance (|Z|) and 
the phase-shift  (') on the Y-axis. Taken from (Gamry, c2014). 
!) b) 
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Chapter 4. Development of a novel non-antibody based 
recognition molecule 
 
4.1. Introduction 
Over the past few years antibody-based biosensors called immunosensors have been 
used to detect various protein biomarkers (Conroy et al., 2009). The main limitations 
in using antibodies as recognition molecules has been the complex and bulky nature 
of antibodies (see Chapter 2). Moreover antibodies require post translational 
modifications like formation of disulphide bonds and glycosylation, which restrains 
their production to eukaryotic expression systems.  
An alternative to using antibodies is to utilise an entirely different class of small 
robust proteins as scaffolds, into which variable peptide sequences are inserted into 
their loops to generate artificial antibodies (Colas, 2008). Considerable efforts have 
been made to engineer many different protein scaffolds over the past years. These 
include, affibodies based on the Z-domain of Staphylococcal protein-A (Nord et al., 
1997; Wahlberg et al., 2003), Kunitz domains (Nixon and Wood, 2006), designed 
ankyrin repeat proteins (DARPins) (Mosavi et al., 2004), anticalins (Skerra, 2008) 
and repebodies (Lee et al., 2012). The smaller size of these artificial antibodies 
reduces the steric hindrance when immobilised on the substrate and increases surface 
coverage during immobilisation (Huang et al., 2005). These alternative scaffold 
proteins do not require post-translational modifications and therefore, are produced 
more economically and easily in yeast or bacteria (Colas et al., 1996).  
One of the approaches to produce a highly stable protein is to use a consensus design 
strategy wherein, a protein is designed based on the consensus from multiple 
sequence alignment of independent protein sequences all folding stably to the same 
structure (Main et al., 2003). The underlying hypothesis of this approach is that as a 
result of selection during evolution of proteins, the residues that are important for 
their functioning and stability are the most conserved ones amongst the homologous 
proteins. Proteins generated through consensus design have shown higher stability 
86 
 
 
over their natural counterparts e.g. enzymes (Lehmann et al., 2002) and antibodies 
(Knappik et al., 2000). It has also shown that evolution selects for function and 
optimises stability only to the required environment but through consensus strategy 
the stability can be improved so that the protein can withstand different 
environmental conditions. Based on such a strategy, a new artificial binding protein 
scaffold called Adhiron has been engineered by McPherson group at the Centre for 
the Structural and Molecular Biology at the University of Leeds (Tiede et al., 2014). 
It is based on a consensus sequence of plant-derived phytocystatins. Phytocystatin 
proteins (~100 amino acids) naturally inhibit cysteine proteinases (Kondo et al., 
1991). This designed consensus protein is an ideal scaffold, due to its small 
monomeric nature, high solubility, stability and no requirement for post-translational 
modification. Due to its potential to present constrained peptide sequences for 
molecular recognition it was investigated as an option for a non-antibody protein 
scaffold. The consensus sequence was shortened to give rise to two versions namely 
Adhiron 92 that consists full-length adhiron scaffold and Adhiron 81 with 
N-terminal truncated amino acids. Codon optimisation was done on Adhiron 92 
sequences so that it is well expressed in E. coli. Figure 4-1 shows the amino acid 
sequence of the codon-optimised Adhiron 92 scaffold with secondary structure 
elements that include four "-sheets and one "-helix. 
The crystal structure of Adhiron scaffold (92 residues) has been revealed. Adhiron 
consists of a four-strand anti-parallel "-sheet core and a central helix, which is a 
characteristic of proteins belonging to cystatin family (Figure 4-1). It has a compact 
structure and the unstructured loops are limited, which signifies a stable protein. 
Residues 1-10 and 90-92 were not clearly visible in the crystal structure and were 
assumed to be disordered. Loop 1 was positioned between the first and the second 
"-strand. The loop 2 was present between the third and the fourth "-strand. 
The Adhiron scaffold showed a melting temperature of 101 ºC that makes it a highly 
thermally stable scaffold. The high thermal stability and compact structure of 
Adhiron scaffold supported the fact that consensus sequence based protein modelling 
results in designing highly stable proteins. 
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Figure 4-1 Amino acid sequence of Adhiron92 scaffold with secondary 
structure elements. 
The figure depicts the amino acid sequence of of codon-optimised Adhiron92 scaffold 
showing the position of secondary structures ("-helix and !-sheets) (Tiede et al., 
2014). 
 
 
Figure 4-2  X-ray crystal structure of Adhiron 92 scaffold. 
Adhiron92 scaffold has a single alpha helix and the four anti-parallel beta strands are 
shown in white with the insertion sites for library production shown in black. Residues 
1-10 and 90-92 are not visible in the structure (Tiede et al., 2014). 
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This chapter discusses briefly the creation of Adhiron based library followed by 
cloning of the library into pBSTG1 phagemid (see section 3.1.7.2.). Adhiron based 
phagemid library was used to select binders against anti-myc tag antibodies using 
phage display library by the BSTG group.  
It then discusses the selection of Adhiron myc binders, their cloning and expression 
in vector pET-11(a). Initially, a random binder-Adhiron GST B4 was selected 
against a different protein (glutathione S-transferase) and was used to optimise the 
cloning of Adhiron sequence into pET-11(a), its expression and purification. The 
optimised conditions were then used for the cloning, expression and purification of 
ten Adhiron myc binders. 
The optimisation of the expression and purification was done to establish the best 
conditions for high yield of Adhiron myc binders and for maintenance of their 
stability and purity for the subsequent analysis. 
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4.2. Materials and methods 
The materials and methods used in cloning, expression, purification and 
characterisation of the Adhiron myc binders are described here in detail. 
 
4.2.1. Materials 
 
4.2.1.1. Bacterial strain  
Different strains of bacterium Escherichia coli were used at various steps of the 
protocol depending upon the requirement. 
XL10 Gold (Stratagene) 
XL10-Gold cells are tetracycline and chloramphenicol resistant. The cells are 
deficient of restriction systems [&(mcrA)183 &(mcrCB-hsdsSMR-mrr)173]. 
Inactivation of endonuclease I gene and deficiency of recA improves the quality of 
miniprep DNA and ensures insert stability. The transformation efficiency of ligated 
and large super-coiled DNA is improved by the Hte phenotype. The lacIqZ&M15 gene 
on the F´episome allows blue-white screening for recombinant plasmids. This plasmid 
is also ideal for constructing complex plasmid libraries as it decreases size bias and 
therefore, produces larger libraries. XL10-Gold ultracompetent cells were purchased 
from. 
BL21 Star (DE3) (Stratagene) 
OmpT, an outer membrane protease present on the chromosomal DNA of E. coli is 
absent in this bacterial strain, therefore reducing the degradation of heterologous 
proteins. DE3 lysogen present in the strain carries the T7 RNA polymerase gene under 
the lacUV5 promoter. T7 RNA polymerase over-expresses itself in the presence of 
IPTG (Isopropyl !-D-thiogalactoside) due to de-repression of the lacUV5 promoter. 
The mutated rne gene that encodes a truncated RNase E enzyme lacks the ability to 
degrade mRNA, thus increasing the mRNA stability. This leads to higher basal 
expression of heterologous genes. This strain is E. coli B/r strain that does not contain 
lon protease.  
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4.2.1.2. Vectors 
Phagemid vector pBSTG1  
pBSTG1 phagemid containing different Adhiron myc binder sequences was obtained 
from BSTG group (see section 3.1.7.2). It consisted of a recombinant coding sequence 
flanked by Nhe I and Not I restriction sites. It contains an ampicillin (amp) resistant 
gene for selection. 
Cloning and expression vector pET-11(a) 
The pET-11a vector carries a T7 promoter and a T7 termination site. It comprises of a 
multiple cloning site, Lac I repressor coding sequence, pBR322 origin of replication 
and an ampicillin resistant gene (amp). It is 5677 bp in size (Figure 4-3). 
 
 
 
Figure 4-3 Schematic representation of pET-11(a) adhiron myc binder 2 
plasmid. 
(Figure provided by Sarah Deacon, Astbury Centre for Structural Molecular Biology). 
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4.2.1.3. Growth media for E. coli 
Luria-Burtani broth (LB) 
The composition of the Luria-Burtani broth (Appendix-Table 1).  
LB agar 
LB media was prepared as mentioned in Appendix-Table 1 and dispensed into bottles. 
Then 15 g/L of agar bacteriological (agar no.1) was added to the bottles to get a final 
concentration of 1.5% (w/v). The agar media was autoclaved immediately at 121ºC, 
15 psi for 20 min and stored at room temperature. 
Autoinduction media 
ZY Component 
Yeast extract 5 g/L and bactotryptose (tryptone) 10 g/L were dissolved in deionised 
water. 
1 M MgSO4 
24.65 g of MgSO4.7H2O was dissolved in 100 mL deionised water. The solution was 
filter sterilised through a 0.22 %m filter. 
40 % (w/v) glucose 
40 g of glucose was dissolved in 100 mL deionised water. Solution was filter sterilised 
through a 0.22 %m filter. 
20 X NPSC 
See Appendix-Table 2.  
Trace elements 
See Appendix-Table 3.  
ZYP-0.8G Media 
See Appendix-Table 4 . 
Pre-formulated autoinduction media 
Pre-formulated autoinduction media from ForMedium™ were used that included: 
LB-Luria Burtani, 2YT-Yeast tryptone, TB-Terrific Broth, SB-Super Broth. The AIM 
92 
 
 
or auto induction media as produced and supplied by ForMedium™ are based on the 
work of F. William Studier (Studier, 2005). 
 
4.2.1.4. Bacterial antibiotic selection 
 See Appendix-Table 5. 
 
4.2.1.5. Bacterial Growth conditions 
LB growth conditions 
The LB agar media plates streaked with the E. coli bacterial culture were incubated in 
a stationary incubator at 37 ºC.  Starter cultures were set-up by inoculating single 
colonies from LB-agar plates into 5-10 mL LB media containing the appropriate 
antibiotic and incubated in an orbital incubator at 37 ºC, 200 rpm. Larger scale 
cultures were set-up by a 1/500 - 1/1000 dilution of starter culture into the required 
volume of media using a flask to media ratio of 5:1.  
For plasmid extraction, cultures were grown to saturation overnight. Unless otherwise 
stated all E. coli cultures were grown at 37 ºC. 
Autoinduction growth conditions  
The plasmids were transformed into selected E. coli strain for expression and the 
transformed culture was streaked on an LB plate. The next day a single colony was 
picked from LB-agar plate and grown in 2 mL of ZYP-0.8G containing appropriate 
antibiotics in a 24 deep-well plate. The plate was incubated at 37 ºC at 1300 rpm for 6 
hr in a plate incubator. 20 %l of the starter culture was used to inoculate 2 ml of pre-
formulated autoinduction media –LB, 2YT, TB, SB (ForMedium, UK) in a 24 deep 
well plate and grown at 25 ºC at 1300 rpm in a plate shaker (Incubator 1000, Heidolph 
UK). At different time intervals -16, 24, 40, 48, 60, 72 hr 200 %l of samples were 
collected from each culture. Cells were harvested and pellets were frozen at -20 ºC. 
For scaling up the culture, 400 mL of selected autoinduction media contained in 2 L 
baffled flask was inoculated with 200 µL of the 2 mL starter culture. Flasks were 
grown at 25 ºC at 250 rpm for the appropriate incubation time.  
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The cells are harvested by centrifugation at 3000 gm (Rotana 460R, Hettich lab 
technology) for 30 min and frozen at -20 ºC. 
 
4.2.2. Techniques 
 
4.2.2.1. Plasmid isolation 
The Wizard Plus SV Minipreps DNA Purification System (Promega) was used for 
plasmid isolation as per the manufacturer’s instructions. 
 
4.2.2.2. Agarose gel electrophoresis  
0.5 to 1 % (w/v) agarose was dissolved in 1 X TAE buffer (Appendix-Table 6). The 
solution was boiled in a microwave oven, poured onto a casting tray. SYBR Safe 
DNA gel stain (Invitrogen) (1:10,000) was mixed in the gel before it solidified. A 
comb was placed across the end of the gel to form wells. The gel was allowed to cool 
down at room temperature until it solidified. The tray was put in 1 X TAE 
buffer-filled electrophoretic chamber, containing positive electrode at one end and a 
negative electrode at the other end. The comb was removed and allowed the buffer to 
cover the gel up to 1mm. 
Gel-loading buffer (Appendix-Table 7) was added to the samples (1/10) and loaded 
into the wells, along with a prestained DNA marker (MassRuler DNA Ladder Mix, 
Fermentas). A DC power source was connected to the electrophoretic apparatus and 
100 V fixed voltage was applied. The power was disconnected when the trail of 
bromophenol was seen at the bottom of the gel. The agarose gel apparatus used was 
RunOne electrophoretic cell (EmbiTec). 
 
4.2.2.3. Restriction digestion 
Restriction enzymes - Nde I, Nhe I-HF, Not I-HF, Bam HI-HF and Dpn I (NEB) were 
used as per the manufacturer’s instructions (Appendix-Table 8). High fidelity (HF) 
enzymes were used to avoid star activity. Star activity is caused when the restriction 
enzymes cleave sequences similar but not identical to the defined restriction site. 
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4.2.2.4. Gel extraction of DNA fragments 
The samples were run on 1 % (w/v) agarose gel and the desired fragments were 
extracted from the gel by using the gel extraction kit (The Wizard SV Gel and PCR 
Clean-Up System, Promega). It is a silica-membrane based method, which can bind to 
40 %g of DNA. After binding to the membrane the DNA was eluted in deionized 
water. The protocol was followed as per the manufacturer’s instructions. 
 
4.2.2.5. Polymerase chain reaction 
KOD Hot Polymerase (Novagen) (Mizuguchi et al., 1999), is a premixed complex of 
KOD DNA Polymerase and two monoclonal antibodies that inhibit DNA polymerase 
and 3’-5’ exonuclease activities at ambient temperatures. This inhibition reduces non-
specific amplification as the mispriming events occuring during initial temperature 
increase. The composition of KOD Hot Polymerase mix for PCR reaction is given in 
Appendix-Table 9. 
Phusion DNA polymerase master mix (NEB) 
 It consists of a novel Pyrococcus–like enzyme fused with processivity enhancing 
domain to increase fidelity and speed. It generates blunt ended products. The 
composition of Phusion DNA polymerase mix is given in Appendix-Table 10. After 
amplification, reaction mixture was incubated in 1 %l of Dpn I enzyme at 37 ºC for 1 
hr. 
Amplification was carried out using MJResearch Thermal Cycler, using the cycling 
conditions mentioned in Appendix-Table 11. A 5 µL aliquot of the PCR product was 
analysed on an agarose gel to confirm the yield and size. 
 
4.2.2.6. DNA ligation 
For the successful ligation of DNA molecules ligation reaction is set up in such a way 
that many recombinant molecules are formed and less of vector / vector and 
insert / insert products are formed. The total concentration of DNA molecules and the 
molar ratio of insert to vector molecules is considered. For cohesive ends:   
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3:1 insert:vector ratio, 9-90 fmol (Femtomoles) of insert, 3-30 fmol of vector and 
10-100 ng of total DNA were used. 
Calculations 
Considering ligation of Adhiron GST B4 into pET-11(a) vector. 
Size of plasmid pET-11(a) = 5639 bp (base pairs) 
Molecular mass of ds(double stranded) DNA fragment = Number of bp x 660Da 
Molecular mass of ds plasmid = 5639 x 660 = 3.7x106 Da 
1 mole = 3.7x106 g 
1 fmol = 3.7 ng 
15 fmol = 55.5 ng 
Size of Adhiron GST B4 insert = 374 bp 
Molecular mass of ds insert = 374 x 660 Da 
1 mole = 374 x 660 g 
1 fmol = 0.24 ng 
45 fmol = 10.8 ng 
Total DNA = 66.4 ng 
Ligation was set up using the composition in Appendix-Table 12, using T7 DNA 
ligase and ligase buffer (NEB). The reaction mixture was kept at room temperature for 
2 hr.  
Note: Restriction enzymes that were used to cut the DNA fragments were heat 
inactivated before setting up ligation reactions. The heat deactivation conditions for 
restriction enzymes are given in Appendix-Table 13. 
 
4.2.2.7. Zero Blunt PCR cloning  
Zero Blunt PCR cloning kit (Invitrogen) was used to clone blunt-end PCR products. It 
consists of a cloning vector pCR  blunt along with ExpressLink™ T4 DNA Ligase for 
ligation purpose. It is designed to clone blunt PCR fragments with a low background 
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of non-recombinants. pCR-Blunt vector contains a lethal E. coli ccdB gene fused to 
the C-terminus of lacZ". On ligation of the blunt fragment into the vector, the lacZ"-
ccdB gene expression is disrupted and therefore, only the positive recombinants are 
able to grow and the non-recombinant cells die. The plasmid has Kanamycin and 
zeocin resistant genes for selection. It has M13 forward and reverse priming sites for 
sequencing. The Zero blunt PCR cloning mixture is given in Appendix-Table 14. The 
reaction mixture was incubated for 5 min at room temperature and transformed into 
XL10 Gold cells. 
 
4.2.2.8. Transformation 
Cells were taken out from the -80 ºC freezer and allowed to thaw on ice. 1 %l of 
plasmids obtained after a miniprep or 5 %l ligation mixture obtained after ligation 
reaction of two DNA fragments were mixed with 50 %l XL10 Gold cells / BL21 Star 
(DE3) cells and incubated on ice for 15 min. Then the mixture was heat shocked at 
42 ºC for 45 sec followed by incubation on ice for 2 min (Hanahan, 1983). 250 %l of 
LB was added to the cells and incubated in a shaker incubator at 37 ºC for 1hr. 100 %l 
of the culture was streaked on agar plates.  
 
4.2.2.9. Colony PCR using GoTaq polymerase 
Single colonies were picked from plates using an inoculation needle and swirled in 
100 %L of deionised water. The needle was then put in 4 mL LB containing 
carbenicilin at 37 ºC on a shaker incubator at 250 rpm to perform minipreps. The 
100 %L solution was boiled at 100 ºC to lyse the cells and 2 %L of the solution was 
added to 18 %l of GoTaq Green mastermix (Promega) in PCR tubes. 
GoTaq Green master Mix 
The composition of the master mix used in the PCR is given in Appendix-Table 15. 
Green GoTaq Flexi Buffer increases the density of the sample and contains two dyes 
(a blue dye and a yellow dye) that separate during electrophoresis, allowing reactions 
to be loaded directly onto an agarose gel without the addition of loading dye. 
Positive control: pBSTG1 vector containing GST B4 insert. 
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Negative control: Uncut pET-11(a) vector and a reaction mixture of the GoTaq 
polymerase without the DNA templates. 
Thermocycling conditions used are given in Appendix-Table 16. 
 
4.2.2.10.  Protein extraction and purification 
Cell lysis 
Using lysis buffer  
Cell lysis was performed using a cell lysis buffer (Appendix-Table 17). In expression 
trials 1 ml sample was collected from 400 mL cell culture, the sample was centrifuged 
at 16000 g using GenFuge 24D from (Progen). The pellet was resuspended in 200 %l 
of lysis buffer and incubated at room temperature with agitation on a plate mixer at 
1000 rpm for 35 min. 
Using sonication 
The cell pellet obtained after centrifugation of 400 mL culture at 3000 g for 30 min 
(4 ºC). The pellet was resuspended in 50 mL binding buffer and pipetted until the 
pellet was completely dissolved. The resuspended pellet was sonicated using Branson 
sonicator. It was done using 50 % duty cycle for 30 seconds on and 30 sec off for 5 
cycles. The tube containing the suspended cells was kept on ice throughout the 
sonication to prevent overheating. 
To separate the solubilised fraction from the cell debris, the sample was centrifuged at 
16000 g (Beckman, Avanti) for 20 min. 
 
Purification 
Purification was done using 1 mL Hitrap column (GE healthcare). The column was 
first washed with deionised water. 100 mM NiSO4 was prepared by dissolving 2.628 g 
in 100 ml of deionised water. 0.5 ml of 0.1 M NiSO4 solution was loaded on the 
column. Then the column was washed with deionised water and preequilibrated with 
10 CV (column volume) of binding buffer (Appendix-Table 18). Using a syringe, the 
cleared supernatant obtained after the cell lysis of the bacterial cell-pellet was applied 
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on to the column. The first flow through was collected for analysis. Then the column 
was washed with 10 CV of binding buffer followed by 10 CV of wash buffer 
(Appendix-Table 19). The fractions were collected from binding buffer and wash 
buffer for further analysis. 10 CV of elution buffer (Appendix-Table 20) was run 
through the column and 1 mL fractions were collected in a 96 well plate. 10 %L of the 
collected samples were run on 15 % (w/v) SDS PAGE. The elution fractions 
containing protein (observed on the gel) were pooled together. The column was 
stripped using 5 CV of stripping buffer (Appendix-Table 21), washed with deionised 
water and then column was stored in 20 % (v/v) ethanol at 4 ºC. 
 
4.2.2.11. Dialysis 
The proteins eluted in elution buffer were dialysed using Biodesign dialysis tubing 
(3.5 kD MWCO) purchased from Thermo Fisher Scientific.  
The tubing was cut according to the volume of the solution and one end was folded 
and pinched in a clamp. The solution was pipetted into the tubing through its open 
end. The end was tied off using another clamp. The tubing was placed in 1 L of 
1 X PBS / phosphate buffer saline (Appendix-Table 22). A stir bar was added in the 
beaker and it was put on a stir plate overnight in the cold room. The dialysis buffer 
was changed twice the following day.  
 
4.2.2.12. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
1/3 volume of sample denaturing mix (Appendix-Table 23) was added to each sample 
(purified and dialysed proteins) and  boiled for 5 min. The samples were left to cool 
on a bench before loading them on to the gel. The samples were analysed on a 15 % 
(w/v) SDS PAGE (Appendix-Table 24 and 25) (Laemmli, 1970). Protean III gel (Bio-
Rad) apparatus was used to set up the gel electrophoresis. 1 X running buffer 
(Appendix-Table 26) was poured into the buffer chamber. A constant voltage of 150 
V was applied across the gel with initial current ~60 mA and the electrophoresis was 
run for 45-60 min. The gel was removed from the apparatus and stained with 
Coomassie brilliant blue (Appendix-Table 27) for 30 min to 1 hr. Then it was 
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destained in destaining solution (Appendix-Table 28) for 6-7 hr and the destaining 
solution was changed thrice in between. 
All solutions were stored at room temperature. 
4.2.2.13. Dot blots 
The samples were lysed using lysis buffer. Lysed cells were dissolved in dot blot 
solubilisation buffer (Appendix-Table 29). 12.5 %l of lysed cells were mixed and 
vortexed thoroughly with 37.5 %l of solubilisation buffer so that the final 
concentration is 37.5 mM TRIS, 225 mM NaCl and 6 M GuHCl. The samples are then 
incubated at room temperature at for 1 hr to achieve complete solubilisation. 
A piece of thick blotting paper and a piece of nitrocellulose membrane were cut to the 
required size for the number of samples. Nitrocellulose membrane was placed on top 
of blotting paper and clamped into place using dot blot apparatus. 3 %l of solubilised 
samples were pipetted on to the membrane aiming to blot onto centre of each well. 
His-tagged TEV concentrations made in the dot blot solubilisation buffer were used as 
control. The samples were allowed to dry once all were loaded onto the membrane. 
The membrane was blocked for 1 hr at room temperature in 3 % (w/v) BSA and 
1 X TBST buffer.  
 
4.2.2.14. Western blots 
A strip of nitrocellulose and 6 pieces of thick blotting paper were cut of the same size 
as the gel. The nitrocellulose and the gel were soaked in transfer buffer 
(Appendix-Table 30) for 10 min. 3 pieces of soaked blotting paper were placed in the 
middle of the lower electrode-anode and the pre-soaked nitrocellulose was placed on 
top. The gel was placed over the stack of the blotting paper and nitrocellulose, which 
was further layered by 3 pieces of blotting paper. The upper electrode-cathode was 
placed onto the stack. The proteins were blotted from the gel to the nitrocellulose 
membrane by applying a constant current 0.8 mA per cm2 for 1 hr. The blot was 
further analysed by immuno detection of proteins.   
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4.2.2.15. Immuno detection of proteins 
The membrane was blocked in 3 % (w/v) BSA in 1 X TBST buffer for 1 hr at room 
temperature. It was then washed in 1 X TBST buffer for 10 min. The buffer was 
decanted and the step was repeated twice. Immunodetection of the proteins was done 
using anti-histidine horseradish peroxidase (HRP) conjugated antibody purchased 
from R&D Systems. 1/5000 dilution of the antibodies was prepared in TBST 
containing 3 % (w/v) BSA. The membrane was incubated in the antibody solution for 
1 hr at room temperature or 4 ºC overnight. 
The chemiluminescent detection was done using SuperSignal West Pico 
chemiluminescent substrate (Thermo Scientific). 
1 mL of reagent A was mixed with 1 mL of reagent B and pipetted onto the 
membrane, covering the area of detection for 2 min and visualised under Syn gene 
bioimaging system (Scientific lab supplies). 
 
4.2.2.16. Characterisation 
Circular Dichroism Spectroscopy 
CD measurements of the purified binders were carried out on an Applied 
Photophysics Chirascan CD spectropolarimeter. 1 mg/mL of each protein was 
prepared in 1 X PBS for analysis. The spectra were collected from 190 to 260 nm and 
repeated with two scans. The data were analysed using Dichroweb analysis server 
(Whitmore and Wallace, 2004) based on CDSSTR algorithm calculated using SP175 
reference data set (Sreerama and Woody, 2000; Lees et al., 2006). 
 
Differential Scanning Calorimetry  
DSC measurements were carried out on VP-DSC (Microcal). The Adhiron scaffold 
and Adhiron myc binders were prepared at a concentration of 0.5 mg/mL in 1 X PBS 
at pH 7.4. Protein samples and buffer were degassed twice under vacuum for 10 min. 
The scanning was performed between 11 ºC and 130 ºC at a scan rate of 90 ºC/hr with 
a 15 min prescan equilibration. Repeated heating and cooling cycles were performed 
on the proteins.
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4.3. Results 
The consensus strategy based design of Adhiron scaffold showed high thermal 
stability (101 ºC) and well-defined secondary structures with two variable loops 
(Figure 4-1 and 4-2). The application of this scaffold as an artificial antibody was still 
to be determined. To check the functioning of the adhiron scaffold when different 
randomised inserts are present in the two loops and the N-terminus of the scaffold, a 
library based on Adhiron with randomised inserts in the three variable regions was 
obtained from Sloning technologies.  
 
4.3.1. Generation of Adhiron based library by BSTG 
The Adhiron scaffold with randomised insertions in the three variable regions were 
cloned into pBSTG1 phagemids  by the BSTG, University of Leeds, UK. 
These phagemids were transformed into the E. coli ER2738 cells and the phage 
particles were produced using M13KO7 helper phage for superinfection. The library 
size was approximately 1 x 1010, with a complexity up to 86 % after phage production, 
indicating a very high quality of the library. 
 
4.3.1.1. Phage display 
A phage display was performed by using polyclonal anti-myc tag antibodies, to prove 
the versatility and stability of the Adhiron scaffold when peptide inserts were present 
in different loops to target c-myc epitope (EQKLISEEDL). This epitope was chosen 
to compare the sequences of the binding scaffolds with the c-myc epitope.   
Anti-myc tag antibodies were biotinylated to allow immobilisation via streptavidin. 
The phage particles eluted were incubated with ER2738 cells and then the cells were 
infected with M13K07 helper phage. After three rounds of panning, 48 Adhiron myc 
binder clones were picked up randomly and then a phage ELISA was performed. 
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4.3.1.2. Phage ELISA 
The phase ELISA was performed to investigate binding of the 48 Adhiron myc binder 
clones to anti-myc tag antibodies. 
Streptavidin coated plates were labelled with biotinylated anti-myc tag antibodies. The 
phage-containing medium was added to the wells. The binding was confirmed by 
using HRP-conjugated anti-phage antibody. The binding was visualised using 
3,3#,5,5#-Tetramethylbenzidine (TMB) liquid substrate. Figure 4-4 shows the 96 well 
ELISA plate, wherein the binding of all clones was checked against anti-myc tag 
antibodies (well A1 to H6). The binding of the clones was also checked against the 
blocking agent (casein) from well A7 to H12. Binder in A1 has a control in A7 and 
likewise for the other binders. Binders in C5 and H6 showed signal in their 
corresponding control wells thus they were not specific for the anti-myc tag 
antibodies. 
Out of the 48 clones, 20 were randomly selected and sequenced (Figure 4-5). Their 
sequencing results confirmed the similarity of sequences in different loops of the 
Adhiron myc binders with the myc epitope sequence (EQKLISEEDL).  
The similarity of the sequences in different loops with the myc epitope proved the 
functionality of the scaffold to present the binding regions in different loops. 
Depending on the intensity of colour obtained in the phage ELISA, the 20 binders 
were named from clone 1 to clone 20 and were investigated  further as the candidate 
binders to be used for the biological layer of the biosensor.  
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Figure 4-4 ELISA to show binding of Adhiron myc binders. 
Shows the 96 well plate ELISA done on 48 Adhiron myc binder clones randomly chosen after three 
rounds of panning of phage display library. A1 to H6 were immobilised with the 48 clones and A7 to 
H12 corresponding to the control against the blocking against where A1 has a control well A7 and 
similarly each clone has its corresponding control well. The binders in well C11 and H12 shows non-
specific binding. (Provided by Christian Tiede, Bioscreening Technology Group, Biomedical and 
Health Research Centre, University of Leeds). 
 
 
Figure 4-5 The sequences of the 20 Adhiron myc binders. 
The Adhiron myc binders were numbered from position of clone 1 to clone 20 in decreasing order of 
their intensities obtained in the phage ELISA. (Provided by Christian Tiede, Bioscreening Technology 
Group, Biomedical and Health Research Centre, University of Leeds). 
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4.3.2. Selection of Adhiron myc binders 
Ten out of the twenty binders were chosen for this project. The selection was based on the position 
of sequences resembling the myc epitope  presented in different loops of the scaffold. The following 
Adhiron myc binders were chosen: 
Adhiron myc binders 1, 2, 4, 5, 7, 11, 13, 17, 18 and 20. Figure 4-6 shows the sequence alignment 
of the chosen Adhiron myc binders. The sequence alignment was done using Clustal W. The 
Adhiron myc selected show binding to anti-myc tag antibodies and similarity in the sequences 
corresponding to the myc epitope EQKLISEEDL. 
 
 
Figure 4-6 The sequence alignment of the ten selected Adhiron myc binders.  
The sequence alignment of Adhiron myc binders shows the following- Single letters: aminoacids, star 
(*): conserved sequence, the N-terminal, loop 1 and 2 represent the three variable regions where the 
random amino acids sequences have been inserted. (Key: Colour Red: small hydrophobic, aromatic and 
not Y. Blue: acidic. Magenta: basic, Green: hydroxyl, amine, amide, basic aminoacids.) 
 
4.3.3. Cloning  
The phage coat proteins fused with Adhiron myc binders could obscure the study of interaction of 
Adhiron myc binders with the anti-myc tag antibodies. Thus, the Adhiron sequence was cloned into 
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pET-11(a), to increase its expression and to remove the phage coat particles fused with the protein. 
The expression and purification of the Adhiron based sequences had not been optimised previously 
and therefore, at the start of the project it optimisation was performed using a random binder-
Adhiron GST B4, selected against a different protein (glutathione S-transferase). The optimised 
conditions were then used for the cloning, expression and purification of the Adhiron myc binders. 
 
4.3.3.1. Checking plasmids on agarose gel 
Different pBSTG1 phagemids containing the ten Adhiron myc binders and Adhiron GST B4 binder 
were transformed into XL10 Gold cells. pET-11(a) expression vector was also transformed into 
XL10 Gold cells. Colonies were obtained on LB plate from each transformation. Single colony was 
picked from each plate and used for plasmid miniprep. The minipreps were run on 1 % (w/v) 
agarose gel Figure 4-7. The two bands obtained on loading the minipreps of pBSTG1 constructs and 
GST B4 were most likely corresponding to open-circular (nicked) and supercoiled DNA. The open-
circular (nicked) form of the plasmid migrates slowly than the supercoiled DNA. The DNA from 
pET-11(a) transformed cells showed a single band corresponding to the intact plasmid DNA in the 
cells.  
 
 
Figure 4-7 Gel electrophoresis of Adhiron binders from plasmid. 
Showing agarose gel electrophoretic analysis on 1% (w/v) agarose gel of pBSTG1 construct containing 
Adhiron myc binder sequences, Adhiron GST B4 binder and pET-11(a) vector. Marker lane consists of 
a MassRuler DNA ladder mix. 
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4.3.3.2. Incorporating Nde I and Bam HI restriction sites into Adhiron GST B4 sequence. 
To incorporate the Not I and Nhe I restriction sites into the Adhiron myc binders, the same 
restriction sites needed to be incorporated into the pET-11(a) vector. This was done using the 
Adhiron GST B4 binder sequence by inserting the Adhiron GST B4 sequence was cloned into pET-
11(a) vector using the following strategy. 
pET-11(a) vector contained Nde I and Bam HI restriction sites. The Nde I and Bam HI restriction 
sites were incorporated into the Adhiron GST B4 binder sequence so that it could be incorporated 
into pET-11(a). PCR amplification of the Adhiron GST B4 binder was done using primers that were 
designed to incorporate Nde I and Bam HI restriction sites along with an octa-histidine tag flanking 
the Adhiron GST B4 binder sequence. Octa-histidine tag was incorporated for the purification of the 
binders in the subsequent experiments. Figure 4-8 shows the schematic of the steps involved in 
creating Not 1 and Nhe 1 restriction sites in pET-11(a) vector. 
The primers used were forward primer containing Nde I restriction site and a reverse primer 
containing 8-histidine tags and Bam HI restriction site. The PCR was done using KOD Hot Start 
DNA Polymerase to produce blunt ended DNA fragments.  
 
4.3.3.3. Ligation of PCR products into pCR-Blunt vector 
The PCR products were then ligated into pCR-Blunt vector. pCR-Blunt vector is designed to clone 
blunt ended PCR fragments with a low background of non-recombinants. 
The blunt ended PCR products were loaded on 1% (w/v) agarose gel and then gel extracted using 
the Wizard SV Gel and PCR Clean-Up System. The gel-extracted fragments were ligated into the 
linearised pCR-Blunt vector that included kanamycin resistant gene and lethal ccdB gene based 
selection to avoid the survival of non-recombinant cells. The ligation reaction was transformed into 
XL10 cells and grown on kanamycin containing LB plates. No colonies were obtained on the LB. 
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Figure 4-8 A schematic of incorporating Not I and Nhe I restriction sites into pET- 
11(a) vector.  
The Adhiron GST B4 sequence containing Not I and Nhe I was inserted into pET-11(a) vector after 
amplifying Adhiron GST B4 sequence using PCR amplification. Primer 1 corresponds to forward 
primer and primer 2 corresponds to the reverse primer used in PCR amplification. 
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plate inoculated with ligation mixture containing only pCR-Blunt vector and no insert whereas 
colonies were obtained on the experimental LB plate (pCR-Blunt vector + insert). Three single 
colonies were picked and grown overnight for plasmid miniprep. The plasmids obtained from the 
cultures of three selected colonies, were sent for sequencing.  
The sequencing result for one of the colonies was correct. The result confirmed the correct insertion 
of Adhiron GST B4 sequence flanked by Nde I, Bam HI and 8 his-tag incorporated into pCR-Blunt 
with no addition or deletion of amino acids. 
 
4.3.3.4. Ligation of Adhiron GST B4 sequence into pET-11(a) 
The minipreps of the pCR blunt adhiron GST B4 and the pET-11(a) vectors were then double 
digested using Nde I and Bam HI restriction sites. The digested fragments were run on a 1% (w/v) 
agarose gel. The inserts as well as the linearised pET-11(a) vector were gel extracted and ligated. 
The ligated mixture was transformed into XL10 Gold cells, grown and plated on carbenicilin 
containing LB plates. Colonies were obtained on the plates containing ligation mixture (pET-11(a) + 
insert) whereas no colonies were obtained on the control plates (pET-11(a) and no insert). In order 
to select the colonies for sequencing of the inserts initially a direct screening of the colonies was 
done using colony PCR. 
 
4.3.3.5. Colony PCR 
To confirm the presence of Adhiron containing fragment in the pET-11(a) vector, five single 
colonies were picked from the plate for analysis. To screen the inserts directly from the bacterial cell 
colonies, the cells were subjected to colony PCR. The PCR on the cells was done using GoTaq Hot 
start Polymerase and the PCR products were directly loaded on 1% (w/v) agarose gel. The controls 
used in colony PCR were as follows: 
For positive control – XL10 Gold cells with pBSTG1 plasmid incorporated with Adhiron GST B4 
binder.  
For negative control - XL10 Gold cells with pET-11(a) vector without an insert and a PCR reaction 
mixture with no template DNA. 
Figure 4-9 shows the products of the colony PCR done on five selected colonies along with the 
negative and positive controls. The bands were observed migrating in between 300 and 400 bp size 
corresponding to the expected length of the insert fragments. The primers corresponded to the 
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Adhiron sequences and therefore, the PCR amplification was observed in case of pET-11(a) vector 
containing Adhiron sequence as well as in case of the positive control pBSTG1 vector, incorporated 
with Adhiron GST B4 sequence. Cells with pET-11(a) vector without an insert and a reaction 
mixture with no template DNA, used as negative controls showed no band on the gel. 
 
 
Figure 4-9 Colony PCR. 
Colony PCR products from the 5 selected Adhiron clones run on a 1 % (w/v) agarose gel. Bands 
corresponding to bp were observed in each lane corresponding to the expected size of the Adhiron 
fragments. GST B4 binder containing pDHis vector was used as a positive control where a band is 
observed near 300 bp. Negative controls including pET-11(a) without the Adhiron fragment and PCR 
reaction mixture containing no cells were used. 
 
The five colonies showing bands on the 1% (w/v) agarose gel in Figure 4-9 were further grown and 
the plasmids were extracted using miniprep kit. The DNA obtained was sent for sequencing. 
The sequences obtained from the five colonies confirmed the correct Adhiron GST B4 sequence 
flanked by Not I and Nhe I restriction sites followed by an octa-histidine–tag incorporated in the 
pET-11(a) vector. No mutations were identified in the sequences. This vector was named as 
pET-11(Ad) expression vector (Figure 4-10). 
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Figure 4-10 Vector pET-11(Ad). 
The vector map of pET-11(Ad) expression vector after the incorporation of Not 1, Adhiron GST B4 
named as cystatin GST B4 in the figure, Nhe 1 restriction site and octa-histidine tag. It has a T7 
promoter and terminator gene. Ampicillin resistant gene for selection and pBR322 origin of replication. 
(Figure provided by Sarah Deacon, Astbury Centre for Structural Molecular Biology). 
 
4.3.3.6. Cloning Adhiron myc binders into pET-11(Ad) expression  system 
The Adhiron myc binder fragments present in pBSTG1 vector were amplified using PCR (Phusion 
DNA polymerase).  
The PCR products obtained were digested with Dpn I to get rid of the methylated template plasmid 
DNA and to retain the PCR amplified products. The products were purified using gel extraction 
purification. The purified fragments were digested using Nhe I and Not I restriction enzymes. 
Figure 4-11 shows the bands obtained after running the double digested fragments on 1 % (w/v) 
agarose gel. The PCR products obtained corresponded to the theoretical size of Adhiron myc binder 
inserts (374 bp). 
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Figure 4-11 Gel electrophoresis for Adhiron myc binder inserts.  
The 1 % (w/v) agarose gel showing the bands at migrating between 300-400 bp.The myc adhirons 
binder fragments were amplified using PCR amplification. 10 kb DNA marker was used.  
 
pET-11(Ad) was digested with Not I and Nhe I restriction enzymes. The digested mixture was run 
on 1 % (w/v) agarose gel and the linearised pET-11(Ad) fragment was gel extracted. The gel-
extracted pET-11(Ad) fragment was ligated with previously obtained Adhiron myc binder inserts. 
Figure 4-12 shows the schematic of the incorporation of Adhiron myc binder into pET-11(Ad) 
expression vector. 
The ligation mixture of each binder was transformed into XL10 Gold cells and colonies were 
obtained for all the transformations except the negative control transformation that contained 
pET-11(Ad) fragment and no insert. Plasmid DNA was extracted from positive colonies from each 
transformation by miniprep kit. The plasmids DNA obtained corresponding to each Adhiron myc 
binder was sent for sequencing. The sequencing results confirmed successful cloning of the anti-
myc tag antibody binders into the pET-11(Ad). These plasmids were used for expression and 
purification of the respective binders. 
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Figure 4-12 Shows the schematic of incorporating Adhiron myc binders into the 
pET-11(Ad) vector. 
The PCR amplified Adhiron myc binder sequences and pET-11(Ad) was digested with Not I and Nhe I 
restriction sites and were ligated using T7 ligase enzyme. 
 
4.3.4. Optimisation of expression of Adhiron based binders  
Out of all the Adhiron based binders cloned, Adhiron GST B4 binder was used to optimise the 
expression and purification protocol to be used for remaining Adhiron based myc binders. Adhiron 
GST B4 binder cloned into pET-11(Ad) vector was transformed in a number of different E. Coli 
strains. Optimum production conditions were determined by culturing transformed E. coli strains in 
a wide range of auto induction media for varying intervals.  
 
4.3.4.1. Dot blot 
pET-11(Ad) vector containing Adhiron GST B4 binder was transformed into four different 
expression hosts - BL21 Star (DE3), C41 (DE3), C43 (DE3) and BL21 Gold (DE3) cells, each 
grown in a starter culture and then sub-cultured in different ForMedium™ autoinduction media (LB, 
TB, SB and 2YT). 200 %l of sample was collected from each subculture at six different time points 
16, 24, 40, 48, 60, 72 hr post inoculation and analysed on a dot blot (see section 4.2.4.5).  
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Figure 4-13 shows the chemiluminescent detection of 200 %l of sample collected from each sub-
culture at different time points of 16, 24, 40, 48, 64, 72 hr into a 96 well plate.  BL21 Star cells 
showed maximum chemiluminescence. Based on it, six combinations of growth media and time 
points were chosen for further analysis - BL21 Star cells incubated in 2YT for 24, 40 and 48 hr; 
BL21 Star cells incubated in TB for 40, 48, and 72 hr. 
 
 
Figure 4-13 Dot blot for optimising expression of Adhiron binders. 
Chemiluminescence detection of dot blot on GST B4 protein samples collected from cell cultures of 
BL21 Star (DE3), C41 (DE3), C43 (DE3), BL21 Gold (DE3) harvested at different time intervals of 
16, 24, 40, 48, 64, 72 hr. The various media used were LB, TB, SB, 2YT. In the final column different 
concentrations of his-tagged TEV protein provide a positive control. 
 
4.3.4.2. Western blots  
The expressed Adhiron GST B4 binder was used for determining solubility of the proteins. A 
western blot was done on the samples collected from the cell cultures selected in the dot blot 
analysis. The cells were harvested from the following combinations - BL21 Star cells grown in 2YT 
for 24, 40, 48 hr and in TB for 40, 48, 72 hr. 
The total cell lysate as well as the supernatant of the cell lysates was analysed by western blot using 
anti-histidine tag antibodies (see section 4.2.4.6). Figure 4-14 shows the western blot done on the  
(a) supernatant and (b) total cell lysate.of the samples obtained from the selected combinations. 
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Figure 4-14 Western blotting to detect expression of Adhiron GST B4.  
Western blot showing the chemiluminescent detection using anti his-tag antibodies  done on the  a) 
soluble fraction and (b) total cell lysate obtained from the harvested cultures expressing Adhiron 
GST B4 in ForMedium™ 2YT and TB and harvested at different incubation times (24 hr, 40 hr, 48 hr 
and 72 hr). Bands are observed migrating in the range of 12-15 kDa. 
 
The western blot confirmed expression of the octa-histidine tagged GST B4 binder. Protein bands 
were observed migrating in the range of 11-13 kDa when compared to the protein markers. The 
bands corresponded to the molecular weight of the Adhiron GST B4 binder. Protein was found in 
the soluble fraction for all of the samples, however, the band intensity was higher when expressed in 
2YT for 24 hr, TB for 48 hr and TB for 72 hr. TB 72 hr was not used further to grow Adhiron based 
binders  because of time constraints. Therefore, combinations 24 hr 2YT and 48 hr TB were further 
selected for expression of the Adhiron GST B4 binder in BL21 Star cells. 
 
4.3.4.3. Expression and purification of Adhiron GST B4 binder in 2YT and TB ForMedium™ 
autoinduction media 
To further optimise the growth conditions of Adhiron GST B4 binder, pET-11(Ad) containing 
Adhiron GST B4 binder was transformed into BL21 Star DE3 cells. A single colony was picked and 
incubated in the starter culture. 400 mL of 2YT and TB ForMedium™ autoinduction media each 
were inoculated with the starter culture. The cells were harvested, lysed and the solubilised fraction 
was used for affinity column purification of Adhiron GST B4 binder (see section 4.2.4.2). At each 
step of the purification 1 ml samples were collected. 10 %l of the each sample was used to run on a 
15 % (w/v) SDS PAGE in order to check the amount of Adhiron GST B4 binder in the collected 
samples as well to assure its purity.  
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Figure 4-15 shows the 15 % (w/v) SDS PAGE analysis of the protein samples obtained from a 
culture of BL21 Star DE3 cells grown in 2YT and TB ForMedium autoinduction media for 24 and 
48 hr respectively.  
In both the gel profiles in Figure 4-15 (a, b) the bands migrating between 10 and 15 kDa protein 
markers correspond to the expected size of Adhiron GST B4 binder i.e. 14.4 kDa. The band 
corresponding to the Adhiron GST B4 binder present in the cell lysate confirmed the expression of 
the binder whereas its presence in the soluble fraction (S) obtained after the crude cell lysate was 
centrifuged showed that the proteins were most likely correctly folded. The fraction of the flow 
through obtained after the supernatant was allowed to run through the affinity column showed that 
most of the endogenous proteins were eluted out and also some of the unbound Adhiron GST B4 
binder has also eluted in the flow through. 
The fractions obtained after washing the column with binding buffer (BB) and wash buffer (WB) 
showed no bands on the gel suggesting that either the Adhiron GST B4 binders were specifically 
bound to the Ni+-chelated column or were eluted in the previous steps as non-specifically bound 
proteins. The bands corresponding to the Adhiron GST B4 binders were observed in the elution 
fractions. 
In case of expression of Adhiron GST B4 binder in BL21 Star DE3 cells, grown in 2YT 
ForMedium™ for 24 hr (Figure 4-15(a)) fractions of proteins (E1 to E10) were eluted in elution 
buffer containing 500 mM imidazole (see section 3.2.1.5). Imidazole was used to elute his-tagged 
Adhiron GST B4 binder bound to the columns as it displaces the his-tag, bound to the Ni+-chelated 
column via a co-ordination complex. Intensity of the bands corresponding to the Adhiron GST B4 
binder was observed to decrease in the subsequent elutions and the first three fractions had the 
maximum amount of eluted protein. Due to the high concentration of imidazole, it was difficult to 
measure the true concentration of the proteins. Imidazole interferes with determination of protein 
concentration as its UV absorption spectra coincides with that of the proteins i.e. 280 nm. Moreover 
to avoid the effect of imidazole on the Adhiron GST B4 binder lower concentration of imidazole 
was used. In case of Adhiron GST B4 binder expressed in TB ForMedium™ for 48 hr 
(Figure 4-15(b)), fractions E1 to E8 were eluted in 200 mM imidazole and then fractions from E9 to 
E11 were eluted using 500 mM imidazole solution so as to check if the proteins were still bound to 
the column.  
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Figure 4-15 Purification of Adhiron GST B4 grown  in different autoinduction media.  
Showing a 15 % (w/v) SDS PAGE profile of the fractions collected during the purification of Adhiron 
GST B4 expressed in BL21 Star DE3 cells grown in (a) 2YT ForMedium™ for 24 hr and  (b) TB 
ForMedium™ for 48 hr. Elution fractions were collected in 500 mM and 200 mM imidazole containing 
elution buffer. 10 %L of each fraction was loaded in the wells. 10 µL of total cell lysate and soluble 
fraction was loaded per lane. A total of 20 µL out of each 100 µL elution was loaded onto the gel. The 
gel was run at 200 V for 1 hr. M= Marker lane, S= Soluble fraction, T= Total cell lysate, BB= fractions 
collected from binding buffer wash, WB= Fractions collected from wash buffer.  
 
4.3.4.4. Dialysis 
Dialysis of proteins was important to exchange the buffer to 1X PBS as well as get rid of imidazole 
and other contaminants, that can affect the Adhiron binders and their interaction with the myc 
antibodies in the subsequent experiments. All the eluted fractions were pooled together and dialysed 
in 10 mM PBS, pH 7.2 (see section 4.2.4.3). Adhiron GST B4 binder samples from both the un-
dialysed pooled fractions and dialysed pooled fractions were run on a 15 % (w/v) SDS PAGE. 10 
%L of the pooled elutions of GST B4 Adhiron grown in 2YT and TB ForMedium™  (24 hr) eluted 
in 500 mM imidazole was run on 15 % (w/v) SDS PAGE before and after dialysis (Figure 4-16). 
The gel profile of the elution showed that the Adhiron GST B4 binder was intact after dialysis in 
10 mM PBS (pH 7.2) and no degraded was observed after the dialysis. 
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Figure 4-16 SDS PAGE of Adhiron GST B4 after dialysis in 10 mM PBS (pH 7.2). 
SDS PAGE (15% (w/v)) showing pooled elution fractions from the purification of GST B4 Adhiron 
grown in 2YT ForMedium™  (24 hr) and TB ForMedium™  (48 hr) after and before dialysis in 10 mM 
PBS. GST B4 binder was eluted in elution buffer containing 200 mM and 500 mM imidazole 
concentration. 20 %L of sample was loaded in each well. 
 
The yield of Adhiron GST B4 binder when expressed in BL21 Star (DE3) in TB ForMedium™ for 
48 hr was 6.5 mg/L whereas when expressed for 24 hr in 2YT ForMedium was 3.5 mg/L. Thus, the 
expression of Adhiron GST B4 in BL21 Star (DE3) (TB ForMedium™) for 48 hr followed by 
purification using 200 mM imidazole solution was chosen as the best condition for the expression 
and purification of Adhiron myc binders. 
 
4.3.5. Expression of Adhiron myc binders 
pET-11(Ad) vector carrying Adhiron fragment with the myc binder sequences - were transformed in 
BL21 Star (DE3) cells. Single colonies corresponding to each binder were picked and a starter 
culture was inoculated followed by sub-culturing into 400 mL of TB ForMedium™ .  
To confirm the expression of the Adhiron myc binders before harvesting cells from 400 mL cultures, 
1 mL sample was harvested, lysed and the binder expression was analysed using 15 % (w/v) SDS 
PAGE and western blot (see section 3.2.1.3).  
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4.3.5.1. Adhiron myc binders 1, 2, 4 and 18 
Adhiron myc binders 1, 2, 4 and 18 were grown in two batches. Figure 4-17 shows analysis of 1 ml 
sample from both the batches on 15 % (w/v) SDS PAGE (see section 4.2.4.4). Bands were 
migrating in the range of 11-12 kDa molecular weight. The theoretical molecular weights of the 
Adhiron myc binders were in the range of 13-14 kDa (Appendix-Table 31). The difference could be 
due to the folding properties of the binders. 
On the 15 % (w/v) SDS PAGE, Adhiron myc binder 1 (M.W. 13.8 kDa) and Adhiron myc binder 2 
(M.W. 14.08 kDa) showed higher molecular weights as compared to Adhiron myc binder 4 
(M.W. 14.05 kDa) and Adhiron myc binder 18 (M.W. 14.2 kDa). This could again be attributed to 
the fact that the binders showed different extent of denaturation depending on their stability. The 
variation in denaturation affects the mobility of the proteins on SDA PAGE. So most likely 
Adhiron myc binder 1 and 2 can be more unfolded as compared to the other binders thus migrating 
at a higher molecular weight.  
A second band was observed in each lane running in the range of molecular weight 22-24 kD, which 
corresponded to the molecular weight of dimer. 
 
 
Figure 4-17 SDS PAGE of Adhiron myc binder 1,2,4 and 18. 
Shows the 15 % (w/v) SDS PAGE profile of soluble fractions obtained from 1 ml sample of cell 
cultures growing Adhiron myc binders 1, 2, 4, 18 in two different batches each. 10 %L of the soluble 
fraction was loaded onto the wells and the SDS PAGE was run at 220 V for 1 hr. 
 
To check the expression of the Adhiron his-tag myc binders a western blot was done using anti-his 
tag antibodies on the total cell lysates (C) as well as the soluble fraction (S) of the 1 ml samples. 
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Figure 4-18 shows the chemiluminescent detection of bands in the cell lysate and soluble fractions 
of different cultures migrating in the range of 10-15 kDa molecular weight, which corresponds to 
the molecular weights of Adhiron his-tag myc binders. The bands obtained on the gel corresponding 
to the cell lysate depicts the expression of the Adhiron his-tag myc binders and the ones 
corresponding to the soluble fraction indicated that the Adhiron his-tag myc binders were more 
likely in correctly folded state. The intensity of the bands was brighter in the cell lysate as compared 
to the soluble fraction.  
The faint bands observed in the range of 22-24 kDa molecular weight confirmed the formation of 
intra-molecular dimers within Adhiron his-tag myc binders. The bands corresponding to Adhiron 
his-tag myc binder 1 and 2 from both the batches corresponded to higher molecular weights as 
compared to the other binders. 
 
 
Figure 4-18 Western blot of total cell lysates and soluble fractions of Adhiron myc 
binder 1, 4, 2 and 18.  
Shows the western blot done on the total cell lysates and the soluble fractions obtained from 1ml 
sample of two different batches of cell cultures growing Adhiron his-tag myc binders 1, 4, 2 and 18. 
Total cell lysate obtained from batch 1 and 2 designated as C1 and C2 respectively. Soluble fraction 
obtained from batch 1 and 2 designated as S1 and S2 respectively.  
 
4.3.5.2. Adhiron myc binders 5, 7, 13 and 17 
1 mL samples collected from two different batches of cell cultures growing Adhiron binders 5, 7, 13 
and 17 were subjected to 15 % (w/v) SDS PAGE (see section 4.2.4.4). Figure 4-19 shows the gel 
profile of the cell lysate and supernatant of 1 ml samples. Bands migrating between 10-15 kDa 
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corresponded to the expected molecular weights of Adhiron binders 5, 7, 13 and 17 
(Appendix-Table 31). The intensity of bands corresponding to Adhiron myc binders 5, 7, 13 and 17 
observed in Figure 4-19 is lower as compared to that observed in case of Adhiron myc binders 1, 2, 
4,18 shown in Figure 4-17. This could be due to difference in handling of cultures or attributed to 
different levels of protein expression. Bands were also observed in the range of 22-25 kDa 
molecular weight indicating dimerisation of the binders taking place. 
Western blotting done on the cell lysates and soluble fractions of 1 ml samples using anti his-tag 
antibodies is shown in Figure 4-20. It confirmed the expression of Adhiron his-tag myc binders 5, 7, 
13 and 17. 
The 15 % (w/v) SDS PAGE (see section 4.2.4.4) and western blot done (see section 4.2.4.6) on the 
samples established the expression of the Adhiron myc binders, which were then purified from the 
cell cultures of larger volume (400 mL). 
 
 
Figure 4-19 SDS PAGE of total soluble fraction and cell lysate of Adhiron myc binder 
5, 7, 13 and 17. 
Shows the 15 % (w/v) SDS PAGE done on the total cell lysate (C) and the soluble fraction (S) obtained 
from 1 ml sample of two different batches of cell cultures growing Adhiron myc binders 5, 7, 13 and 
17. Total cell lysate from batch 1 and 2 designated as C1 and C2 respectively. Supernatant from batch 
1 and 2 designated as S1 and S2 respectively. 10 %L of the sample was loaded onto the wells and the 
SDS PAGE was run at 220 V for 1 hr. 
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Figure 4-20 Western blot of soluble fractions and the cell lysates of Adhiron myc 
binder 5, 7, 13 and 17.  
Shows the western blot done on the total cell lysates and the soluble fractions of cell lysates obtained 
from 1ml samples of two different batches of cell cultures growing Adhiron myc binders 5, 7, 13 and 
17. Total cell lysate from batch 1 and 2 designated as C1 and C2 respectively. Supernatant from batch 
1 and 2 designated as S1 and S2 respectively.  
 
4.3.6. Purification of Adhiron myc binders 
Purification of the Adhiron myc binders was done using Ni+ chelated Hi-trap affinity columns. The 
400 mL culture of BL21 Star (DE3) cells transformed with pET-11(Ad) vector containing Adhiron 
myc binder was harvested and cells were lysed using sonication. The cell lysate was centrifuged and 
the soluble fraction of the crude extract was allowed to flow through the column. The flow through 
fractions were collected (FT) followed by collecting fractions after adding different buffers –binding 
buffer (BB), wash buffer (WB) and finally the elution buffer (E) for eluting the Adhiron myc 
binders. 10 %L of the samples collected were run on a 15 % (w/v) SDS PAGE. 
 
4.3.6.1. Adhiron myc binders 1, 2, 4,18 
Figure 4-21 shows the 15 % (w/v) SDS PAGE profiles of fractions collected during purification of 
Adhiron myc binders 1, 4, 2 and 18. Most of the endogenous proteins corresponding to different 
molecular weights were eluted in the flow through (FT). Bands of non-specifically bound 
endogenous proteins were observed in the fractions collected from the binding buffer and wash 
buffer flows.  
In the elution fractions (E1-E6) bands migrating in the range of 12-15 kDa molecular weight were 
observed that corresponded to the molecular weights of the Adhiron myc binders. In case of first two 
elution fractions (EI and E2) of Adhiron myc binders 1, 2 and 18, some discrete bands are observed 
in the range of 12-10 kDa other than the main band corresponding to Adhiron myc binders. These 
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could be due to degradation of the binders taking place or due to different folding of the binders that 
gives rise to different migration properties.  
Some bands observed in the elution lanes (E) showed host protein contaminants that could be 
minimised by using Tween 20  in the wash buffer. Tween 20 was used during the purification of the 
other binders to get rid of the non-specifically bound endogenous proteins. 
  
 
Figure 4-21 Purification of Adhiron myc binder 1, 2, 4 and 18.  
Shows 15 % (w/v) SDS PAGE profile of fractions collected during the purification of Adhiron myc 
binders 1, 4, 2 and 18. The bands obtained are in the molecular weight range of 12-15 kDa. 10 %L of 
the soluble fraction was loaded onto the wells and the SDS PAGE was run at 220 V for 1 hr.  
M= Marker lane, FT= Flow through fraction on Ni+ chelated column, BB= Fractions collected after 
binding buffer was applied to the column, WB= Fractions collected after wash buffer was applied to 
the column. E= Elution fractions collected by applying elution buffer containing 200mM imidazole. 
 
4.3.6.2. Adhiron myc binders 5, 7, 13 and 17 
An extra step of washing with wash buffer containing tween was included in purification of Adhiron 
myc binders 5, 7, 13 and 17. Figure 4-22 (a, b) shows gel profile of fractions collected during the 
purification of Adhiron myc binder 5. The flow through (FT) fraction did not contain the Adhiron 
myc binder 5. The binding buffer (BB) and wash buffer (WB) fractions showed the removal of non-
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specifically bound proteins. Running wash buffer containing tween (TW) was followed by running 
wash buffer (W) without tween to get rid of tween in the column. Fainter bands of endogenous 
proteins were observed in the later wash buffer fractions (W1, W2). The elution fractions E1 to E9 
depicted in Figure 4-22(a, b), eluted in elution buffer with 200 mM imidazole showed a gradient of 
decreasing band intensity corresponding to Adhiron myc binder 5. Bands corresponding to 22-25 
kDa marker proteins were observed that were more likely due to dimerisation of the binders (see 
section 4.2.2.14). A light band observed for elution fraction E10 collected after running elution 
buffer containing 500 mM imidazole showed that most of the specifically bound Adhiron myc 
binder 5 proteins were eluted in the previous elutions.  
Figure 4-22(b, c and d) shows the 15 % (w/v) SDS PAGE profile of fractions collected during the 
purification Adhiron myc binder 7. Band corresponding to Adhiron myc binder 7 was observed in 
the elution fractions. In Figure 4-22(c) the gel profile of fractions corresponding to binding 
buffer (BB), wash buffer containing tween (TW) followed by washes with wash buffer (W) showed 
very light bands of host protein contaminants. Elutions fractions (E1-E7) showed bands migrating at 
the Adhiron myc binder 7 molecular weight. In Figure 4-22(d) shows the gel profile of elution E8 
containing band corresponding to Adhiron myc binder 7 along with some contaminant proteins and 
a higher elution of specifically bound Adhiron myc binder 7 in 500mM imidazole containing elution 
buffer (E9) than observed in E8.  
Figure 4-22(d, e) shows 15 % (w/v) SDS PAGE gel profile of fractions collected during the 
purification of Adhiron myc binder 13. Endogenous proteins were collected in the flow through 
fractions as observed in the gel profile. The elution fractions (E4-E9) of binder 13 show a more 
dimerised form of the binder as compared to all other binders. 
Figure 4-22(e, f) shows fractions collected during purification of Adhiron myc binder 17. Bands 
corresponding to molecular weight 12-15 kDa were observed in the gel profile of elution fractions 
corresponding to the Adhiron myc binder 17. 
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Figure 4-22 Purification of Adhiron myc binder 5, 7, 13 and 17. 
Shows 15 % (w/v) SDS PAGE done on fractions collected during the purification of binder 5, 7, 13 and 
17 using a Hitrap protein purification column.  
M= Marker lane, S= Supernatant of cell lysate, FT= Flow through, BB= Fractions collected with 
binding buffer, TW = Wash with tween, W= Fractions with wash buffer and E= Elution fractions. 
 
4.3.6.3. Adhiron myc binders 11 and 20 
Figure 4-23 shows the 15 % (w/v) SDS PAGE profile of the fractions obtained during the 
purification of the Adhiron myc binder 11 and 20. Most of the unwanted proteins present in the 
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supernatant of the cell lysate were extracted in the flow through (FT) fractions. In case of Adhiron 
myc binder 11 the band corresponding to the binder protein (12-15 kDa) showed less intensity in the 
elution fractions. This could be because of low expression level of the binder in the bacterial strain 
or degradation of the proteins due to sequence specific proteolysis. The Adhiron myc 20 binder 
bands migrating at the molecular weight to 12-15 kDa showed a gradient in band intensity from E1 
to E7 corresponding to elutions done in 200 mM imidazole. Higher intensity bands are obtained 
from E8 - E10 corresponding to elutions done in 500 mM imidazole.  
 
 
Figure 4-23 Purificaiton of Adhiron myc binder 11 and 20. 
SDS-PAGE (15% (w/v)) showing fractions collected during the purification of Adhiron myc (a) binder 
11 and (b) binder 20, using a Hitrap protein purification column. The elution fractions from E1-E7 in 
case of both the binders were collected using elution buffer containing 200mM imidazole and fractions 
E8-E10 were collected using elution buffer containing 500 mM imidazole concentration.  
M= Marker lane, S= Soluble fraction, FT= Flow through, BB= Fractions collected with binding buffer, 
WB= Fractions collected with wash buffer and E = Fractions collected with elution buffer.
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4.3.7. Dialysis of purified Adhiron myc binders  
All the elutions of respective binders were pooled together and then dialysed in 10 mM PBS 
(pH 7.2). Adhiron myc 13 showed formation of precipitate during dialysis. The dialysed binders 
were then analysed on 15 % (w/v) SDS PAGE shown in Figure 4-24. Adhiron scaffold showed a 
lower molecular weight (Figure 4-24(a)) as compared to the Adhiron based binders. This 
corresponds to the shorter length of loops in Adhiron scaffold. Adhiron myc binder 1 and 2 showed 
higher molecular weight than the rest of the binders (Figure 4-24(b)).  
 
 
Figure 4-24 SDS PAGE of Adhiron scaffold, Adhiron GST B4 binder and ten Adhiron 
myc binders. 
Shows the 15 % (w/v) SDS PAGE profile of proteins after dialysis in 1 X PBS (a) Adhiron scaffold, 
Adhiron GST B4 binder, Adhiron myc binder 11 and 20, (b) Adhiron myc binders 1, 2, 4, 18 and (c) 
Adhiron myc binders - 5, 7, 13 and 17. 10 %g of protein was loaded in each lane. 
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4.3.8. Characterisation 
4.3.8.1. Circular Dichroism (CD) 
The secondary structure of the proteins was analysed using CD. In Figure 4-25, the CD spectrum of 
Adhiron scaffold and Adhiron myc binders show well-defined anti parallel !-pleated sheets 
corresponding to positive peak at 195 nm and a broad negative peak above 210 nm (see section 
3.2.3). The higher percentage of !-sheets had masked the "-helical structure. Myc 18 showed a 
prominent "-helical structure depicted by negative bands at 208 nm and 218 nm (see section 3.2.3). 
The variation in the measured ellipticity was different for different binders perhaps due to the 
difference in folding of various sequences of the loop regions in the Adhiron scaffold and Adhiron 
myc binders.  
 
 
Figure 4-25 Circular dichroism of Adhiron myc binders.  
Secondary structure of wild type phytocystatin based Adhiron scaffold and the binder variants shown 
by CD. At 195 nm a positive peak is observed and above 210 nm a broad negative peak is observed in 
all the binders. The spectra were recorded in the far-UV (190-260 nm) range at a protein concentration 
of 0.5 mg/ml. The analysis was done using the Dichroweb reference set CDSSTR.  
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4.3.8.2. Differential Scanning Calorimetry (DSC) 
Thermal stability of the protein was analysed using DSC. Figure 4-26 shows the profiles of heat 
capacity (CP) vs. temperature of proteins subjected to temperature scans, between 11 ºC to 90 ºC/ 
130 ºC at the rate of 90 ºC/hr. The normal functioning of the instrument was assured by checking the 
unfolding of lysozyme protein (Figure 4-26(a)) under the same heating and cooling conditions 
which showed a Tm of 72 ºC for protein lysozyme (Chôma, 2006). 
Amongst all the ten binders, Adhiron myc binder 2 was chosen for forming the biological 
recognition layer of the EIS based biosensor (see Chapter 5). Due to interest in the best binding 
candidate (Adhiron myc binder 2), the transition temperature of Adhiron myc binder 2 was studied. 
The transition temperature of Adhiron myc binder 2 was analysed by using temperature ranging 
from 11 ºC to 90 ºC . Figure 4-26(b) establishes that the Adhiron myc binder 2 shows reversibility of 
unfolding reaction. The repeated scanning of the Adhiron myc binder 2 under identical conditions 
gave endotherms having the same transition temperature of 85 ºC. The sharpness of the peaks 
indicates that the process is cooperative in nature.  
The initial temperature scan on Adhiron scaffold was done from 11 ºC to 90 ºC  and no peak was 
observed. This experiment was repeated twice (data not shown). Later, the maximum temperature 
was increased to 130 ºC and the Adhiron scaffold showed a melting temperature of 101 ºC 
(Figure 4-26(a)).1 As compared to the Adhiron myc binder 2, the melting temperature for Adhiron 
scaffold increased to 101 ºC shown in Figure 4-26(c). The lower melting point of Adhiron myc 
binder 2 can be attributed to the structural instability brought by the inserts in the loops. The non-
reversibility of unfolding reaction (scan 2) in case of Adhiron scaffold (Figure 4-26(c)) could be 
because of the high maximum temperature of scanning that prevents proper refolding of the 
polypeptide chain. The high transition temperature of the Adhiron scaffold corresponds to the high 
thermostability of the scaffold. This was most likely due to the consensus-based design of the 
Adhiron scaffold that gives it high thermostability. The disulphide bridges do not contributing to the 
stability as neither the scaffold nor the loops in the binders contain any cysteine residues. It can also 
be due to more salt bridges and hydrogen bonding (Jaenicke, 2000) for which the crystal structure of 
the Adhiron scaffold needs to be analysed.  
                                            
1 Acknowledgement: As there was not enough Adhiron scaffold protein left of the original 
purification for this DSC experiment, this experiment was performed by William Morton and Sarah 
Deacon on the Adhiron scaffold protein purified by William Morton using the vector and protocols 
used in the rest of this study. 
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Figure 4-26 Differential scanning calorimetry of lysozyme, Adhiron myc binder 2 and 
Adhiron scaffold.  
DSC profiles of heat capacity vs. temperature performed on 0.5 mg/mL protein samples prepared in 
1 X PBS buffer at pH7.4. The temperature scanning was done between 11 ºC and 130 ºC at the rate of 
90 ºC/hr. (a) lysozyme as control, (b) Adhiron myc binder 2 and (c) Adhiron scaffold. 
 
The characterisation results depicted high thermal stability and intact secondary structure of the 
Adhiron myc binders. The binders were further characterised in order to choose the best binder 
against monoclonal anti-myc tag antibodies and develop an EIS based biosensor.  
 
4.4. Discussion 
This chapter describes the cloning and purification of binders based on a novel protein scaffold 
called Adhiron developed by McPherson group at the Centre for the Structural and Molecular 
Biology, University of Leeds. Adhiron is based on a consensus sequence of plant-derived 
phytocystatin. It consists of four-strand anti-parallel "-sheet core and a central helix. It showed a 
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high melting temperature of 101 ºC which could be attributed to the consensus protein design of the 
Adhiron scaffold.  
To prove the versatility of the Adhiron scaffold, a library based on randomised aminoacid sequences 
commercially obtained from Sloning Biotechnology was created. The BSTG at the Centre for the 
Structural and Molecular Biology, University of Leeds cloned these randomised oligonucleotides 
into a phagemid named as pBSTG1 and selected binders against monoclonal anti-myc tag antibodies 
using phage display library. The ten Adhiron myc binders were selected for this project from the 
phage display library. These binders were successfully cloned into the pET expression vector. As 
the expression of the Adhiron scaffold was not performed previously in the pET expression vector 
therefore optimisation of the conditions for expression and purification was done. All the Adhiron 
myc binders were expressed in soluble form with a yield in the range of 4-8 mg. The Adhiron myc 
binder 13 was forming aggregates. The observed precipitation of Adhiron myc binder 13 could be 
due to difference in the folding of the loops. It will be useful to change the buffer conditions or use a 
stabilising agent in the dialysis buffer like glycerol that can prevent precipitation of the binder. 
Although on 15 % (w/v) SDS PAGE, most of the Adhiron myc binders showed less endogenous 
contaminants in the elution fractions but there was a band observed in the range of 24-25 kDa that 
could be because of the formation of dimers. In order to get binders of high purity, a size exclusion 
chromatography can be performed to get rid of the dimers. Formation of dimers can interfere with 
the use of Adhiron binders in different biological assays. 
The secondary structure of the binders was maintained as was seen in the circular dichroism, 
although the fractions of "-helices and !-sheets varied amongst the binders.  The thermal stability of 
the Adhiron scaffold and Adhiron myc binder 2 was high. Moreover, Adhiron myc binder 2 showed 
reversibility in folding. Over the past few years various scaffolds have been introduced. The recent 
consensus based artificial antibody called repebodies exhibited a melting temperature of 85 ºC but 
the thermal stability of the phytocystatin based Adhiron scaffold and its variant Adhiron binder 2 
was unusually high. The factors that provide a high melting temperature to the scaffold will be an 
interesting field to explore. The thermostability of a protein influences its overall stability and 
therefore the Adhiron based binders will be quite promising when used in different environmental 
conditions. Although the thermal stability of the scaffold has been established, the determination of 
the resistance of the binder stability to different pHs will prove to be very significant.  
Full characterisation of all the Adhiron myc binders was not possible because the main objective of 
the work was to get a well-characterised binder with maximum binding affinity and use that for 
further electrochemical experiments to fabricate a biosensor.  
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Chapter 5. Fabrication of an impedimetric biosensor based of a non-antibody 
recognition protein –Adhiron myc binder 2 
 
5.1. Introduction 
The previous chapter discussed a non-antibody based capture molecule based on a scaffold called 
Adhiron, which was used to present different peptides in its three variable regions consisting of an 
N-terminal region and two variable loops (loop1 and loop2). The scaffolds presenting different 
peptides were then selected against anti-myc tag antibody using a phage display library. The chapter 
discussed the selection of ten Adhiron myc binders, their cloning into the pET expression system, 
expression, purification, as well as the detailed characterisation of the binders. 
This chapter discusses the work carried out to create an EIS based biosensor, built on the best 
Adhiron myc binder against monoclonal anti-myc tag antibodies. To determine the best Adhiron 
myc binder against monoclonal anti myc tag antibodies, ELISA was performed on all the ten 
binders. To detect the binding of the Adhiron myc binders to monoclonal anti-myc tag antibodies an 
indirect ELISA was performed using an enzyme conjugated secondary antibody against the 
monoclonal anti-myc tag antibodies. 
The affinity of the best Adhiron myc binder against monoclonal anti-myc tag antibodies was 
established using SPR. SPR is used to detect biomolecular interaction in real time in a label-free 
environment (see section 3.2.5). SPR was used to determine the affinity of binding and analyse the 
kinetics involved, including the dissociation and association of the binding of monoclonal anti-myc 
tag antibodies to the surface immobilised Adhiron myc binder. 
The selected Adhiron myc binder as the biological recognition layer was then used to fabricate a 
label-free EIS based biosensor for the detection of monoclonal anti-myc tag antibodies. 
  
5.1.1. Electrochemical impedance spectroscopy 
EIS measures the electrochemical impedance of an interface in AC steady state with constant DC 
bias. A small sinusoidal voltage is applied at a particular frequency and the resulting current is 
measured. The process is repeated at different frequencies. We are particularly interested in non-
faradaic biosensing, which allows a more precise study of the interfacial layer. In case of 
electrochemical biosensors the interface is composed of the electrochemical double layer, which 
forms above the surface of a metal electrode submerged in an electrolyte (see Chapter 2). In non-
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faradaic measurements the biosensing depends on the changes in the local environment of the 
electrode surface arising due to change in capacitive or resistive behaviour of the surface. 
 
5.1.1.1. EIS based biosensor 
EIS based biosensors have been promising for the development of label-free biosensors. They are 
generally categorised as faradaic and non-faradaic biosensors (see section 2.2.2). Since the non-
faradaic EIS based biosensors do not require an additional redox agent to improve their sensitivity 
they can be used in label-free point of care diagnostics. For the fabrication of EIS based biosensor, it 
is important to develop a sensitive detection platform, formed by a substrate on to which biological 
recognition molecules are immobilised.  
In terms of electrochemistry the interface between the electrode and the electrolyte can be compared 
to a parallel plate capacitor capacitor, potentially with significant leakage. The capacitance depends 
on the change in the dielectric properties or the thickness of the dielectric layer according to 
Equation (5.1). 
                                                                C=##0A/d                                                                      (5.1) 
Where C, capacitance between the parallel plates of the condenser (Farad /F); #, permittivity of the 
medium between the condenser plates (F/m); #0, permittivity of the vacuum (F/m); A, electrode area 
(m2); d, distance between the charged plates (m). 
The sensitivity to detect the binding of analytes is dependent on the capacitance of the sensor, which 
is inversely proportional to the thickness of the dielectric layer as given in the relationship 
Equation 5.1 (Gebbert et al., 1992; Berggren et al., 2001). If Ci is the initial capacitance of the 
sensor formed by the insulating layer and the recognition molecules and Ca is the capacitance of the 
analyte binding to the surface, then the total capacitance measured, is given by Equation (5.2). 
                                                          1 / Ci +1 / Ca = 1 / Ct                                                     (5.2) 
For the sensor to be highly sensitive the initial capacitance formed by the insulating layer and the 
biological recognition molecules should be very large as compared to the capacitance due to the 
analyte binding so that any change in the capacitance due to the binding of the analyte can be 
detected.  
Directly immobilised biological recognition molecules do not act as ideal dielectric layers and 
therefore non-conducting polymer –polyethylene glycol was used to lower the the ionic movement 
through the layer (Berney et al., 1997). Although this was not a success because the biological 
recognition molecules could not detect the analytes. This could be because of charged protein 
recognition molecules that interact with ions in the solution or due to denaturation of proteins on 
surface (Bergveld, 1991; Schasfoort et al., 1990; Berney et al., 1997). In order to improve the 
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sensitivity of the sensors the biological recognition molecules have been grafted on to insulating 
layers formed on the electrode / substrate.  
Initially one of the most widely used techniques to graft insulating layers on to the gold substrate 
was Langmuir Blodgett technique (LBL) (Bergveld, 1991). Langmuir Blodgett films are formed by 
transferring a layer of amphiphilic molecules from air-water interface to air-solid interface 
(Zasadzinski et al., 1994). In contrast to the arduous formation of LB films, fabrication of self 
assembled monolayers (SAM) was introduced by Nuzzo and Allara, involving the direct absorption 
of alkanethiolates (X-Cn-SH) onto the gold substrate (Nuzzo and Allara, 1983). 
Alkanethiolates form organic assemblies on the gold surface via formation of gold-thiol (Au-S) 
bonds. The tail part of an alkanethiol contains an exposed functional group (X i.e  -COOH, -NH2, 
-CN, -OH etc) that can be used to bind biomolecules (Ostuni et al., 1999). The tethering of 
biomolecules to the SAMs also helps in maintaining their conformational flexibility (Bigdeli et al., 
2008). Formation of SAMs with different lengths of alkyl chain and terminal functional groups has 
been well studied and characterised (Dubois and Nuzzo, 1992; Whitesides et al., 2005; Laibinis et 
al., 1991). The order of the monolayers formed on the gold substrate is dependent on the length of 
the alkyl chain wherein SAMs formed from longer alkyl chain (n>10) are more densely packed as 
compared to those formed from shorter alkyl chains (Bain et al., 1989). Alkanethiolates (n>11) form 
trans-extended monolayers at an angle of 30º (tilt) with respect to the gold substrate (Dubois and 
Nuzzo, 1992; Whitesides et al., 2005). The densely packed SAMs form a highly insulating layer on 
the gold surface that impedes the penetration of electrons and water or ionic molecules at the 
interfacial surface (Boubour and Lennox, 2000a; Porter et al., 1987).  
An important consideration during the immobilisation of biological molecules has been the surface 
fouling or non-specific binding of protein molecules to the surface. In order to form anti-fouling 
surfaces, SAMs presenting poly (ethylene glycol) or PEG groups have been used that resist the 
binding of proteins to the surface (Ostuni et al., 2001; Mrksich and Whitesides, 1997). The protein 
resistance of PEG is associated with the hydrophilic nature of the PEG which prevents the non-
specific protein absorption to the surface (Wang et al., 1997). Owing to the protein resistance 
property, PEG – SAM have been extensively used for modifying biosensing surfaces.  
PEG-SAM used in the following experiments, consists of a functional  –COOH group exposed on 
the PEG molecule for the covalent immobilisation of biological recognition molecules. These bulky 
functional groups cause steric hindrance and therefore destabilise the SAM layer of the sensor-
giving rise to defects (Harder et al., 1998; Mendoza et al., 2007; Schreiber, 2000). The defects can 
be formed mainly due to the presence of a bulky -COOH groups attached to the PEG molecules that 
destabilise the SAM (Love et al., 2005). Defects in a monolayer can also arise due to formation of 
less compact SAMs leading to pinholes. “Pinholes are the result of imperfect absorption of the 
alkanethiols to the gold surface during the self assembly step or subsequent loss of thiol during 
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rinsing, storage, or use” (Finklea et al., 1993). The time dependent formation of pinholes / defects is 
discussed in section 5.4.3.1.  
These pinholes / defects increase the permeability of ions (non-faradaic) or electrons (faradaic) to 
and from the surface and thus an ideal capacitive / insulating surface is not formed. The movement 
of ions through the SAM is called as the non-faradaic charge transport which can be detected using 
EIS (Zaccari et al., 2014).  
EIS is based on the superimposition of sine wave potential of small amplitude over polarisation 
potential of constant value. The relation between voltage and current can be represented by the 
complex electrical impedance Z of the surface (see section 3.2.6.4) (Evans et al., 2008). The 
complex impedance is measured as the ratio of electrochemical voltage applied (Et) to the current 
response (It).  
                                                        Z = Et/ It 
                                                            = E0 sin (%t) / I0 sin (!t + ')  
                                                            = Z0 sin (%t) / sin (!t + ') 
Where E0 is the amplitude of the signal, I0 is the amplitude of current and ' is the phase shift of 
response signal (It) from the input signal (Et) (see section 3.2.6.4).  
The changes taking place on the surface can be depicted by a Bode plot that represents logarithm of 
the absolute impedance, |Z| and the phase, ', plotted against the logarithm of the excitation 
frequency.  In case of pure capacitive impedance the current and voltage are out of phase by 90º, 
which is observed as the phase of the impedance (-90º) in the lower frequency range. The change in 
the phase (phase shift) from an ideal capacitive phase (>-90º) can be attributed to the non-faradaic 
movement of ions or water molecules through the defects (Ihalainen et al., 2014; Boubour and 
Lennox, 2000a; Zaccari et al., 2014). Based on such changes in interfacial ionic movement, an EIS 
based biosensor fabricated for detecting the binding of monoclonal anti-myc tag antibodies to  
Adhiron myc binder. 
This chapter discusses the development of EIS based Adhiron myc binder biosensor which also 
includes selection of the best Adhiron myc binder against monoclonal anti-myc tag antibodies from 
the ten binders discussed in the previous chapter.  
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5.2. Materials 
 
Reagents and chemicals were purchased from Sigma-Aldrich unless mentioned. TMB (3, 3), 5, 5)-
Tetramethybenzidine) / substrate solution (SeramunBlau fast purchased from Seramun Diagnostica 
GmbH). Carboxymethylated dextran chips (CM5) were purchased from GE Healthcare Life 
Sciences. Chemicals used in SPR were supplied by GE health care - NHS, EDC, and ethanolamine. 
Monoclonal anti-myc tag antibodies, anti-B2M antibodies  were purchased from Abcam. 
Alkanethiol-PEG (SH-(CH2)11-(EG)3-OCH2-COOH) was purchased from Prochimia, Poland. 
Ag/AgCl saturated KCl reference electrode, Potassium ferrocyanide K4[Fe(CN)6]3-/4- were 
purchased from WVR. 
 
5.3. Methods 
 
5.3.1. Surface Plasmon Resonance 
A BIAcore 3000 instrument from GE LifeSciences was used to carry out affinity assays. The 
Biocore 3000 has a microfluidic chamber with open channels. On pressing the sensor chip against 
the open channels of the chamber, four flow cells are formed where continuous flow of liquid is 
maintained and the buffers or samples can be switched during the analysis without disturbing the 
sample boundaries.  
A CM5 chip was used for all SPR studies, and the immobilisation of the binders on the CM5 chip 
was done using amine coupling chemistry. The dextran surface was activated using a mixture of 
equal volumes of 10 mM NHS (N-hydroxysuccinimide) and 400 mM EDC (N-ethyl-N'-
(dimethylaminopropyl)-carbodiimide). 10 %g/mL Adhiron scaffold, Adhiron myc binder 2 and 
Adhiron myc binder 4 was immobilised in 10 mM acetate buffer pH 5.5 (pH chosen based on the 
scouting experiments) on channel 2, 3 and 4 respectively. No binder was immobilised on channel 1. 
Only buffer was allowed to flow on channel 1. The flow rate was maintained at 5 %L/min. Excess 
reactive groups on the surface were deactivated by using 35 %L of 1M ethanolamine (pH 8.5). A 
concentration series of monoclonal anti-myc tag antibodies prepared in 1 X PBS, pH 7.4 was 
injected over the four channels at a constant flow rate of 20 %L/min. The surface was regenerated 
using 1 X PBS containing 1M NaCl.  
The binding curves were fitted using the proFit software, Quansoft Switzerland.  
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5.3.2. ELISA 
10 %g/ml of Adhiron myc binder, Adhiron scaffold and Adhiron GST B4 binder were incubated in a 
96 well plate (Nunc MaxiSorp). Solutions were prepared in 10 mM PBS buffer, pH 7.2. Each one of 
them was incubated in three wells in a column. The plate was incubated overnight at 4 ºC. The 
samples were decanted and 250 %l of 2 X casein blocking buffer was added in each well and 
incubated for 2 hr at room temperature. The wells were washed 3 times with 10 mM PBST (0.1% 
(w/v) Tween-20 in 10 mM PBS, pH 7.2).  
The first row corresponding to each binder was incubated in 1 %g/ml of monoclonal anti-myc tag 
antibodies. The second row corresponding to each binder was incubated in 1 %g/ml BSA (bovine 
serum albumin) and third row corresponding to each binder was incubated in 1 %g/ml anti-B2M 
antibodies. The antibodies and BSA were prepared in 10 mM PBS (pH 7.2). The plate was 
incubated for 1 hr at room temperature. An anti-mouse-antibody conjugated with horseradish 
peroxidase (1:4000) was added as manufacturer's protocol (Promega) in all the wells and incubated 
for 1 hr at room temperature. After washing ten times with 1 X PBST, 1 ml of TMB substrate 
solution was added and the intensity of emission was measured after 5 min at 650 nm using a 
Multiskan ascent plate reader (Thermo Fisher Scientific). 
 
5.3.3. Electrochemical impedance spectroscopy 
 
5.3.3.1. Electrochemical cell set up 
EIS measurements were done using VSP-3 electrochemical workstation (BioLogic science 
instruments) consisting of a conventional three-electrode system that included a working electrode, 
Ag/AgCl saturated KCl reference electrode and platinum wire as a counter electrode. The 
measurements were taken in the frequency range of 100 kHz to 50 mHz at 80 mV DC potential vs. 
reference (Ag/AgCl). The gold electrodes were fabricated by Evatec (Switzerland) by evaporating 
20 nm Ti followed by 80nm gold onto Si/SiO2 wafers using EBM (Electron beam evaporation) 
using gold of 99.999% purity. 
 
5.3.3.2. Cleaning the gold electrode 
The gold electrode was sonicated in acetone for 5 min twice in fresh acetone solutions. Then the 
surface was rinsed in ethanol. After cleaning, the surfaces were used within 15 min. 
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5.3.3.3. SAM formation 
The cleaned gold surface was incubated for 24 hr or 48 hr in a solution of 1 mM alkanethiol-PEG 
solution prepared in 200-proof ethanol containing 0.05% (v/v) acetic acid. The surface was then 
dried in nitrogen and mounted on to the cell.  
 
5.3.3.4. CV Measurements 
The mounted gold surface was firstly rinsed with 10 mM PBS (pH 7.2) 2-3 times and then incubated 
in 800 %L volume of 10mM PBS for 15 min. The CV measurements were done in 10 mM PBS 
(pH 7.2) buffer containing 1 mM [Fe(CN)6]3-/4- probe at a scan rate of 62 mV/sec.  
 
5.3.3.5. Immobilisation of binders 
The carboxyl groups of the alkanethiol-PEG monolayer were activated by incubating the surface in 
EDC (400 mM)–NHS (100 mM) for 10 min. EDC-NHS solution was prepared in 100 mM MES 
buffer, pH5.5. The surface was incubated in 10 %g/mL Adhiron myc binder 2 (prepared in 100 mM 
acetate buffer pH 5.5) for 1 hr. Then blocking of the remaining active sites was accomplished by 
incubating the surface in 1M ethanolamine (pH 8.5) for 30 min. The surface was then washed with 
10 mM PBS (pH 7.2).  
 
5.3.3.6. EIS measurements 
The EIS measurements were taken in 10 mM PBS (pH 7.2) in the frequency range of 100 kHz to 
50 mHz at 0 mV or 80 mV DC potential vs. reference (Ag/AgCl). 
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5.4. Results 
 
In order to build the biological recognition layer for the detection of monoclonal anti-myc tag 
antibodies the best binder amongst all the ten Adhiron myc binders expressed and purified in the 
previous chapter was selected. The selection was based on ELISA and SPR results. 
The well-characterised binder was then used for fabrication of EIS based biosensor that included 
surface modification, immobilisation of the selected binder and the use of different strategies to 
detect the monoclonal anti-myc tag antibodies. 
 
5.4.1. ELISA 
The ten binders selected from the phage ELISA were Adhiron myc 1, 2, 4, 5, 7, 11, 13, 17, 18 
and 20. The optimisation of the expression and purification conditions was done on Adhiron 
GST B4 binder, which has been used as a control in ELISA. To check the interaction of Adhiron 
myc binders to the monoclonal anti myc-tag antibodies ELISA was performed in a 96 well plate.  
The binding of different Adhiron myc binders, Adhiron scaffold and Adhiron GST B4 binder to 
monoclonal anti myc tag antibodies was detected by using anti-mouse-antibody conjugated with 
horseradish peroxidase. In order to check the non-specific binding of the secondary antibody i.e. 
anti-mouse-antibody conjugated with horseradish peroxidase to the adhiron binders, control wells 
immobilised with the binders (Adhiron myc binders, Adhiron scaffold and Adhiron GST B4 binder) 
were incubated in 1 %g/mL BSA. The wells were then subjected to anti-mouse antibody conjugated 
with horseradish peroxidase without the intermittent step of incubation in anti-myc tag antibodies. In 
order to check the non-specific binding of antibodies to Adhiron myc binders, the wells immobilised 
with the respective binders were also incubated in monoclonal anti-B2M antibodies. 
The presence of the anti-myc tag antibodies on the surface was detected by the intensity of blue 
colour produced on addition of TMB substrate. The intensity of the colour depicted the strength of 
binding which was measured using an ELISA plate reader. Figure 5-1 shows the intensity plot of 
Adhiron myc binders, Adhiron scaffold and Adhiron GST B4 binder against monoclonal anti-myc 
tag antibodies after dividing their response from the BSA control wells that corresponded to the 
non-specific binding of anti-mouse-antibody conjugated with horseradish peroxidase.  
Adhiron myc binder 13 demonstrated the maximum response against monoclonal anti-myc tag 
antibodies followed by Adhiron myc binder 2, binder 11 and binder 7. Adhiron myc binder 2 was 
chosen as the best candidate for further experiments, because Adhiron binder 13 was prone to 
aggregation as discussed in section 4.3.6. Amongst the Adhiron myc binders, Adhiron myc binder 4 
and 18 showed least response to monoclonal anti-myc tag antibodies. The response of the 
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immobilised binders to monoclonal anti-B2M antibodies was negligible thus further establishing the 
specificity of the binding of Adhiron myc binders to monoclonal anti-myc tag antibodies. 
 
 
Figure 5-1. ELISA on Adhiron myc binders, Adhiron scaffold and GST B4 binder.  
The ELISA results shown in the figure give the absorbance measured by the ELISA plate reader at 
650 nm. The binding of monoclonal anti-Myc tag antibodies to the Adhiron myc binders was detected 
using anti-his tag antibodies conjugated with HRP (horseradish peroxidase). The chart has been 
developed after dividing the BSA-control absorbance from the absorbance obtained from each ligand 
on the surface. The green dots represent the intensity of absorbance obtained by incubating the binders 
with monoclonal anti-B2M antibodies. 
 
Adhiron scaffold and the Adhiron GST B4 binder showed minimal binding to the monoclonal anti-
myc tag antibodies establishing that the interaction shown by the Adhiron myc binders towards 
monoclonal anti-myc tag antibodies was a result of the sequences inserted in the variable regions of 
the adhiron scaffold. This further proved that the Adhiron myc binder 2 was not binding non-
specifically to monoclonal anti myc-tag antibodies.  
The variability in the binding of monoclonal anti-myc tag antibodies to the Adhiron myc binders 
was attributed to the different sequences inserted into the Adhiron loops corresponding to each 
Adhiron myc binder. Figure 5-2 shows the sequence alignment of the loops of the ten selected 
Adhiron myc binder showing similarity with the myc epitope sequence EQKLISEEDL that is 
recognised by the anti myc tag antibodies. Adhiron myc binder 2, 1, 18 and 7 show maximum 
similarity with the myc epitope. The sequence similarity of Adhiron myc binder 2, 1 and 7 
corresponds to the binding signal obtained in ELISA but Adhiron myc binder 18 does not show 
binding in ELISA. Adhiron myc binder 13 shows the highest binding in ELISA but has less 
similarity with the epitope. This could be attributed to the fact that the binding of monoclonal anti-
myc tag antibodies is not only dependent on the myc epitope, but also on the neighbouring 
sequences or the folding of the loops. There could also be cross talk between the different loops or 
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the Adhiron scaffold while the monoclonal myc-tag antibody binds to the Adhiron myc binders. 
Based on the ELISA result SPR was done on Adhiron myc binder to obtain its affinity to 
monoclonal anti myc-tag antibody. 
 
 
Figure 5-2 Sequence alignment of Adhiron myc binders with myc epitope. 
The sequence alignment of the three variable regions of the ten selected Adhiron myc binders showing 
similarity with myc epitope EQKLISEEDL. The end row represents the number of amino acids. Key: 
Single letters present aminoacids, “.” semi-conservative substitution, “:” conservative substitution, 
Colour Red: small hydrophobic, aromatic and not Y. Blue: acidic. Magenta: basic, Green: hydroxyl, 
amine, amide, and basic aminoacids. 
 
5.4.2. Surface plasmon resonance 
To characterise the interaction of Adhiron myc binder 2 with monoclonal anti myc tag antibodies, 
SPR was used. The SPR sensor chip has a layer of carboxymethylated dextran (a flexible 
unbranched carbohydrate polymer) (CM) on top of the gold layer carboxyl groups. The carboxyl 
groups allow the attachment of the ligands to the surface by covalent bonding. It also creates a 
hydrophilic environment for the interaction. Each CM5 chip consists of four flow cells to allow 
running of parallel experiments. These channels were named as channel 1, 2, 3 and 4. 
The injection of different buffers or binding of molecules on the surface results in the change of 
refractive index on the sensor surface, which is then detected, with the change in resonance angle 
(see section 3.2.5). For the immobilisation of the ligands to the surface, NHS-EDC chemistry was 
used. Figure 5-3 shows the activation of the carboxylic groups on the SAM surface by using the 
EDC-NHS coupling. The carboxyl groups are activated to NHS which are subsequently displaced 
by an amine containing ligand molecule. The immobilisaton of the ligand molecule takes place 
through the formation of peptide bond between the carboxylic group of the SAM and the amine 
group of the ligand. 
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Figure 5-3 Activation of carboxylic group using EDC-NHS chemistry. 
Schematic of activation of carboxymethyl dextran of the CM5 chip using EDC and NHS coupling. The 
biological recognition layer binds to the activated carboxylic group and forms an amide bond with the 
dextran surface. Taken from (GE healthcare, 2011)  
 
Channel 1 of the SPR instrument was used to check the change in the SPR angle due to the 
refractive index of the buffer. The channel 2 was functionalised with Adhiron scaffold so as to 
check binding of the monoclonal anti-myc tag antibodies to the wild type Adhiron scaffold. Adhiron 
myc binder 2 was immobilised on Channel 3 and Adhiron myc binder 4 was immobilised on 
channel 4. Adhiron myc binder 4 was used as a negative control as it showed minimal binding to 
monoclonal anti-myc tag antibodies in ELISA. 
Figure 5-5 shows the response obtained after injecting 250 nM monoclonal anti-myc tag antibodies. 
Monoclonal anti-myc tag antibodies lower than 250 nM of concentration could not be detected using 
SPR (data not shown). Figure 5-5(a) shows the binding curve obtained for Adhiron myc binder 2 
after subtracting the response due to the change in refractive index of 10 mM PBS, pH 7.2 (channel 
1). Based on the association and dissociation curve, the dissociation constant (KD) of Adhiron myc 
binder 2 was calculated using Profit. The KD was 140±10 nM. The rate of dissociation of the 
monoclonal anti-myc tag antibodies, koff was calculated as 0.01 s -1 which was much higher than the 
rate of association i.e. kon i.e. 72x10-6 nM-1 sec-1.  
Figure 5-4 (b) shows the sensogram of Adhiron scaffold after subtracting the response due to the 
change in refractive index of buffer (channel 1). There was no response observed against 
monoclonal anti-myc tag antibodies, which corresponded to the ELISA result where Adhiron 
scaffold did not show response (Figure 5-1).  
The sensogram shown in Figure 5-4 (c) showed the response of Adhiron myc binder 4 after 
subtracting the response due to change in refractive index of buffer (channel 1). Adhiron myc 
binder 4 did not show any binding against monoclonal anti-myc tag antibodies, which corresponded 
to the ELISA result wherein Adhiron myc binder 4 was showing minimal response against 
monoclonal anti-myc tag antibodies (Figure 5-1). 
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Figure 5-4 Surface Plasmon resonance sensograms of Adhiron myc binder 2, 
Adhiron scaffold and Adhiron myc binder 4. 
Sensograms obtained after 250 nM monoclonal anti-myc tag antibodies were allowed to flow across 
the sensor chip immobilised with (a) Adhiron myc binder 2, (b) Adhiron scaffold and 
(c)  Adhiron myc binder 4. The sensograms were obtained after subtracting the response from channel 
1 (not shown) that was used to detect the change in refractive index due to 10 mM PBS (pH 7.2) 
injection.
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5.4.3. Electrochemical impedance spectroscopy 
Based upon the results obtained from the ELISA and SPR experiments, Adhiron 
myc binder 2 was selected as the biological layer to fabricate the label-free EIS 
based biosensor.  
For the fabrication of a non-faradaic impedimetric biosensor a clean gold surface 
was incubated in 1mM alkanethiol-PEG (SH-(CH2)11-(EG)3-OCH2-COOH) (see 
section 5.1.1.1). Gold has been used as the substrate in biosensing because of its 
inertness to form stable oxide surfaces and resistance to various atmospheric 
contaminants (Bain et al., 1989). Through the thiol group, the SAM forms self-
assembled monolayer on the gold surface via Au-S (gold-sulphide) bond and 
through the carboxy head group it facilitates the attachment of the amine containing 
groups of the ligand. 
 
5.4.3.1. Establishing the formation and properties of the PEG-SAM  
The formation of a SAM on a gold surface was characterised by investigating the 
impedance of the SAM. The insulating property of the SAM was investigated by 
studying the movement of electrons as well as ions to and from the gold electrode in 
the following sections. 
Electron transfer through the PEG-SAM 
To check the quality of SAM on the gold surface and the electronic transfer through 
the SAM cyclic voltametry (CV) was performed on the surface. CV was done on a 
clean gold electrode incubated in 1mM SH-(CH2)11-EG3-OCH2-COOH for 24 hr. 
The CV was performed using 1 mM potassium ferro/ferri cyanide [Fe(CN)6]3-/4- 
dissolved in 10 mM PBS (pH 7.2) buffer solution.  
Figure 5-5 shows the comparison of cyclic voltametry of the bare gold (a) and the 
gold surface incubated in SAM for 24 hr measured in equal concentration of 
[Fe(CN)6]3-/4- complex . The CV of bare gold (black curve) resembles the current-
voltage curve of a gold surface when exposed to buffer containing ferro / ferri 
cyanide redox couple (Rickert et al., 1996). The cathodic peak (EPC) was observed at 
0.23 V and the anodic peak (EPA) was observed at 0.14 V (see section 3.2.6.3). The 
formal potential (EPC+ EPA)/2 was 0.16 V. The CV plot of the SAM modified 
electrode (red curve) showed the behaviour of a well-defined highly ordered 
monolayer. The current was decreased in case of SAM immobilised surface showing 
that the electron transfer property of the surface was almost completely blocked by 
the SAM. 
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Figure 5-5. Cyclic voltametry on bare gold and gold grafted with self 
assembled monolayer.  
Shows the cyclic voltamogram of a bare gold electrode (black) and a gold electrode 
incubated in 0.1 mM thiol solution (red curve) both measured in 10 mM K3Fe(CN)6 in 
10 mM PBS, pH 7.2. The cathodic peak (EPC) was observed at 0.23 V and the anodic 
peak (EPA) was observed at 0.14 V. 
 
Ionic transfer through the PEG- SAM 
Cyclic voltametry depicted the decrease of movement of electrons through the 
formation of PEG-SAM on the gold electrode. Furthermore, the effect of PEG-SAM 
formation on the movement of ions through the surface was investigated. This was 
done by measuring the absolute impedance (|Z|) as well as phase angle (') of the 
interfacial surface. 
The absolute impedance (|Z|) as well as the phase angle (') were measured in the 
frequency range of 100 kHz to 50 mHz at 0 mV DC potential applied at the working 
electrode vs. reference (Ag/AgCl) in 10mM PBS without the redox active species. 
To assess the behaviour of SAM formed on the gold electrode the Bode plots 
showing the absolute impedance (|Z|), as well as the phase angle (') vs. frequency 
were studied. 
The Bode plots of four different surfaces were compared- a bare gold surface, three 
gold electrodes incubated in 1 mM thiol solution (SH-(CH2)11-EG3-OCH2-COOH) 
for 24, 48 and 64 hr respectively. Incubation for different time periods was done to 
optimise the incubation time for the formation of SAM with least defects or 
pinholes.  
Figure 5-6 (a) shows the absolute impedance log |Z| vs. log frequency plot of a bare 
gold surface and surfaces incubated in 1 mM thiol solution for 24, 48 and 64 hr. The 
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measurements were taken in the frequency range of 100 kHz to 50 mHz, the 
response was noted at 0.1 Hz (Figure 5-6(b)) because at this frequency the phase 
showed least change due to change in bulk solution and it was more responsive 
towards the changes in the interfacial layer.  
The absolute impedance of the gold electrodes was observed to increase when 
incubated in thiol solution compared to bare gold surface. The formation of SAM on 
the gold electrode impedes the movement of ions or water molecules thus showing a 
three time increase in the absolute impedance (Boubour and Lennox, 2000a). 
Figure 5-6(b) shows that the absolute impedance was more when the surface was 
incubated for 48 hr than for 24 hr. This was attributed to the fact that the prolonged 
incubation reduces pinholes and defects in the SAM (Agonafer et al., 2012). The 
impedance shown by surfaces incubated in 48 hr or more was varying with different 
surfaces but always higher than 24 hr incubation (data not shown). This showed that 
the gold surface incubated for 48 hr or more in thiol solution produced more 
compact SAM film thus impeding the change in dielectric properties of the SAM. 
The effect of incubation is more pronounced when the phase shift was compared in 
the following section.  
 
 
Figure 5-6. Absolute impedance vs. frequency of various surfaces.  
Shows the plot of absolute impedance |Z| vs. frequency measurement of bare gold 
surface, a gold surface incubated in thiol solution for 24, 48 and 64 hr (a) frequency 
range 100 kHz to 50 mHz  (b) lower frequency range 0.1 Hz to 1 Hz. 
 
Figure 5-7 shows the change in phase vs. frequency plots of bare gold, gold surface 
incubated in thiol solution for 24, 48 and 64 hr depicting the phase vs. frequency 
plot in the frequency range of (a) 100 kHz to 50 mHz and (b) 0.1 Hz to 0.3 Hz. In 
Figure 5-7 (a) the phase shown by the bare gold is different along the whole 
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frequency range from the SAM immobilised surfaces. On comparing the phase in 
between the SAM immobilised surfaces, the change was minimal in the higher 
frequency range (0.5 Hz to 100 kHz). This could be attributed to the fact that the 
solution resistance remains the same in case of all the SAM immobilised surfaces.  
 
 
Figure 5-7. Phase vs. frequency of different surfaces.  
Shows the Bode plot of phase vs. frequency measurement of bare gold surface, a gold 
surface incubated in thiol solution for 24, 48 and 64 hr (a) frequency range 100 kHz to 
50 mHz, (b) lower frequency range 0.1 to 0.3 Hz. 
 
In Figure 5-7(b) the phase obtained at 0.1 Hz for the bare gold, gold surface 
incubated in thiol solution for 24, 48 and 64 hr was -72.9º±0.3, -79.1º±0.9, 
-84.9º±0.5 and -82.6º±0.6 respectively.  The phase change from bare gold to the 
SAM coated surfaces is attributed to the formation of an insulating layer of SAM 
that changes its interfacial ionic permeability, observed in the lower frequency 
range. The phase for an ideal electrochemical double layer capacitor is * -88º 
(Boubour and Lennox, 2000a). The deviation in phase from an ideal electrochemical 
double layer observed in case of bare gold can be attributed to the 
roughness / contamination of the gold electrode. On incubating the surface in thiol 
solution for 24 hr the phase observed (-79.1º±0.9) was lower than that of bare gold. 
This could be because of the formation of SAM on to the gold surface that covers 
the electrode surface and decreases surface contamination. The phase angle 
observed for the gold surface incubated in thiol solution for 48 hr (-84.9º±0.5) was 
four degrees lower as compared to that of gold incubated in thiol solution for 24 hr. 
This showed that incubation of SAM for more than 24 hr allowed more surface 
coverage by SAM thus reducing the pinholes / defects and thus reducing the 
movement of ions through the SAM (see section 5.1.1.1).  
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The time dependent formation of pinholes / defects in SAMs immobilised on gold 
electrodes has been well studied (Ulman, 1996; Agonafer et al., 2012; Whitesides et 
al., 2005). The SAM formation is described in two major steps. The initial quick 
step (5-6 min) of chemisorption of SAMs from the solution onto the substrate 
(bonding between head group and gold surface), followed by the slow process of 
reordering of alkane chains that are held by van der Waals forces. The longer 
incubation period of gold substrate helps in annealing the pinholes / defects thus 
decreasing the permeation of ions through the SAM (Agonafer et al., 2012; Boubour 
and Lennox, 2000a).  
The phase obtained for SAM incubated in thiol solution for 64 hr was -82.6º±0.6. 
The increase in phase observed when SAM was incubated for more than 48 hr could 
be due to change in the the rearrangement of PEG molecules over time.  
As the 48 hr incubation time formed more compact SAM on the gold surfaces and 
64 hr incubation time, sometimes showed worst phase than 48 hr, therefore in the 
future experiments the cleaned gold surfaces were incubated for 48 hr in 1 mM 
SH-(CH2)11-EG3-OCH2-COOH.  
Although both absolute impedance |Z| and phase ' of impedance (Z) were used to 
assess the formation of SAM, it has been observed that measuring the change in 
phase is more reliable than measuring the change in absolute impedance as the phase 
does not change with the electrode area (Boubour and Lennox, 2000a; Evans et al., 
2008). Therefore, in the following experimental sections, change in phase (') has 
been used to measure changes at the interface of SAM and buffer. 
 
Stability of SAM over time 
The decreased current in the CV (Figure 5-5) and a phase angle of -84.9º±0.5 
(Figure 5-7) signified that the insulating layer impeded electron transfer and any 
change in dielectric properties of the surface respectively. In order to immobilise the 
Adhiron myc binder 2 onto the surface and later detect the binding of monoclonal 
anti-myc tag antibodies to the binder, it was important to establish a stable insulating 
monolayer. 
To check the change in the surface behaviour with time, the stability of SAM was 
checked in 5 subsequent measurements by changing the 10 mM PBS buffer (pH 7.2) 
after every 15 min. The phase (') of impedance (Z) was measured in the frequency 
range of 100 kHz to 50 mHz at 0 mV DC potential applied at the working electrode 
vs. reference (Ag /AgCl). 
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The contribution of non-faradaic charge transport was higher in the lower frequency 
range therefore, the change in interfacial layer with time was detected by the change 
in phase in the lower frequency range (0.1 Hz). Figure 5-8 shows the change in 
phase of SAM in the lower frequency range (0.09-0.36 Hz). At 0.1 Hz, the phase 
was drifting by approximately 2º in five subsequent readings. Thus there was a 
change involved at the surface of the monolayer with time, imparting instability to 
the surface.  
 
 
Figure 5-8. Phase vs. Frequency of surface in 10 mM PBS (pH 7.2).  
Shows the phase in the lower frequency range of 0.09-0.36 Hz for 5 subsequent 
readings taken after incubation of the SAM immobilised surface in 10 mM PBS (pH 
7.2) for 15 min. 
 
This change was most likely due to the reorganization of monolayer surface with 
time. The effect of different functional groups present at the terminal ends (-OH, 
-COOH) of SAMs, has been well studied. It has been observed that the hydrophilic 
end groups  attributed to orientational changes of the hydrocarbon chain. The COOH 
group-terminated SAMs showed higher degree of disorder (Dannenberger et al., 
1997; Himmel et al., 1997). The reorganization was attributed to the fact that the 
monolayers have high surface free energies that they tend to reduce by burying their 
polar functional groups in the monolayer surface (Evans et al., 1991). Although the 
reason for unstability could not be understood completely but it could also arise due 
to the effect of solvent that destroys the ordered structure of PEG-SAM by 
penetrating into the PEG part or underlying alkane chain (Zolk et al., 2000; 
Vanderah et al., 2003). 
In order to detect the binding of biological molecules in the interfacial layer formed 
by the insulating layer of SAM and the physisorbed ionic layer of the buffer, the 
stability of SAM was important, and this will be addressed in the following section. 
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Stabilisation of SAM by potential tuning 
The instability of SAM with time was attributed to the time dependent 
reorganization of the polar functional groups into the carbon chain. This issue of 
instability was reduced by introducing the potential induced stabilisation of the 
surface by ramping of surface to a higher DC potential of 200 mV (Bioelectronics 
group, University of Leeds).  
Clean gold surfaces were incubated in 1mM thiol solution for 48 hr as above. The 
surfaces were then subjected to a ramping DC potential from 0 V to 0.2 V vs. 
reference (Ag/AgCl) over 15 cycles. After 15 cycles of ramping, the phase 
measurements were taken on incubating the surface in 10 mM PBS (pH 7.2) for 
15 min and changing the buffer each time. Figure 5-10(a) showed that the change is 
phase over 4 subsequent cycles was in the acceptable range of 0.1º to 0.4º unlike 
observed in case when no ramping was done (Figure 5-9 (b)). The surface becomes 
stable and the drift in baseline was not observed after third reading.  
Most likely the ramping step reorients the flexible carboxylic group terminated PEG 
of the SAM and aligns all in such a way that a compact high SAM is formed. The 
time dependent reorientation made faster by subjecting the SAM to a higher 
potential, could also be due to interaction of Au-S bond. At more positive potential, 
the gold substrate is positively charged as compared to the electronegative sulphur 
head groups. This can increase the dipole–dipole interactions and arranges the SAM 
more compactly (Sahalov et al., 2007). The stability observed makes the surface 
suitable to be used as a sensor surface. 
The stable SAM formed after subjecting it to 15 cycles of 200 mV DC voltage was 
then used after immobilisation of the biological recognition layer i.e. Adhiron myc 
binder 2. 
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Figure 5-9. Comparison of surface stability in buffer before and after 
200 mV potential tuning.  
Shows the phase at 0.1 Hz for five subsequent readings taken after incubation of the 
SAM immobilised surface in 10 mM PBS (pH 7.2) for 15 min (a) after potential 
tuning at 200 mV (b) before potential tuning at 200 mV. 
 
5.4.3.2. Immobilisation of Adhiron myc binder 2 
After immobilisation of carboxylic group containing PEG-SAM on the gold surface, 
the surface was incubated in 10 %g/mL Adhiron myc binder 2 using amine coupling 
chemistry (see section 6.3.3). The surface was then subjected to a DC potential of 
0 mV vs. reference (Ag/AgCl) in the frequency range of 100 kHz to 50 mHz.  
Figure 5-10 shows Bode plot depicting phase response of the surface before and 
after immobilisation of Adhiron myc binder 2. The phase (') of impedance (Z)  
shown by surface at 0.1 Hz, before immobilisation of the binder was -85º. SAM with 
a phase of -85º (non-ideal capacitive layer) depicted that the SAM formed allowed 
the movement of ions (through defects) unlike in case of perfectly insulating layer. 
This could be attributed to the amorphous nature of PEG on the SAM that allows the 
formation of defects on the SAM (Love et al., 2005) (see section 5.1.1.1). The phase 
at 0.1 Hz after immobilisation of Adhiron myc binder 2 was -88º. The change in 
phase showed a reduction in the non-faradaic movement of ions near the interfacial 
layer. This change could be attributed to the formation of a more compact layer by 
the immobilisation of Adhiron myc binder 2 (diameter of 3 nm) blocking the 
pinholes or due to the interaction of COOH-terminated PEG molecules with the 
Adhiron myc binder 2 changing the electronic environment of the interfacial surface 
(Mendoza et al., 2007; Schreiber, 2000).   
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Figure 5-10. Phase vs. Frequency before and after immobilisation of 
10 !g/ml of Adhiron myc binder 2.  
Shows the Bode plot depicting the phase of a SAM immobilised gold surface before 
the immobilisation of Adhiron myc binder 2 and after the immobilisation of 10 %g/mL 
Adhiron myc binder 2. The surface was subjected to a DC potential of 0 mV and the 
frequency range shown is from 0.1 Hz – 0.36 Hz. 
 
5.4.3.3. Demonstration of biosensing using Adhiron based biological recognition 
molecule 
After the immobilisation of Adhiron myc binder 2, the surface was subjected to 
200 mV DC voltage vs. reference (Ag/AgCl) for stabilisation. This was done to 
obtain a stable phase after immobilisation of the Adhiron myc binder 2.  
Figure 5-11 shows the change in phase (&') of the sensor at 0.1 Hz after incubating 
the surface in different concentrations of monoclonal anti-myc tag antibodies. 
Change in phase, (&') corresponds to the change in phase angle (degree) with 
respect to the initial phase angle, measured in 10 mM PBS (pH 7.2) before adding 
the monoclonal anti-myc tag antibodies. The surface was subjected to 80 mV DC 
potential vs. reference (Ag/AgCl) for the measurements. 80 mV DC potential was 
chosen because of the higher sensitivity observed at a higher potentials > 0 mV DC 
bias (see Chapter 6).  
To check the stability of the surface before adding the monoclonal anti-myc tag 
antibodies, the phase of the surface was measured in 10 mM PBS (pH 7.2) twice 
after incubation for 15 min each. No change in phase was observed in 10 mM PBS 
(pH 7.2) incubations establishing stability of the sensor surface.  
On addition of 1 nM of monoclonal anti-myc tag antibodies to the surface and 
incubating for 15 min, the sensor showed a response of 0.4º phase shift. So as to 
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check the response of the sensor when incubated in the same concentration, the 
sensor was incubated again in 1 nM of monoclonal anti-myc tag antibodies and the 
phase shift increased by 0.2º. The phase shift observed increased when the surface 
was incubated in higher concentrations of monoclonal anti-myc tag antibodies 
(10-50 nM). A saturation phase was observed after 50 nM concentration of 
monoclonal anti-myc tag antibodies i.e. from 50-150 nM. The surface was rinsed 
with 10 mM PBS (pH 7.2) after each incubation. 
 
 
Figure 5-11. response of the sensor surface towards different 
concentration of monoclonal anti myc tag antibodies.  
Shows change in phase (&') vs. different concentrations of monoclonal anti-myc tag 
antibodies. The measurements were taken after incubating the surface immobilised 
with Adhiron myc binder 2 in different concentrations of monoclonal anti-myc tag 
antibodies for 15 min. The surface was incubated in 1 nM monoclonal anti-myc tag 
antibodies twice. 
 
The phase shift observed when monoclonal anti-myc tag antibodies were added to 
the surface could be because of the change in the the dielectric properties of the 
interfacial surface or the charge distribution that arrises due to the binding of a 
charged bulky monoclonal anti myc tag antibodies. The binding of the antibodies 
can cause rearrangement of the PEG layer. These rearrangement in the PEG can then 
destabilise the underneath alkyl monolayers (Schreiber, 2000). This in turn can 
increase the non-faradaic ionic movement which is observed as the increase in phase 
shift (Zaccari et al., 2014). 
This shows that the sensing platform formed by the SAM and the biological 
recognition molecules / Adhiron myc binder 2 was sensitive enough to detect the 
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binding of monoclonal anti-myc tag antibodies. It also showed that the sensing 
platform was more sensitive than SPR, which was detecting the concentration of 
monoclonal anti-myc tag antibodies two orders of magnitude higher 
(see section 3.2.5).  
As an alternative approach to rinsing the surface in between subsequent incubations, 
a different strategy of adding monoclonal anti-myc tag antibodies was used which is 
discussed in the following section. 
 
5.4.3.4. Using cumulative addition of anti-myc tag antibodies  
The surface immobilised with SAM was incubated in 10 %g/mL of Adhiron myc 
binder 2 and 200 mV DC voltage induced stabilisation of surface was done after the 
the SAM formation. The stabilisation of the surface was also done after the 
immobilisation of 10 %g/mL of Adhiron myc binder 2 on the surface. The 
measurements were taken at 80 mV DC potential applied to the surface vs. reference 
(Ag/AgCl).  
Figure 5-13 shows the change in phase (&') vs. increasing concentration of anti 
myc-tag antibodies. Two initial readings were taken in 10 mM PBS (pH 7.2). The 
buffer was changed twice and the readings were taken after 15 min incubation each. 
To avoid the regeneration and washing steps in between, new concentrations were 
added so as to prevent the surface from drifting from its initial baseline, a 
cumulative addition of concentrations (0.1 nM to 200 nM) of monoclonal anti-myc 
tag antibodies was done. The response of the sensor was linear from 0.1 nM to 
100 nM and then the sensor showed saturation at 200 nM. The change in phase (&') 
on addition of 0.1 nM anti-myc tag antibodies was 0.3º. Although the linear 
response was observed but the change in overall phase observed was lower than the 
change in phase observed in Figure 5-12. This was most likely due to fewer Adhiron 
myc binder 2 left unoccupied on the surface with subsequent injections, as there was 
no removal of the solution and no rinsing in between the addition of new 
concentrations. The cumulative way of addition of antibodies most likely leads to 
the setting up of a new baseline for the next concentration to be added. 
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Figure 5-12. Cumulative addition of different concentrations of 
monoclonal anti-myc tag antibodies. 
Shows the phase response (&') of a sensor surface, immobilised with Adhiron myc 
binder 2, when incubated in different concentrations of monoclonal anti-myc tag 
antibodies for 15 min. The concentrations were added in a cumulative way without 
rinsing the surface in between or changing the buffer. 
 
The following section gives a brief overview of the EIS based Adhiron myc binder 2 
depicted by a schematic diagram (Figure 5-13). 
Figure 5-13 shows a schematic of the EIS based Adhiron myc binder 2  biosensor 
used to detect monoclonal anti-myc tag antibodies. After the formation of 
-COOH-PEG-SAM on the surface, the initial phase observed was > -90º, which is 
attributed to the presence of defects or pinholes in the monolayer depicted in the 
Figure 5-12 (see section 5.1.1.1). On immobilisation of Adhiron myc binder-2 on to 
the surface, the phase decreases as compared to the initial phase. One of the 
potential explanations, can be in terms of a compact layer of Adhiron myc binder 2 
formed that decreases the penetration of ions. Although a direct cause of this change 
is still under investigation, there are various possible factors involved in changing 
the electrical environment of the interfacial surface upon the binding of monoclonal 
anti-myc tag antibodies, such as, the flexible –PEG molecules, conformational 
changes in the biological recognition layer (Adhiron myc binder 2) or the change in 
ionic environment at the interface due to the charged antibodies bound to the surface 
(see section 5.4.3.3). 
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Figure 5-13. The working of Adhiron myc binder 2 based impedimetric 
biosensor. 
Shows the schematic of the working of Adhiron myc binder 2 based EIS biosensor. 
(a) The immobilisation of carboxylic acid terminated alkylthiol self-assembled 
monolayer on to the gold surface via thiol bonding (Au-S). (b) The Adhiron myc 
binder 2 was immobilised on the SAM surface through amine coupling to form a 
sensitive sensing platform. (c) Binding and detection of monoclonal anti-myc tag 
antibodies. 
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5.4.4. Discussion 
The present work demonstrated the working of a label-free impedimetric biosensor 
using Adhiron myc binder 2 as the biological recognition molecule to detect 
monoclonal anti-myc tag antibodies.  
In ELISA Adhiron myc binder 13 showed the maximum response followed by 
Adhiron myc binder 2, 11 and 7. On relating the binding with the similarity of the 
sequences present in the three variable regions of the binders with the myc epitope 
EQKLISEEDL, Adhiron myc binder 13 showed sequence similarity to myc epitope 
in its second loop. Although it showed the maximum signal in ELISA, it was 
discarded during the experiments because it was aggregating. Adhiron myc binder 2 
and myc 11 presented similarity in sequences with the myc epitope EQKLISEEDL 
in the first variable region of the Adhiron scaffold (Figure 5-3). Although Adhiron 
myc binder 18 was also showing similarity with the myc epitope but the loop 
presenting the similar sequences was the second variable region. The difference in 
binding could be because of the presentation of the binding epitope in different 
variable regions that affects the binding of the antibodies to the Adhiron myc 
binders.  
In the process of biosensor fabrication, the sensing platform constituted of the 
Adhiron myc binder 2 immobilised on the SAM layer (SH-(CH2)11-(EG)3-OCH2-
COOH) formed on a gold electrode. The sensing platform allowed the non-faradaic  
movement of ions, which was used to detect the binding of monoclonal anti-myc tag 
antibodies to the Adhiron myc binder 2 molecules. The lowest concentration of 
monoclonal anti-myc tag antibodies detected was 0.1 nM and the detection was done 
over 3 orders of magnitude. The detection of the monoclonal anti-myc tag antibodies 
was done over a range of concentrations (0.1-200 nM), which shows that the system 
could be used for many different concentrations without the need for a regeneration 
step. 
One of the limitations of the sensor was the variation of the response with respect to 
detection limit and dynamic range on different sensor surfaces, which could be 
attributed to the fact that the immobilisation of the ligand on the surface was a 
multistep process, that could lead to variability in the number of ligands bound to 
the SAM molecules and thus change the impedence between sensors. Moreover the 
immobilisation of Adhiron myc binder 2 on to the SAM through amine coupling can 
conceal the anti-myc tag binding site. This can be a reason for the difference in 
sensor response. The limitations in the system are also coherent with those observed 
in the work done by other researchers in similar field (Bart et al., 2005). These 
limitations need to be addressed and worked upon so as to get more reproducible 
and similar responses from different sensor surfaces. 
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Chapter 6. Voltage induced modulation of the sensitivity of the 
impedimetric biosensor 
 
6.1. Introduction 
After the fabrication of an impedimetric biosensor with the Adhiron myc binder 2 
forming the biological recognition layer for detection of monoclonal anti-myc tag 
antibodies, the next aim of the project was to improve the sensitivity of the label free 
biosensor.  
Sensitivity of a biosensor is an important aspect in case of detection of biomarkers in 
clinical samples. Blood serum contains different concentrations of biomarkers 
depending upon the physiological condition of a person. The detection of the 
biomarkers by a biosensor can vary depending upon the concentration of the 
biomarkers in the sample or the affinity of the biological recognition molecules 
towards the biomarkers. To improve the sensitivity of the biosensors various 
strategies have been employed to enhance the detection signal. Electroactive probe 
molecules (methyl blue) – modified reporter probe complementary to the capture 
probes have been used to detect the target molecules (Yang and Zhang, 2010). This 
is a limitation in case of label–free impedimetric biosensors in which label-free 
strategies have to be explored for increasing the sensitivity. Using a higher affinity 
probe molecule or biological recognition molecule can also enhance the sensitivity 
of the biosensor e.g. smaller antibody fragments for detection of E. coli  cells proved 
to increase the sensitivity of the sensor (based on quartz crystal microbalance) over 
the use of whole antibodies (Sharma and Mutharasan, 2013). Another approach to 
detect biomarkers at extremely low concentrations has been to use the desirable 
properties of nano particles that include high surface area to volume ratio and 
electrical conductivity (Li and Cui, 2013). Cai et al. fabricated a molecular 
imprinting based recognition molecule (molecularly imprinted polymer-MIP) to 
detect template proteins. A non-conducting polymer  was coated over an array of 
carbon nanotubes which increased the sensitivity of the sensing platform and the 
binding of the template proteins was detected (subpicogram per litre) using change 
EIS (Cai et al., 2010).  
The label-free detection of monoclonal anti-myc tag antibodies on the EIS-based 
Adhiron biosensor was mainly dependent on the non-faradaic changes at the 
interfacial plane. These changes in the non-faradaic movement of ions through the 
PEG-SAM was facilitated by the presence of pinholes / defects in the SAM. In such 
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a case the sensitivity of the SAM can be varied by tuning the number of 
pinholes / defects present in the SAM that largely depends on the packaging of 
SAM. The order or packaging of SAM can be changed using mixed SAMs 
(Chapman et al., 2000; Zaccari et al., 2014). The number of pinholes / defects and 
therefore the non-faradaic movement of ions can be tuned by varying the 
concentration ratios of the mixed SAMs (Zaccari et al., 2014).  
One of the inspiring approaches that nature has provided is based on bilayer 
membranes. The SAMs can be compared to bilayer membranes that have been 
widely studied to understand the mechanism of transport of molecules into the cells. 
The permeability of these biological membranes increases by using strong electrical 
pulses (voltage pulse). The phenomenon is widely used to transport molecules in 
and out of cells (Weaver and Chizmadzhev, 1996). An interesting work was 
published in the year 2000 (Boubour and Lennox, 2000b) wherein impedance 
spectroscopy was used to study the effect of applying different voltages (DC biases) 
on SAMs formed from n-alkanethiols. The work showed that SAMs behaved like 
insulators until a critical potential (Vc) was applied and at potentials more cathodic 
than the Vc, the SAMs show a significant change in the phase angle in the low 
frequency region. These changes suggested that the defects formed in the SAMs 
allowed ion and water penetration. The change in phase was also shown partly 
reversible showing that the changes induced due to DC potential were not 
permanent. 
The working of the Adhiron myc binder 2 biosensor is based on the dielectric 
properties of the interfacial layer formed by the SAM and the Adhiron myc binder 2. 
When the Adhiron myc binder 2 binds to monoclonal anti-myc antibody, there is a 
change at the interface of the sensor surface that can be detected as the change in 
phase. In an ideal situation, if the SAM layer and the biological recognition 
molecules are compactly bound such that no holes or defects are present, it will 
impede the passage of ions through the SAM. Thus, there will be no detection of any 
change encountered by the interfacial layer. In such a situation if defects are induced 
in the SAM so that the movement of ions is allowed, the detection will be possible. 
Bart et al observed a higher sensor response at 0.2 V than 0 V vs. a saturated 
calomel reference electrode during the detection of interferon-Y (IFN-Y) (Bart et 
al., 2005). 
Based on such lines one of the promising approaches to improve the sensitivity of 
the EIS based Adhiron myc binder 2 biosenor was to induce defects in the SAM in 
using a higher DC bias. Figure 6-1 shows a schematc depicting the change in the 
movement of ions through the interfacial layer on applying a positive DC potential 
to the working electrode against the reference electrode (Ag/AgCl). The surface at 
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0 V DC bias consists of some defects, which corresponds to its non-ideal insulating 
behaviour (phase > -90º). On applying a higher DC bias there are various effects that 
can increase the permeability of the ions. Firstly, on applying higher potential the 
number of ions moving towards the surface increases thus increasing the non-
faradaic current. Secondly, since the PEG molecules on the surface are charged 
therefore the effect of voltage can cause conformational changes in the PEG 
molecules. Such changes can either induce new defects in the SAM or can enhance 
the movement of ions to the unreachable defects of the SAM by opening paths for 
the ions to move to and from the electrode. The reversibility in the rearrangement of 
SAM was depicted by the restoration of the original phase of the SAM at 0 V DC 
bias and back to the same higher bias. This shows that the change in the 
rearrangement is not permanent as long as the voltage does not cause the desorption 
of the alkyl thiols from the surface. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
160 
 
 
 
 
Figure 6-1. Schematic representation of potential induced defects in 
SAM.  
Schematic showing the change in interfacial surface from (a) to (b) when a higher DC 
bias is applied to the surface with respect to the reference electrode. It shows the 
defects induced in the PEG-SAM surface (b) at a higher DC bias that increases 
permeation of ions into the SAM. It also depicts the reversibility of the SAM when 
the DC bias is restored to the original potential. 
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In light of inducing defects by applying higher DC voltages and thus changing the 
sensitivity of the biosensor, the project aimed to develop a model system in order to 
investigate any change in the sensitivity by changing the DC bias.  
The initial experiments to investigate the modulation of the biosensor sensitivity 
using DC biases were done using Adhiron myc binder 2. The concept was then 
carried forward to change the sensitivity of a biosensor based on Adhiron IL8 binder 
to detect IL8 protein. IL8 protein is a biomarker in various clinical disorders e.g 
urinary bladder cancer, pulmonary diseases (Shahzad et al.). IL8 is a cytokine 
produced in blood cells and tissues and is associated with different inflammatory 
diseases (Baggiolini and Clark-Lewis, 1992). Recently, a biosensor for the detection 
of IL8 protein was developed by the Bioelectronics Laboratory at the University of 
Leeds, and this biosensor essay was then employed for the DC bias studies for 
tuning the sensitivity of a biosensor. This biosensor was chosen for further 
investigation as it showed very low detection limit (<100 fg/ml), large dynamic 
range, and furthermore, is clinically more relevant than the Adhiron myc binder 2. 
This chapter discusses about the behaviour of SAM at different DC biases and the 
improvement of sensitivity of EIS based biosensor. 
 
6.2. Materials  
Reagents and chemicals were purchased from Sigma-Aldrich unless mentioned. 
Alkanethiol with terminal ethylene glycol functionalised with carboxylic group 
(SH-C11-(EG)3-OCH2-COOH) was purchased from Prochimia, Poland. IL8 protein 
and monoclonal anti-myc tag antibodies were purchased from Abcam. Ag/AgCl 
saturated KCl reference electrode.  
 
6.3. Methods 
The cleaning of gold surface was done using method described in section 5.3.3. The 
cleaned gold surface was incubated in 1 mM alkanethiol-PEG 
(SH-(CH2)11-(EG)3-OCH2-COOH) solution for 48 hr. The surface was then 
subjected to 15 cycles of 0.2 V DC potential vs. reference (Ag/AgCl). The 
immobilisation of 10 %g/mL Adhiron myc binder 2 and Adhiron IL8 protein was 
done using the EDC-NHS coupling chemistry (section 5.3.3.). This was followed by 
subjecting the surface to 15 cycles of 0.2 V DC potential vs. reference (Ag/AgCl). 
The surface was then incubated in different concentrations of monoclonal anti –myc 
tag antibodies and IL8 protein. The EIS measurements were taken in 10 mM PBS, 
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pH 7.2 (for Adhiron myc binder 2 sensor) and in 10 mM PB, pH 7.2 (for Adhiron 
IL8 binder sensor) in the frequency range of 100 kHz to 50 mHz at different DC 
biases vs. reference (Ag/AgCl). 
 
6.4. Results 
 
To investigate the change in sensitivity of a sensor with the change in DC bias 
various experiments were done initially to ascertain the behaviour of the SAM 
immobilised gold electrode on applying different DC voltages. 
 
6.4.1. Applying different voltages to the SAM 
To investigate into the effect of different DC biases on SAM (with respect to 
reference Ag/AgCl), the surface was subjected to different potentials with respect to 
the reference (Ag/AgCl). So as to set the potential range where the surface behaves 
reversible, an arbitrary range of 0 to 0.35 V DC potentials was chosen. After 0.1 V 
the voltage was applied in 0.05 V steps.  
 
6.4.1.1. Phase change vs. frequency 
Figure 6-2 shows the phase vs. frequency (100 kHz to 50 mHz) profile obtained 
after the surface was subjected to 0, 0.1, 0.15, 0.2, 0.25, 0.3 and 0.35 V vs. reference 
(Ag/AgCl). There was negligible change observed in the frequency range of 
100 kHz to 10 Hz. This is attributed to the fact that the solution resistance dominates 
in the higher frequency range and therefore no shift was observed in the range of 
100 kHz to 10 Hz.  
Figure 6-2(b) shows the change in the phase in the frequency range 10 Hz to 
50 mHz. The phase at 0.1 Hz was increasing with the increase in DC bias.  Although 
the phase shift is observed at 10 Hz as well but the shift at 0.1 Hz was more 
prominent and therefore 0.1 Hz was chosen as the frequency to measure the phase. 
The phase at 0.1 Hz was less negative (> -90º) with the increase in DC bias. The 
change was attributed to the defects created in the SAM that increased the 
movement of ions (Boubour and Lennox, 2000b). 
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Figure 6-2. Phase vs. Frequency at different DC biases applied to the 
SAM immobilised gold surface.  
Shows the Bode plot depicting phase vs. frequency. The surface was subjected to 
different DC biases (0, 0.1, 0.15, 0.2, 0.25, 0.3 and 0.35 V) against the working 
electrode with respect to reference (Ag/AgCl). (a) shows the plot in the frequency 
range of 100 kHz to 50 mHz and (b) shows the response in the frequency range of 
0.05 Hz to 0.3 Hz. 
 
6.4.1.2. Absolute impedance vs. frequency 
Figure 6-3 shows the change in absolute impedance |Z| vs. frequency (0.1-0.5 Hz) on 
applying different DC bias 0, 0.1, 0.15, 0.2, 0.25, 0.3 and 0.35 V. The absolute 
impedance of the surface decreases with the increase in voltage, which proved that 
the surface showed less resistant to the movement of ions at higher voltages due to 
interfacial changes allowing non-faradaic movement of ions. The absolute 
impedance at different DC biases coincide in the higher frequency range (data not 
shown). 
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Figure 6-3. Absolute impedance change with respect to frequency at 
different DC biases. 
Shows the absolute impedance vs. frequency (0.1 to 0.3 Hz). The surface was 
subjected to different DC biases (0, 0.1, 0.15, 0.2, 0.25, 0.3 and 0.35 V) against the 
working electrode with respect to reference (Ag/AgCl).  
 
6.4.1.3. Reversibility of phase at DC bias 
In order to investigate whether the DC voltages caused any permanent perturbation 
to the SAM and on basis of that select an appropriate voltage range to work with, the 
SAM immobilised surface was subjected to various voltages.  
The reversibility in the potential induced defects in the SAM was checked on the 
basis of restoration of the original phase of the SAM at 0 V after applying  higher 
DC biases. The reversibility of the defects was also checked by checking the 
restoration of phase at a particular DC bias when different DC voltages were applied 
in between. 
Clean gold surface with immobilised SAM was incubated in 10 mM PBS (pH 7.2) 
and the measurements were taken at different DC potentials (0-0.4 V) vs. reference 
(Ag/AgCl) in the frequency range of 100 kHz to 50 mHz. The phase corresponding 
to 0 V DC bias was taken as a reference phase for comparing the surface 
reversibility at different DC biases. The reversibility at each potential was checked 
by returning back to the 0 V DC bias. The phase at the same DC bias was also 
checked twice by applying different voltages in between. This was done to check if 
different voltages were causing any permanent change in the interfacial layer of the 
sensor. The DC biases applied to check the reversibility were as follows: 
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0 V and 0.1 V  
Figure 6-4 shows that the phase measured over the whole range of frequencies at 
0 V potential did not change after applying 0.1 V of DC bias. The phase measured at 
0 V  before and after applying 0.1 V DC bias were overlapping. The phase measured 
at 0.1 V also overlapped after the potential was set back to 0 V. Figure 3(b) 
elaborates the phase measured in the lower frequency range (0.1 to 0.36 Hz). 
 
 
Figure 6-4 Reversibility in defects caused by potential change, checked 
at 0 V and 0.1 V applied to the surface against reference (Ag/AgCl). 
Shows the phase vs. frequency in the range of a) 100 kHz to 50 mHz and b) 0.1 Hz to 
0.3 Hz. The reversibility of the defects induced in the SAM were analysed by 
checking the restoration of the phase of the surface subjected to different DC biases 0 
and 0.1 V vs. the reference (Ag/AgCl). 
 
0 V, 0.15 V, and 0.2 V 
Figure 6-5 shows the phase measured over the whole range of frequencies (100 kHz 
to 50 mHz) at DC potentials corresponding to 0, 0.15, and 0.2 V. After subjecting 
the surface to 0.15 V as well as 0.2 V, it did not show change in phase with respect 
to 0 V. The phase at 0.2 V overlapped with the previous phase measured at the same 
potential in the lower frequency range (0.1 to 0.36 Hz) (Figure 6-5). This showed 
the maintenance of reversibility in the rearrangement of SAM at 0.15 V and 0.2 V 
DC potentials. 
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Figure 6-5 Reversibility in defects caused by potential change, checked 
at five different voltages applied to the surface against reference 
(Ag/AgCl). 
Shows the phase vs. frequency in the range of a) 100 kHz to 50 mHz and b) 0.1 Hz to 
0.3 Hz. The reversibility of the defects induced in the SAM were analysed by 
checking the restoration of the phase of the surface subjected to different DC biases 0 
V, 0.15 V and 0.2 V vs. the reference (Ag/AgCl). 
 
0 V, 0.25 V, 0.3 V and 0.4 V  
Figure 6-6 shows the phase measured over the whole range of frequencies (100 kHz 
to 50 mHz) when the surface was subjected to 0, 0.25, 0.3 and 0.4 V DC bias.  After 
subjecting the surface to 0.25, 0.3 and 0.4 V, the phase did not change at 0V with 
respect to the previous phases measured before applying higher voltages. 
Figure 6-6(b) shows the phase response measured in the lower frequency range 
(0.1 to 0.36 Hz). In the lower frequency range the phase at 0 and 0.4 V overlapped 
with the previous phase measured at the same potentials respectively. This showed 
the reversibility in the phase response of the SAM-immobilised surface subjected to 
0.25, 0.3 and 0.4 V DC potentials.  
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Figure 6-6 Reversibility in defects caused by potential change, checked 
at six different voltages applied to the surface against reference 
(Ag/AgCl). 
Shows the phase vs. frequency in the range of a) 100 kHz to 50 mHz and b) 0.1 Hz to 
0.3 Hz. The reversibility of the defects induced in the SAM were analysed by 
checking the restoration of the phase of the surface subjected to different DC biases 0, 
0.25, 0.3 and 0.4 V vs. the reference (Ag/AgCl). 
 
The coinciding of the phase readings corresponding to different frequencies when 
measured at the same DC bias and no change in the phase observed at 0V confirmed 
that the DC bias was not causing any permanent change to the interfacial layer of the 
sensor and the defects formed were replaceable. This could be attributed to the 
rearrangement of the –COOH-PEG-SAM surface.  
In order to investigate into the change of sensitivity of the surface, a model system 
based on Adhiron myc binder 2 for the detection of anti myc tag antibodies was 
used.  
 
6.4.1.4. Using different potentials to detect monoclonal anti-myc tag antibodies 
The concept of potential induced defects was used in the Adhiron myc binder 2 
based biosensor in order to check the change in sensitivity of the biosensor detecting 
monoclonal anti-myc tag antibodies. 
Immobilisation of Adhiron myc binder 2  
In order to compare the phase at different DC potentials after the immobilisation of 
Adhiron myc binder 2 the surface was subjected to different DC biases. 
The surface was immobilised with 10 %g/mL of Adhiron myc binder 2 using 
NHS-EDC coupling. The measurements were taken in the frequency range of 
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100 kHz to 50 mHz at the following DC potentials vs. reference (Ag/AgCl) - 0, 0.05, 
0.08, 0.1, 0.15, 0.18 and 0.2 V. Figure 6-7 shows the phase vs. frequency plot in the 
lower frequency range (0.1 to 0.3 Hz). There was an increase in phase (-88.5º to -
68.2º) shown in Figure 6-7(b). The increase in phase was attributed to the increase in 
the movement of ions into the SAM surface. 
 
 
Figure 6-7 Phase vs. Frequency measured at different potentials after 
incubating the SAM surface with Adhiron myc binder 2.  
Shows the phase vs. frequency at different potentials of the SAM surface incubated in 
10 %g/mL Adhiron myc binder 2. (a) shows the phase vs. frequency plot in the 
frequency range of 0.1 - 0.3 Hz and (b) shows the phase at 0.1 Hz at different voltages 
ranging from -88.5 to -68.2º. 
 
Adding monoclonal anti-myc tag antibodies  
In order to compare the phase shift in between DC biases different concentrations of 
monoclonal anti–myc tag antibodies were added to the surface immobilised with 
Adhiron myc binder 2.  
The sensor was incubated in different concentrations of monoclonal anti-myc tag 
antibodies ranging from 30 nM to 60 nM for 15 min. The surface was subjected to 
four different DC biases against reference Ag/AgCl. Although the complete 
frequency scan of the response was taken in the range of 100 KHz to 50 mHz but the 
binding curve was plotted corresponding to the measurements taken at 0.1 Hz 
frequency.  
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Figure 6-8 Change in phase ("') measured at 0.1 Hz after incubating 
the sensor surface in different concentrations of monoclonal anti myc 
tag anti bodies at different voltages applied to the surface.  
Shows the change in phase (&') at 0.1 Hz at DC potentials 0, 0.05, 0.1 and 0.15 V vs. 
the reference (Ag/AgCl). The measurements were taken after incubation of the 
surface immobilised with 10 %g/mL Adhiron myc binder 2 in different concentrations 
of monoclonal anti-myc tag antibodies ranging from 30 to 60 nM. 
 
A comparison of the change in phase (&') at 0.1 Hz with respect to the initial phase 
measured in 10 mM PBS (pH 7.2) to the phase obtained after binding different 
concentrations of monoclonal anti-myc tag antibodies (30 nM to 60 nM) at various 
DC biases is shown in Figure 6-8. The phase shift at each concentration of anti-myc 
tag antibodies was measured with respect to the initial phase reading of the surface 
immobilised with Adhiron myc binder 2 in 10 mM PBS (pH 7.2).  
At each concentration, the change in phase (&') was increasing in the increasing 
order of the applied DC bias. At 0 and 0.05 V the sensor showed minimal response 
to all the three concentrations. The response increased at 0.1 V DC bias and was 
maximum at 0.15 V for all three concentrations of the monoclonal anti-myc tag 
antibodies. An increase in response on applying a higher DC bias could be related to 
the increase in the number of defects that increase the permeability of the surface to 
ions / water molecules thus showing higher phase shifts. 
 
6.4.1.5. Checking the reversibility of phase Adhiron myc binder 2 sensor  
In order to be sure that the response was due to the interaction of monoclonal 
anti-myc tag antibodies with Adhiron myc binder 2, buffer injections were done in 
between the injections of monoclonal anti-myc tag antibodies. Figure 6-9 shows the 
change in phase (&') at 0.1 Hz, when buffer injection was done after 100 nM and 
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after 300 nM concentration of monoclonal anti-myc tag antibodies. The complete 
solution was taken out and the sensor was incubated in fresh 10 mM PBS (pH 7.2) 
for 15 min. It was observed that with the buffer injections the phase was shifting 
back towards the original baseline. This was attributed to the fact that the 
dissociation constant of the interaction of Adhiron myc 2 binder and monoclonal 
anti myc-tag antibodies was quite high (140±10 nM) as observed in the SPR data 
(see section 5.4.2) therefore on incubation of the surface in buffer, the equilibrium 
shifts and the phase observed corresponds to the initial phase when no antibodies 
were added. A constant shift in baseline was observed in this case. This was because 
in this experiment the sensor surface was washed after taking each measurement, 
which could change the arrangement of the PEG-SAM. In the following experiments 
the analytes were added in a cumulative way avoiding the rinsing steps in between.   
 
 
Figure 6-9 Regeneration of sensor surface on incubating in 10 mM 
PBS, pH 7.2. 
Shows the change in phase (&') at 0.1 Hz at 0.1 V DC bias applied to the surface 
against the reference (Ag/AgCl). The phase obtained when the surface is incubated in 
100 nM and 300 nM restores back to the phase obtained when incubated in 10 mM 
PBS (pH 7.2). 
 
6.4.1.6. Voltage induced sensitivity using Adhiron IL8 binder 
After observing an increase in the response of the Adhiron myc binder 2 biosensor 
for detecting monoclonal anti-myc tag antibodies, the voltage induced sensitivity 
was further applied to an Adhiron IL8 binder based impedimetric biosensor. The 
biosensor was developed to detect interleukin 8 protein (IL8). The sensitivity 
improvement of this biosensor for the detection of IL8 protein was more relevant 
clinically as it is an important biomarker for different diseases (see section 6.1).  
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The following section discuses the effect of higher DC bias on the sensitivity of an 
Adhiron IL8 biosensor. 
 
Immobilisation of IL8 binder on the sensor surface. 
Adhiron IL8 binder was immobilised on the SAM derivatised surface using 
NHS-EDC chemistry. The measurements were taken at 0V DC bias applied to the 
surface against the reference (Ag/AgCl).   
Figure 6-10 shows the change in phase before and after the incubation of 10 %g/mL 
Adhiron IL8 binder on the surface in the frequency range of 100 kHz to 50 mHz. A 
phase change from -80.5º before immobilisation to -83.4º after 10 %g/mL Adhiron 
IL8 binder immobilisation was observed at 0.1 Hz (shown with an arrow) 
(Figure 6-10(b)). The change in phase showing a less non-faradaic movement of 
ions in the lower frequency range shows the formation of a more packed SAM that 
does not allow ions to permeate through it.  
 
 
Figure 6-10 Change in phase vs. Frequency before and after incubation 
of 10 !g/ml of Adhiron IL8 binder. 
Shows the Bode plot depicting change in phase vs. frequency range (a) 100 kHz to 
50 mHz and (b) 0.1 to 0.3 Hz before and after the incubation of gold surface in 10 
%g/mL Adhiron IL8 binder. The phase changes from -80.5º to -83.4º at 0.1 Hz (shown 
by an arrow). 
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Checking surface stability after immobilisation of Adhiron IL8 binder 
After the immobilisation of Adhiron IL8 binder on the SAM containing gold 
surface, stability of the sensor surface was checked in 10 mM phosphate buffer, 
pH 7.2, before adding different concentrations of IL8 protein.  
The surface was incubated in 10 mM PB (pH 7.2) without adding the IL8 protein. 
The measurements were taken after every 15 min for 5 subsequent buffer 
incubations at 0, 0.04, 0.08 and 0.12 V DC bias against the reference (Ag/AgCl).  
Figure 6-11 shows the phase of the surface plotted against 0.1 Hz frequency at 0, 
0.04, 0.08 and 0.12 V DC bias. The change in phase observed increased with the 
increase in the DC bias that was corresponding to the increase in defects with the 
increase in DC bias.  
At 0 V the overall phase change observed in the five subsequent buffer incubations 
was ± 0.3º. Similarly for 0.04, 0.08 and 0.12 V the observed phase change was 
±0.3º, ±0.4º and ±0.5º respectively as shown in Figure 6-11 (b). This range of 
change in phase observed was kept as the baseline drift corresponding to each DC 
voltage for the IL8 biosensor.  
 
 
Figure 6-11 Stability check of the SAM immobilised surface at different 
potentials.  
Shows phase of a surface after immobilisation of 10 %g/mL Adhiron IL8 binder in 
five subsequent incubations in 10 mM PB (pH 7.2). The Adhiron IL8 binder was 
immobilised on a gold electrode modified with SAM. (a) The measurements were 
taken at 0.1 Hz at 0, 0.04, 0.08 and 0.12 V DC bias applied to the surface vs. reference 
(Ag/AgCl). (b) The overall phase change observed in the five subsequent buffer 
incubations for the Adhiron IL8 sensor.  
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Adding different concentrations of IL8 protein 
The gold surface containing SAM immobilised with Adhiron IL8 binder showed 
drift in the baseline over five subsequent buffer incubations corresponding to each 
voltage (0, 0.04, 0.08 and 0.12 V). The phase change observed over five subsequent 
buffer incubations was considered as the baseline drift. The above mentioned 
voltages were then used to check the change in sensitivity of the sensor against 
different concentrations of IL8 protein, keeping in consideration the baseline drift. 
For checking the phase response (0.1 Hz) to different concentrations of IL8 protein 
at different DC potentials i.e. 0, 0.04 and 0.08 V vs. reference (AgCl) three different 
surfaces immobilised with Adhiron IL8 binder were used respectively. Before 
injecting the IL8 protein concentration on to the surface immobilised with 10 %g/mL 
Adhiron IL8 binder, a baseline was established by incubating the surface in 10 mM 
PB (pH 7.2) for 15 min. Then the different concentrations of IL8 protein ranging 
from 0.1 pM to 106  pM were added in a cumulative way (see section 5.4.3.4).  
After injecting the first concentration of IL8 protein (0.1 pM), a measurement was 
done at 3 min and then 15 min of incubation. The measurement of phase after 3 min 
of injecting the first concentration of IL8 protein was done to take into consideration 
the change in the baseline (phase shift) due to addition of IL8 protein that changes 
the interfacial environment and causes a transition in baseline.  
Figure 6-12 shows the phase vs. frequency profiles of Adhiron IL8 immobilised 
surfaces subjected to three different voltages 0 V(a), 0.04 V(b) and 0.08 V(c).  A 
decrease in phase was observed after 3 min incubation in 0.1pM IL8 protein 
concentration for each DC bias. The initial decrease in phase could be due to the 
change in the dielectric properties of the interfacial surface that causes 
conformational changes in the SAM impeding the movement of ions. This effect is 
more prominently observed in the sensor surface subjected to 0.08 V DC bias. 
The measurement of phase at 0.1 Hz after 15 min of incubation of the first 
concentration of IL8 protein did not show any change in case of 0 V and showed a 
phase shift of less than 0.1º in case of 0.04 V DC bias. A less than 0.1º shift could 
not be considered a response to the IL8 protein concentration because the baseline 
shift in buffer for 0.04 V DC bias was ' ±0.3º (Figure 6-11). In case of sensor 
subjected to 0.08 V DC bias, the phase shift was 2º that was attributed to the 
increased sensitivity of the surface due to higher DC potential applied to the surface.  
The change in the phase from 3 min incubation to 15 min incubation was an 
interesting feature. It was more likely due to the flexible –COOH-PEG that causes 
some rearrangemnt in the SAM initially and then reaches a stable arrangement. 
174 
 
 
The response was linear for IL8 protein concentrations from 0.1 pM to 104 pM 
(10 nM). On incubating the surface in 106 pM (1 %M) concentration of IL8 protein, 
the phase decreases. This phenomenon was observed in IL8 based sensors after a 
saturation was reached (data not shown). This could be attributed to the increase in 
the number of IL8 protein molecules bound to the sensor surface that change 
interfacial properties and impede the movement of ions / water molecules.  
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Figure 6-12 Response of the Adhiron IL8 biosensors to different 
concentrations of the IL8 protein at different potentials.  
Shows the phase response of different SAM derivatised gold surfaces immobilised 
with 10 %g/mL Adhiron IL8 binder against different concentrations of IL8 protein. 
The measurements were done after incubating the surfaces in 10 mM PB (pH 7.2) for 
15 min, concentration of 0.1 pM IL8 protein for 3 min and then 15 min for each 
concentration of IL8 protein (0.1 pM to 106 pM). The DC bias applied against 
reference Ag/AgCl was (a) 0 V, (b) 0.04 V and (c) 0.08 V. 
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6.4.1.7. Limitations of the current set-up 
The main limitation of the Adhrion based IL8 biosensor based experiments was the 
non-reproducibility of the results on different sensors corresponding to the same 
voltage. The phase shift observed on addition of first concentration of IL8 protein 
was different on different sensors when subjected to the same DC potential. 
Figure 6-13 shows the variation in response to monoclonal anti-myc tag antibodies 
between two different sensor surfaces immobilised with 10 %g/mL Adhiron IL8 
binder. The change in phase (&') at 0.1 Hz, observed in case of sensor 1 after 
incubating the surface in 0.1 pM IL8 protein concentration was 1º whereas for 
sensor 2 was 2º. This inter-sensor variation could arise due to various reasons such 
as the difference in the number of IL8 binders immobilised on to the surface, the 
conformation of binders once immobilised on the surface, the handling of the sensor 
during the various steps involved from the cleaning of gold surface till the addition 
of IL8 protein.  
In order to avoid intersensor variations, same sensor was used to detect the binding 
of IL8 protein under different DC biases. 
 
 
Figure 6-13 Inter-sensor variation in response of the Adhiron IL8 
biosensor to the IL8 protein.  
Shows the change in phase (&') response of two different SAM derivatised gold 
surfaces, immobilised with 10 %g/mL Adhiron IL8 binder, on adding different 
concentrations of IL8 protein. The measurements were taken after incubating the 
surfaces in 10 mM PB (pH 7.2) for 15 min, 0.1 pM concentration of IL8 protein for 3 
min, 15 min followed by incubation in 10 pM concentration of IL8 protein for 15 min.  
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6.4.1.8. Checking change in sensitivity with different potentials on the same 
sensor. 
A SAM derivatised surface was used to immobilise 10 %g/mL Adhiron myc binders 
using EDC-NHS chemistry. The stability of the surface was checked in 10 mM PB 
(pH 7.2) by measuring the phase (at 0.1 Hz) of the surface subjected to increasing 
order of DC bias i.e. 0, 0.04 and 0.08 V. The surface was then incubated in different 
concentrations of IL8 protein.  
Figure 6-14 shows that that the response at 0 mV and 0.04 mV was negligible. 
Whereas the phase shift  at 0.08V and 0.12V (Appendix-Figure 1) was higher as 
compared to 0 and 0.04V but range of phase shift observed was similar to phase 
shifts obtained when buffer injections were done on the surface immobilised with 
Adhiron IL8 binder 5 (Figure 6-11). The phase shift observed in case of surface 
subjected to 0.08V DC bias was around -0.3º and in case of 0.12V was -0.35º. 
Taking the response in buffer injections into consideration, it can be said that there 
was no response detected by the sensor when incubated in IL8 protein. As the 
Adhiron IL8 binder was showing interaction with the IL8 protein on SPR (30mº 
shift) (data not shown) and when different surfaces were used for single DC biases 
applied (Figure 6-12, 6-13), there can be a possibility that the surface immobilised 
with Adhiron IL8 binder was affected by the range of different DC biases applied to 
the same surface affecting the conformation of the Adhiron IL8 binder or the IL8 
proteins. 
The effect of applying subsequent higher DC potential to the sensor immobilised 
with Adhiron IL8 binder needs to be further investigated.  
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Figure 6-14 Response of IL8 biosensor to IL8 protein on a surface 
subjected to different potentials. 
Figure shows the phase response of a SAM derivatised gold surface immobilised with 
10 %g/mL Adhiron IL8 binder at different concentrations of IL8 protein. The 
measurements were taken by subjecting the surface to different DC biases against 
reference electrode Ag / AgCl at 0.1 Hz. The DC biases applied were (a) 0 V, (b) 0.04 
V and (c) 0.08 V. 
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Conclusion 
This chapter aimed at increasing the sensitivity of the label-free impedimetric 
biosensor by tuning the DC potential applied to the surface. Initially the effect of DC 
bias on the surface of SAM was studied by applying different DC biases (0-0.4 V) to 
the surface vs. reference Ag/AgCl. It was demonstrated that the voltage was able to 
induce defects in the SAM surface and the defects were increasing as the applied DC 
voltage increased. This was monitered with the change in phase in the lower 
frequency range (0.1-0.3 Hz) that corresponded to the change in the dielectric 
properties of the interfacial layer whereas no significant change was observed in the 
higher frequency range (100 kHz - 50 mHz), indicating that the solution resistance 
was not affected by the applied DC bias.  
It was more likely that a higher DC bias changed the conformation of the flexible 
-COOH-PEG chain, grafted on to the hydrophobic alkyl chain and induced defects 
in the SAM that facilitated the penetration of water and ion molecules through the 
SAM. It has been observed that the change in the insulating properties of a SAM 
depends on its length as well as the terminal functional group (-X) attached to the 
SAM. More hydrophilic terminal group (-COOH) instead of hydrophobic group (–
CH3) leads to increased permeability of ions through the SAMs (Boubour and 
Lennox, 2000b). 
The reversibility of the defects on the surface was observed for a range of DC 
potentials (0-0.4 V), which indicated that the restoration of the surface was possible 
after subjecting the surface to different voltages. Also the defects could be induced 
without causing any permanent change to the surface. The reversibility of the effect 
needs to be studied with respect to time so as to know the time frame in which the 
sensor can be more effective.  
Initially to investigate the change in sensitivity of the sensor by increasing the DC 
potential induced defects, Adhiron myc binder 2 based sensor was used. It was 
observed that the sensitivity of the surface immobilised with Adhiron myc binder 2 
to detect the monoclonal anti-myc tag antibodies was increasing as the potential was 
increased in a defined range of DC potentials (0 V to 0.15 V). In case of Adhiron 
IL8 based biosensor, although the increase in sensitivity observed with the increase 
in DC potential was promising but it also showed inter sensor variations between 
different sensor surfaces subjected to same DC bias. This could be attributed to 
various factors involved like the variability of the immobilisation of SAM on the 
gold surface, immobilisation of the Adhiron based binders on the surface, changes 
taking place on the surface with time as there were various steps involved in 
between (Bart et al., 2005). The inter sensor variations involving various factors was 
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an important limitation in the study of DC bias induced sensitivity and needed 
further investigation.  
Using the same sensor surface (subjected to different DC biases) for checking the 
change in sensitivity of the Adhiron IL8 binder based sensor, was not successful. 
The DC potentials applied to the surface could be affecting the conformation of the 
biological recognition layer. Although the stability of the SAM subjected to 
subsequent DC potentials was estalished but the effect of different DC potentials on 
the biological layer formed by Adhiron IL8 binder has not been studied in details. 
The conformational stability of Adhiron IL8 binder on applying different potentials 
needs to be investigated in more details. 
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Chapter 7. Conclusions  
 
Biosensors have been an important tool of diagnostics. The performance of a 
biosensor is strongly dependent on the biological layer that interacts with the analyte 
or the biomarkers and the transducer surface that converts the detection of binding 
into an electronic signal. Despite this the majority of the work aimed at improving 
the detection sensitivity, speed and reduction of signal / noise ratio has been done on 
the electrical part of the biosensors. But the role of the biological recognition 
molecules is equally important, as they are the ones that bind the analyte molecules.  
The affinity of the biological molecules to the analytes, specificity in binding, the 
stability of the biological recognition molecules affect the over all performance of 
the biosensor. Thus, the aim of this project was to study alternative biomolecular 
recognition molecules other than the commonly used antibodies, and to investigate 
the performance of label-free biosensors based on such anti-body mimetics. 
To achieve this aim amongst the various biological recognition molecules available 
like antibodies, nucleic acid aptamers, molecular imprinted polymers etc, a class of 
biological recognition molecules was selected called peptide aptamers. Peptide 
aptamers are defined as ‘combinatorial protein molecule consisting of a variable 
peptidic sequence inserted within a constant scaffold protein’ (Baines, 2006). 
Peptide aptamers unlike their naturally occurring antibodies counterparts are smaller 
and structurally less complex, devoid of disulphide bonds and post-translational 
modifications. Such properties exhibited by peptide aptamers make them suitable for 
the in vitro production.  
A novel peptide scaffold based on phytocystatin protein, was developed by the 
McPherson group at the Astbury Centre for Structural Molecular Biology at the 
University of Leeds. This newly developed peptide scaffold is called Adhiron. 
Adhirons were designed according to a consensus protein design strategy, which 
involves designing the protein on the basis of sequence alignment of a number of 
other proteins that fold into the same structure. This strategy has been successful in 
developing proteins with more stability as compared to the other counterparts. 
Adhiron consists of a four-strand anti-parallel "-sheet core and a central helix. It has 
two loops, one positioned between the first and the second b-strand, and the second 
between third and fourth b-strand.  
An Adhiron-based set of binders against the myc epitope (EQKLISEEDL) was 
selected using a phage display library by the Bioscreening Technology Group 
(BSTG), University of Leeds. Ten Adhiron-based myc binders against the anti-myc 
tag antibodies were initially selected for this project to develop the biological 
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recognition layer of an impedimetric biosensor. All the binders were successfully 
cloned into pET 11(a) expression vector. Expression and purification of Adhiron-
based binders was optimised and the binders were expressed at high yields. The 
yield of each purified myc binders in soluble form ranged from 4-8 mg and the 
molecular weight of the binders ranged from 11-14 kDa. The different molecular 
weight of binders was attributed to difference in the amino acid sequences in the 
variable regions of the Adhiron scaffold. Additional bands were observed at a higher 
molecular weight (24-25 kDa) that corresponded to dimerised Adhiron myc binders. 
The formation of dimers can hamper the use of Adhiron myc binders in detection 
assays. To eliminate dimerised Adhiron myc binders contamination, the expressed 
binders were purified using standard techniques. The purified and characterised 
Adhiron myc binders were soluble proteins with well defined structural properties 
("-helical and !-sheet structures) and high thermal stability. The melting 
temperature of the Adhiron scaffold and Adhiron binder 2 were 101 ºC and 85 ºC, 
respectively. The high thermal stability of Adhiron scaffold can be  attributed to the 
consensus protein design of the scaffold. On the basis of ELISA, done against the 
monoclonal anti-myc tag antibodies, Adhiron myc binder 2 was selected to form the 
biological recognition layer for the detection of monoclonal anti-myc tag antibodies 
on an impedimetric biosensor. The empty Adhiron scaffold did not show any 
binding to monoclonal anti-myc tag antibodies. The difference in binding efficiency 
of the Adhiron myc binders was attributed to the variability in amino acid sequences 
in the three variable loops. Adhiron myc binder 2 contained the sequences similar to 
myc epitope at the N-terminus of the scaffold. This provides more flexibility to 
Adhiron myc binder 2 to bind the monoclonal anti myc tag antibodies. Although the 
N-terminus of Adhiron myc binder 1 as well as 11 were also showing similarity to 
myc epitope sequences they did not show binding to monoclonal anti-myc tag 
antibodies. This reflects the possibility of involvement of other loops and the 
Adhiron scaffold in the binding.  SPR results showed that the KD value of Adhiron 
myc binder 2 was 140±10 nM with a high dissociation rate. 
The Adhiron myc binder 2 was then used for forming the biological layer of label-
free impedimetric biosensor. A self assembled monolayer 
(SH-(CH2)11-(EG)3-OCH2-COOH) was formed on a gold surface. It was observed 
that the formation of SAM decreased the electron transfer and formed a highly 
insulating SAM layer. The impedimetric measurements were based on the phase 
change observed for the electrochemical impedance at 0.1 Hz when a DC bias was 
applied to the working electrode surface.  
The PEG-SAM formed on the gold surface showed instability when incubated in 
10 mM PBS (pH 7.2). This could be attributed to the reorganisation of the 
polyethylene chain as it is conformationally more flexible than the hydrocarbon 
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chain on which it is grafted. A methodology to stabilise the sensor before use was 
developed by the Bioelectronics Group at the university of Leeds. The methodology 
used potential tuning of the surface by applying a 0.2 V DC bias to the working 
electrode against the reference electrode Ag/AgCl over 15 cycles and demonstrated 
to lead to highly stable sensor surface.  
The Adhiron myc binder 2 was grafted onto the SAM via amine coupling. The 
interface formed by Adhiron myc binder 2 on the SAM was a highly insulting layer 
that was important in formation of a sensitive impedimetric biosensor. The lowest 
concentration of monoclonal anti-myc tag antibodies detected after immobilisation 
of Adhiron myc binder 2 on the surface was 0.1 nM and the detection was done over 
3 orders of magnitude. Different concentrations of the monoclonal anti-myc tag 
antibodies, over a range of 0.1-200 nM, were successfully detected. The fabricated 
Adhiron myc binder 2 based impedimetric sensor showed high sensitivity to the 
monoclonal anti myc tag antibodies. Due to high KD of binding of Adhiron myc 
binder 2 to monoclonal anti-myc tag antibodies, the detection of binding was 
observed at a high concentration of 200 nM whereas with the highly sensitive 
impedimetric biosensor, concentration of monoclonal anti-myc tag antibodies as low 
as 0.1 nM was detected.  
A cumulative method of adding different concentrations of monoclonal anti-myc tag 
antibodies to the sensor surface was used to avoid any disturbance on the interfacial 
surface caused due to rinsing of the surface in between the measurements. The 
response was lower as compared to the previous methodology. This could be 
because the number of binding sites were decreasing with each new concentration of 
monoclonal anti-myc tag antibodies being added.  
One of the limitations of the sensor surface was the inter-sensor variation observed 
during the measurement of response on different sensors. The behaviour of inter-
sensor variation was observed by other groups as well (Berggren, 1998). The 
variations in response on different sensors could be due to difference in SAM 
formation, density of adhiron myc binders on the surface, handling errors etc. The 
unpredictable orientation of Adhiron myc binder 2 on the surface (via amine 
coupling) could lead to unavailability of the monoclonal antibody binding site.  
The change in sensitivity on applying different DC biases to the surface against the 
reference electrode was investigated. Finite DC biases could be used to induce 
defects in the SAM. These defects were reversible and were attributed to the 
conformational changes in the flexible acidic chain attached to the hydrophobic 
alkyl chain of SAM. The effect of applying different DC biases on the sensitivity of 
the biosensor was investigated using the Adhiron myc binder 2 as the biological 
recognition molecule to detect the monoclonal anti-myc tag antibodies. The 
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sensitivity of the Adhiron myc binder biosensor increased as increasing DC biases 
were applied to the surface.  
The change in sensitivity was further investigated in a clinically relevant biosensor 
based on Adhiron IL8 binder for detection of IL8 protein, used as a biomarker for 
diagnosis of various clinical conditions. Initially, IL8 sensors showed increased 
sensitivity on sensor surfaces subjected to higher DC bias. But significant inter-
sensor variations were observed between independently prepared sensor surfaces 
subjected to the same DC bias.  This requires to investigate more into the variations 
observed at the surface which might be due to effect of different DC biases on the 
conformational of the biological recognition layer. 
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Appendix 
 
Component g/L % (w/v) 
NaCl 10 1.0 
Yeast extract 5 0.5 
Bactotryptose (tryptone) 10 1.0 
Table 1. Composition of Luria-Burtani broth. 
The components were dissolved in ( volume of deionised water and the pH was 
adjusted to 7.2 with 1 M sodium hydroxide (NaOH) solution. The final volume was 
made up using dd water. The media was autoclaved at 121 ºC, 15 psi for 20 min to 
sterilise and stored at room temperature. 
 
Component g/L Molarity (M) 
NH4Cl 53.5g 1  
Na2SO4 33.3g 0.5  
KH2PO4 68.0g 0.5  
Na2HPO4 471.0g 0.5  
Table 2. The composition of 20 X NPSC. 
The components were dissolved in ( volume of deionised water and the pH was 
adjusted to 6.75 with 1 M sodium hydroxide (NaOH) solution. The final volume was 
made up using dd water. The media was autoclaved at 121 ºC, 15 psi for 20 min to 
sterilise and stored at room temperature. 
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Component g/L Molarity (mM) 
FeSO4.7H2O 1.001  3.6 
ZnSO4.7H2O 8.626  30 
CuSO4.5H2O 0.375  1.5 
MnSO4.4H2O 0.118  0.7 
Na2B4O7.10H2O 0.114  0.3 
(NH4)6MO7O24.4H2O 0.049  0.04 
Table 3. The composition of trace elements.  
Salts were added to 240 mL deionised water. 0.2 mL concentrated HCl was directly 
assed on to the salt crystals to dissolve them. The volume was made up to 1 L using 
deionised water and the solution was filter sterlised through 0.22 %m filter. 
 
Component Volume (mL) 
ZY component 930 
1 M MgSO4 2 
40 % glucose 20 
20X NPSC 50 
Trace elements 1 
Total 1000 
Table 4. The composition ZYP-0.8G Media. 
 
Antibiotics Concentration  
(mg/mL) 
Storage Working 
Concentration (!g/mL)  
Carbenicilin 50  -20ºC 50  
Kanamycin 50  -20ºC 50 
Chloramphenicol 25 -20ºC 50  
Table 5. Bacterial antibiotic selection. 
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Component  
TRIS base 242 g 
Glacial Acetic acid 57.1 mL 
0.5 M EDTA 100 mL 
Table 6. Composition of TAE (50 X) stock solution. 
The components were dissolved in deionised water. The volume was made up to 1 L 
and the pH was ~8.1. 
 
Component g/100 mL (in deionised water) 
0.15 % (w/v) Orange G 0.15 
60 mM EDTA 2.23 
Glycerol 60 % (w/v) 
10 mM TRIS-HCl (pH 7.5) 0.12 
0.02 % (w/v) SDS 0.02 
Table 7. Composition of 10 X gel loading buffer. 
 
Component Volume (!l) 
Buffer 4 2 
1/10 BSA 2  
Restriction enzyme 1 0.5  
Restriction enzyme 2 0.5  
DNA (Plasmid) 5  
Sterile deionised water to final volume 40  
Table 8. Restriction enzyme double digestion mixture. 
The digestion mixture was incubated at 37 ºC for 1 hr. 
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Table 9. The KOD Hot Polymerase mix for PCR reaction.  
 
 
Component Volume (!l) Concentration 
5 X Phusion buffer 10 1 X 
10 mM dNTPs 1 200 !M 
Template DNA 0.5 <250 ng 
5’ primer (10 !M) 2.5 0.5 !M 
3’ primer (10 !M) 2.5 0.5 !M 
DMSO 1.5 3 % 
Phusion DNA polymerase 0.5 1 u/50 !l 
PCR grade water to final volume 50  
Table 10. Composition of Phusion DNA polymerase mix.  
 
 
 
Component Volume (!l) Final concentration 
10X buffer for KOD 5 1 X 
25mM MgSO4 3 1.5 mM 
dNTPs 5 0.2 mM 
Template DNA 5 <250 ng 
5’ primer  1.5 0.3 !M 
3’ primer  1.5 0.3 !M 
KOD Hot Start DNA Polymerase 1 0.02 U/!l 
PCR grade water to final volume 50  
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Step Time Temperature (ºC) 
Activation 2 min 95 
Denature 30 sec 95 
Annealing 30 sec 55 
Extension 1 min/kb 72 
Final extension 5 min 72 
Hold - 4 
Table 11. PCR amplification cycle using MJResearch Thermal Cycler. 
 
 Vector + Insert (!l) 
Experimental 
ligation 
Vector alone (!l) 
Background 
ligation 
10 X Ligase buffer 4 4 
Insert  6 - 
Vector 4 4 
Ligase enzymes (1 U/!L) 1 1 
Deionised water to final volume 20 20 
Table 12. Composition of ligation mixture using T7 DNA ligase. 
 
 Temperature Time (min) 
Nde I 65 ºC 20 
Nhe I-HF 80 ºC 20 
Not I-HF 65 ºC 20 
Bam HI-HF - - 
Table 13. Heat deactivation temperature for restriction enzymes. 
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 Volume  (!l) 
PCR blunt vector  0.5 
T4 DNA Ligase buffer 1 
PCR product 5 
Deionised water to final volume 10 
Table 14. The Zero blunt PCR cloning mixture. 
 
 
 
Table 15. Composition of GoTaq Green master mix for PCR. 
Step Time Temperature (ºC) 
Activation 2 min 95 
Denature 30 sec 95 
Annealing 30 sec 55 
Extension 1 min/kb 72 
Final extension 5 min 72 
Hold - 4 
Table 16. Thermocycling conditions for PCR using GoTaq Green 
master mix. 
 
Component Volume (!l) Final concentration 
5 X Green GoTaq Buffer 10 1 X 
25mM MgCl2 10 1.5 mM 
dNTPs 1 0.2 mM 
Template DNA 5 <250 ng 
5’ primer (10 !M) 1.5 0.3 !M 
3’ primer (10 !M) 1.5 0.3 !M 
GoTaq DNA Polymerase 0.25 1.25 u/50!l 
PCR grade water to final volume 50  
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Component  
Sucrose 25 % (w/v)  
MgCl2 5 mM 
Triton X100 1% (v/v) 
HEPES 50 mM 
Table 17. Composition of lysis buffer. 
The pH of the lysis buffer was adjusted to 8.0 with 5 M NaOH and filter sterlised 
through 0.2 %m filter. A 10 mg/ml stock of lysozyme was prepared, aliquoted and 
stored at -20 ºC. 10 U/L of omnicleave endonuclease (Epicenter) and 0.1 mg/ml 
lysozyme were added to the lysis buffer just before use. 
 
 
 g/L Molarity (mM) 
HEPES (pH 7.5) 11.92 50 
NaCl 11.6 200 
Imidazole 340.4 5 
Table 18. Composition of binding buffer. 
 
 
 g/L Molarity (mM) 
HEPES  (pH 7.5) 11.92 50 
NaCl 11.6 200 
Imidazole 2.7 40 
Table 19. Composition of wash buffer. 
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 g/L Molarity (mM) 
HEPES  (pH 7.5) 11.92 50 
NaCl 11.6 200 
Imidazole 34.04 500 
Table 20. Composition of elution buffer. 
 
 g/l Molarity (mM) 
HEPES  (pH 7.5) 11.92 50 
NaCl 29.2 500 
EDTA 18.6 50 
Table 21. Composition of stripping buffer. 
 
Component Concentration (mM) 
NaCl 136.8 
KCl 2.7 
Na2HPO4 10.1 
KH2PO4 1.7 
Table 22. Composition of 1 X PBS (phosphate buffer saline). 
 
 Volume (mL)  Final concentration  
20% SDS 2  2 % 
1M Tris-HCl (pH7) 1 50 mM 
Glycerol 1 5 % 
Mercaptoethanol 1 5 % 
Table 23. Composition of 4 X Sample buffer used for loading proteins. 
Few grains of bromophenol blue were added to the prepared buffer. Before use, 1/3 
sample volume of mercaptoethanol was added to each and boiled for 2 min. 
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 TRIS SDS 
(0.4%) 
pH 
Gel buffer (GB) 100 ml 18.5 g (1.5 M) 0.4 g  8.9 
Stacking gel buffer (SGB) 100 ml  5.1 g  (0.4 M) 0.4 g  6.7 
Table 24. Composition of gel buffer and stacking gel. 
 
 
 
 
Table 25. Gel composition used for polyacrylamide gel electrophoresis. 
 
 g/L Final concentration 
Tris 30  0.25 M 
Glycine 144 1.91 M 
SDS 10 1 % 
Table 26. Composition of 10 X running buffer.  
The pH was adjusted to 8.3 and the solution was stored at 4 ºC. 
 
 
 Separating gel  
Volume (mL)  
Stacking gel  
Volume (mL) 
GB 1.2 - 
SGB - 0.6 
30 % Acrylamide stock 2.6 0.4 
H20 1.2 1.4 
APS (25 % w/v) 0.03 0.02 
TEMED 0.003 0.002 
Total 5 2.4 
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Component Volume (mL)  Final concentration                  
(%) 
Isopropanol 250 25 
Acetic acid 100 10 
Deionised water to final volume 1000  
Table 27. Composition of Coomassie blue staining solution. 
2.5 g (0.25 %) Coomassie blue 250 was added to the above prepared solution and 
stirred on a stir plate.  
 
Component Volume 
(mL)  
Final Concentration 
(%) 
Ethanol  250  25 
Acetic acid  75  7.5 
Deionised water to final volume 1000  
Table 28. Composition of Destaining solution. 
 
Component g/ 100mL Final concentration (M) 
Tris 0.6 0.05 
NaCl 1.75  0.3 
GuHCl 76.43 8  
 
Table 29. Composition of Dot Blot Solubilisation buffer. 
The solutions were prepared in deionised water. The pH was adjusted to 8.0 with 5 
M HCl. The solution was filter sterilised through 0.2 %m filter and stored at room 
temperature. 
 
Component Concentration 
Tris 0.1 M 
Glycine 0.192 M 
Methanol 20 % (w/v) 
Table 30. Composition of 1 X Transfer buffer. 
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 Number of 
amino 
acids 
Molecular 
weight 
(kDa) 
Theoretical   
Isoelectric 
point (pI) 
Extinction  
Coefficient  
(M-1cm1) 
Adhiron 107 12.109 6.75 1.278 
Adhiron myc 
binder 1 
122 13.8 5.77 0.720 
Adhiron myc 
binder 2 
122 14.08 6.25 1.098 
Adhiron myc 
binder 4 
122 14.05 6.25 0.709 
Adhiron myc 
binder 5 
122 13.9 7.21 1.502 
Adhiron myc 
binder 7 
122 14.07 6.49 0.920 
Adhiron myc 
binder 11 
122 14.02 6.54 1.220 
Adhiron myc 
binder 13 
122 14.2 6.8 1.193 
Adhiron myc 
binder 17 
122 14.02 6.87 0.817 
Adhiron myc 
binder 18 
122 14.2 6.75 1.293 
Adhiron myc 
binder 20 
122 14.2 6.58 1.342 
Table 31. Theoretical molecular weights of the Adhiron myc binders. 
(The values were obtained using online ExPaSy ProtParam tool).  
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Figure 1. Response of IL8 biosensor to IL8 protein on a surface 
subjected to 0.12 V. 
Shows the phase response of SAM derivatised gold surface immobilised with 10 
%g/mL Adhiron IL8 binder against different concentrations of IL8 protein. The 
measurements were done after incubating the surface in different concentration of IL8 
protein (10-100 pM). The DC bias applied against reference Ag/AgCl was 0.12 V. 
 
